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Abstract 
Despite tremendous progress in biological understanding of metabolic diseases and development 
of novel imaging techniques over the past several decades, clinical assessments and epidemiological 
studies for metabolic disease are largely limited to simple surrogate measurements such as body mass 
index. Recent advances in dual-energy X-ray absorptiometry (DXA) and 3D optical surface scanning 
have enabled new opportunities for integrative and clinically-accessible metabolic health assessment. 
The focus of this dissertation was to develop novel 3D and DXA imaging methods for detailed 
metabolic risk assessment that are fast, safe, and accessible. This work centered on the hypothesis 
that detailed descriptors of body shape and compositional distribution of tissues throughout the 
body better reflect health risk than currently-used metrics.  
I present derivation of high-resolution quantitative fat, lean, and bone images from DXA, and 
describe statistical appearance models of these images that can be used to accurately predict 
metabolic syndrome and diabetes status across ethnicities. I demonstrate clinically-viable body 
composition estimation from commercial 3D optical body scans using traditional anthropometric 
measurements, then improved accuracy and precision using more detailed 3D statistical shape 
models that efficiently capture 95% of body shape variance. Finally, I describe integrative methods 
including a combination DXA and bioelectrical impedance technique to provide rapid, accurate, and 
precise four-component (4C) body composition. 4C assessment is useful for monitoring of many 
metabolic conditions including over/de-hydration, malnutrition, obesity, and sarcopenia, and this 
technique enables practical implementation in the clinic. 
vi 
These works collectively provide new tools to researchers, clinicians, and even individuals 
around the world to assess metabolic status and track, visualize, and predict personalized body 
changes towards improved health. 
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1 | Background 
1.1: Motivation: The Burden of Metabolic Disorders 
Obesity is a global epidemic that affects 650 million adults worldwide [1]. Characterized by an 
excess of adipose tissue in the body, obesity is significantly associated with a host of diseases such as 
diabetes, heart disease, and stroke, and responsible for some 2.8 million deaths annually [2]. Despite 
significant research, education, and policy efforts, obesity prevalence continues to rise around the 
world, with particularly stunning increases in children [3], [4]. Obesity is estimated to cause 
approximately 4% of cancers in men and 10% of cancers in women [5]. As of 2008, medical costs 
associated with obesity were estimated at a staggering $147 billion [6]. By 2030, it is estimated that 
50% of American adults will be obese [7], and related medical costs will account for 18% of all US 
healthcare expenditures [8]. 
There are several contributors the rise of the obesity epidemic. At a basic level, fat accumulation 
occurs with a net positive energy balance, where calories consumed but not expended are stored in 
adipose tissues [9]. At a societal level, the proliferation of inexpensive, energy-dense, and often sugary 
foods coupled with general trends towards physical inactivity and increasingly sedentary lifestyles are 
highly conducive to obesity [10]. There is increasing evidence that gut microflora, genetics, 
epigenetics, sleep patterns, and a variety of other factors may contribute to obesity [11]. Whatever 
the case, it is clear that significant work must be done to curb and reverse the obesity crisis. 
Obesity is defined as an abnormal and excessive accumulation of fat tissue, but it is an indicator 
of complex underlying metabolic imbalances. In practice, obesity is classified using the crude metric 
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of body mass index (BMI) that is only a surrogate for body fatness. BMI fails to account for actual 
differences in fat and lean tissue [12], and its generalizability to people of different ages and 
ethnicities has been shown to be limited without statistical adjustments [13]–[15]. Nonetheless, 
BMI and similarly simple metrics such as waist circumference remain the primary tools broadly 
available in clinical practice and epidemiological research. There is clear opportunity and need for 
more sophisticated yet accessible tools for metabolic health assessment. The focus of this dissertation 
research was to develop novel tools and techniques for accurate and precise metabolic health 
assessment that can be readily implemented in clinical and population research settings. 
In the following sections of this chapter, several prominent metabolic disorders will be detailed, 
along with a discussion of clinical tools for diagnosis and management. 
1.2: Metabolic Syndrome 
Broadly, metabolism refers to the conversion of energy through various chemical 
transformations to sustain life. Human metabolic disorders, then, are dysfunctions somewhere in the 
complex biochemical processes, tissues, and systems that extract energy from nutrient intake. Several 
different measurable biomarkers of metabolism have been identified as significant risk factors for 
diseases such as diabetes, heart disease, and stroke, which ultimately lead to decreased quality of life 
and early death. 
Metabolic Syndrome (MetS) has been defined using a particular set of risk factors that directly 
promote disease: abdominal obesity, hypertension, hyperglycemia, and dyslipidemia. Several 
organizations such as the International Diabetes Foundation, the World Health Organization, and 
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the American Heart Association have offered various guidelines for specific diagnosis of MetS [16], 
[17]. The consensus National Cholesterol Education Program and American Heart Association 
guidelines [17], [18] classify MetS as the presence of three or more of the following: 
 Abdominal adiposity: waist circumference >40 inches (men) or > 35 inches (women) 
 Elevated blood pressure: > 130/85 mm Hg, or medication 
 Elevated fasting glucose: ≥ 100 mg/dL, or medication  
 Elevated serum triglycerides: >150 mg/dL, or medication  
 Reduced HDL cholesterol: <40 mg/dL (men) or <50 mg/dL (women), or medication 
Metabolic syndrome represents a clustering of endogenous risk factors associated with obesity, 
atherosclerotic cardiovascular diseases, and diabetes, and conducive to inflammation and thrombosis. 
The particular manifestations of MetS are known to vary among individuals, particularly across 
different ethnicities [18]. Ongoing research is being performed to determine appropriate therapeutic 
strategies for individuals with MetS. 
1.3: Diabetes 
Diabetes mellitus is a metabolic disease estimated to affect 422 million adults worldwide and 
cause 1.6 million deaths annually. The disease is characterized by chronically elevated glucose in the 
blood, generally resulting from either insufficient insulin production by the pancreas (Type I 
diabetes, T1DM), or a developed resistance to insulin (Type II diabetes, T2DM).  In either case, 
elevated blood sugar for prolonged periods of time can lead to a host of systemic issues including 
heart disease, kidney failure, loss of vision, and nerve damage [19].  
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Clinical diagnosis of diabetes, as defined by the World Health Organization, requires one of the 
following positive tests: 
 Fasting plasma glucose ≥ 126 mg/dL 
 2-hour plasma glucose ≥ 200 mg/dL 
 HbA1c ≥ 6.5% 
Fasting glucose indicates a baseline blood sugar level long after a meal, while a 2-hour glucose 
test indicates the body’s ability to respond to glucose load. The fasting glucose cut-point of 126 
mg/dL was identified as a threshold for specific micro-vascular complications such as retinopathy, 
but systemic risks increase even at lower sustained fasting glucose levels. Glycated hemoglobin 
(HbA1c) is a more long-term indicator of blood glucose levels that is insensitive to immediate fasting 
state. Compared to plasma glucose levels, HbA1c has been shown to be a stronger predictor of 
cardiovascular disease and death [20]. 
Type II diabetes, formerly known as “adult-onset diabetes” represents 90% of all diabetes cases. 
Overweight and obesity are the strongest known risk factors for T2DM, and the rise of the 
childhood obesity epidemic has resulted in a concurrent rise in childhood T2DM that has rendered 
the “adult-onset” label inaccurate. Prevalence of T2DM has shown particular growth in low- and 
low-middle income countries. In the Eastern Mediterranean region, prevalence of diabetes increased 
from 5.9% in 1980 to a whopping 13.7% in 2014 [21]. Trends in physical activity and food 
availability – particularly the growth of inexpensive, calorie-dense sugary and fatty foods – have 
created conditions highly conducive to obesity and diabetes. 
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There are several ongoing efforts to curb the rise and effects of diabetes. At the individual level, 
people living with diabetes must regularly monitor their blood sugar levels, commonly using finger 
prick blood tests throughout the day. Health education and lifestyle counseling, targeted at 
improved diet and activity patterns, as well as medications such as insulin or hypoglycemic agents are 
the direct methods for diabetes treatment. Integrated treatment to target associated risk factors such 
as high blood pressure include other medications such as diuretics and ACE inhibitors [22]. More 
drastic treatments such as bariatric surgery to reduce energy intake have been shown to be effective 
for combating severe obesity-related T2DM [23]. At the population and public health level, 
educational programs to increase awareness about healthy lifestyles and diabetes risks, as well as 
regulatory measures to limit food high in sugars, fats, and salt are core efforts to combat diabetes. 
Sugar-sweetened beverage taxes have been shown to be effective at limiting consumption, 
particularly in young people [24], [25]. 
As a growing global epidemic, it is encouraging to see that 72% of countries around the world 
have a specifically funded national program to address diabetes. The causes and effects of diabetes are 
complex, but a commitment to understand the mechanisms of disease and identify multifaceted 
treatment and prevention strategies can significantly counteract the rise of diabetes and improve 
overall metabolic health in societies around the world. 
1.4: Sarcopenia, Cachexia, and Osteoporosis 
While obesity – an excess accumulation of adipose tissue – is perhaps the most visible disorder of 
human metabolism, disorders of muscle and bone tissue represent significant risks for loss of 
function, falls and bone fracture, disability, and death. These diseases significantly can affect quality 
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of life, limiting one’s ability to perform activities and tasks, or in cases of traumatic fracture, 
necessitating a loss of independence. 
Sarcopenia is defined as a loss of skeletal muscle mass and strength associated with aging. The 
Greek roots of the term “sarcopenia” literally translate to “flesh loss”. While it is widely (and 
intuitively) known that aging is associated with wasting and loss of strength, work towards consensus 
definition of the disease is ongoing. The European Working Group on Sarcopenia in Older People 
(EWGSOP) diagnoses sarcopenia as the presence of at least two of the following conditions [26]: 
 Low muscle mass 
 Low muscle strength 
 Low physical performance 
The EWGSOP provides recommended methods and tests for measuring muscle mass, strength, 
and performance. There are currently several proposed cut-off points for classification of each. 
Nonetheless, a new ICD-10 code for sarcopenia was officially introduced in 2016 [27], representing 
a key milestone supporting ongoing sarcopenia research and development of targeted therapies. 
Current research efforts for sarcopenia treatments focus on development of nutrition plans with 
specific macronutrient targets, and development and validation of physical activity regimens and 
medications that are effective for improvement and maintenance of strength and functional ability. 
Cachexia is a closely-related general wasting condition in which muscle mass is lost and often 
energy intake is reduced, generally accompanying diseases such as cancer, HIV/AIDS, and end-stage 
renal disease [28]. Most individuals with cachexia are also sarcopenic, due to the significant loss of 
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muscle mass, but most individuals with sarcopenia are not cachectic (since low strength and 
functional performance can be observed in the absence of dramatic loss of muscle mass) [26]. 
Indeed, it has been shown that strength, but not muscle mass is associated with mortality in an older 
cohort [29], suggesting that muscle quality can be just as important as muscle mass to physical 
function and ability [30]. 
Osteoporosis – literally “porous bones” in Greek – is a disease in which bone strength has 
dropped significantly and risk of fracture is elevated. It is estimated that some 200 million people 
worldwide have osteoporosis, and 8.9 million osteoporotic fractures occur per year [31]. The disease 
affects more women than men, with particularly significant loss of bone strength observed after 
menopause. Osteoporosis is often called a “silent disease” because there are generally few visible 
symptoms until a fracture occurs. Fractures significantly affect quality of life and lead to significant 
pain, loss of independence, institutionalization, and death.  
The gold standard for diagnosis of clinical osteoporosis is measurement of areal bone mineral 
density (BMD) using dual energy X-ray absorptiometry (DXA). A person is classified as osteoporotic 
if his or her BMD is less than or equal to 2.5 standard deviations below reference values for a healthy 
30-year old adult [32]. The WHO international standard site for diagnosis is the femoral neck, but 
the International Society for Clinical Densitometry recognizes low BMD measurements at any of the 
lumbar spine, total hip, or femoral neck (and in some cases the forearm) for diagnosis of osteoporosis 
in postmenopausal women and men over the age of 50 [33]. The FRAX fracture risk assessment tool 
was created using several population-based cohorts around the world to predict individual 10-year 
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fracture risk based on several established risk factors. Several different versions of the tool exist with 
specific calibrations for different ethnicities and regions [34]. 
While bones are generally thought to be relatively static compared soft tissues in the body, bone 
tissues are constantly being resorbed and reformed. In addition to macroscopic bone density (which 
is dominated by mineralized exterior cortical bone), it has been shown that microscopic trabecular 
structure within the bone significantly affects overall bone strength [35], [36]. Medications for 
osteoporosis target various mechanisms of bone formation and turnover [37] – bisphosphonates 
(which cause cell death of the osteoclasts that destroy bone tissue), rank ligand inhibitors (which 
suppress the development of osteoclasts, and hormone replacement (e.g. estrogen for 
postmenopausal women) are the major classes. Nutrition and lifestyle interventions to promote bone 
health are also major components of osteoporosis treatment plans.  
As muscle and bone are tightly integrated, it is not surprising that osteoporosis and sarcopenia 
are often associated conditions. They are key predictors of frailty – a phenotype defined by low 
strength and activity, slowness and exhaustion, and unintentional weight loss [38], [39]. Diverse and 
ongoing loading of bone, mediated by applied muscle forces, is necessary to maintain BMD and 
structural integrity. Resistance training, and in particular impact training, have been shown to 
increase muscle strength and bone density [40]. Indeed, there is a growing body of biochemical 
research evidence for an integrated “bone-muscle unit” with numerous biological interconnections 
and constant “cross-talk” [41]. Identification of underlying biochemical pathways provide more 
holistic targets for improvement of bone and muscle health simultaneously. 
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Obesity, sarcopenia, and osteoporosis each present significant challenges to health and quality of 
life. However, some individuals face a concomitant double- or triple-burden of two or three of these 
diseases. In such individuals, risks are elevated and outcomes are worse than in individuals with only 
one of these diseases alone [42]. Whereas obesity has generally been shown to be protective towards 
bone health (due to increased basal loading, or impact protection), individuals with sarcopenic 
obesity see compounding effects of metabolic risk [43]. The interplay between bone, muscle, and fat 
tissues in the body, and the cross relationships with insulin resistance, inflammation, and blood 
lipids underscore the complex nature of human metabolism, and the need for integrative research 
towards effective treatments. 
1.5: Treatments and Solutions 
The burdens of metabolic disorders are clear. Economic, societal, and individual costs of obesity, 
diabetes, osteoporosis, and associated diseases continue to grow. Combating these trends requires 
effective individual treatment options as well as broader public health initiatives. 
At the individual level, lifestyle changes focused on improved diet and physical activity regimens 
are the first line of treatment. Caloric restriction and physical training plans designed to target a 500- 
to 1000-calorie deficit per day are recommended, with a broader aim of losing 7-10% of body 
weight within 6 to 12 months [18]. Macronutrient recommendations include 25-35% of calories 
from all fats, including mostly unsaturated fats, <7% of total calories from saturated fat, and 
minimal trans-fats. Simple sugars should be limited. Alcohol and sodium consumption should also 
be limited to mitigate hypertension. There is conflicting evidence on the long-term efficacy of low-
carbohydrate / high-fat diets, with some evidence for effectiveness in short-term weight loss (but not 
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long-term maintenance), at a cost of undesirably high fat intake and limited vegetable intake. It is 
generally agreed that an emphasis on fresh fruits and vegetables and low-fat dairy products is 
beneficial. There is growing evidence that a Mediterranean diet rich in plant-based foods, vegetable 
oils, and whole grains, an emphasis on fish and poultry over red meats, limited salt is effective at 
reducing cardiovascular disease risk and overall mortality [44]. Vigorous activity of at least thirty 
minutes per day is recommended most if not all days of the week for all individuals. Increased targets 
of 60 minutes of aerobic activity every day are recommended for individuals with MetS aiming to 
lose significant amounts of body weight [18]. 
Pharmacologic treatments for dyslipidemia include fibrate, nicotinic acid, and statins to improve 
lower LDL and triglyceride levels. For prediabetic and diabetic individuals, drugs that stimulate 
insulin production and inhibit sugar absorption are available, including metformin, 
thiazolidinediones, and acarbose, along with direct insulin treatments. Low dose aspirin is 
recommended to limit risk of thrombosis. ACE inhibitor and diuretic medications are recommended 
address hypertension [18]. 
More broadly, the WHO has created a global action plan to address the burdens of non-
communicable diseases (NCDs) such as cardiovascular disease and diabetes [45]. The plan involves 
recommendations for sweeping multi-sector political and public health efforts at regional, national, 
and global levels to create systems and environments to improve health and lower prevalence of 
NCDs across people of all ages, socioeconomic statuses, and regions. The plan defines nine high-
level voluntary global targets for prevention and control of noncommunicable diseases to be attained 
by 2025 (Figure 1-1). 
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Figure 1-1: World Health Organization voluntary global targets for prevention and control of 
noncommunicable diseases to be attained by 2025. Source: [45] 
The plan focuses on (1) raising awareness and urgency of public initiatives and advocacy efforts 
to address NCDs, (2) creating health-promoting environments to reduce modifiable risk factors at 
the population level, (3) strengthening healthcare systems and coverages to ensure access to 
treatment, (4) supporting research and development for prevention and control of NCDs, and (5) 
monitoring trends and evaluating progress in addressing the burden of NCDs worldwide. The plan 
emphasizes human rights and equity, recognizing that these diseases are global problems that require 
multi-level solutions that are safe, accessible, and culturally sensitive, and that global progress to 
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improve metabolic health worldwide requires broad cooperation across sectors. These efforts can 
include thoughtful taxation and regulation on food advertising, alignment of food production 
incentives with evidence-based research and population health goals, support of fundamental 
research to better understand metabolic health, and dissemination of the latest knowledge, 
diagnostics, and treatments to healthcare providers and systems around the world. 
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2 | Body Composition and Disease Risk 
The tissue composition of the body is a long-term reflection of a person’s accumulated nutrient 
intake, physical activity patterns, and overall health status. There are many levels of description for 
body composition, from elements to tissues, to organs. Body composition research at these various 
levels allows us to understand the metabolic processes of the body and how they become disturbed in 
disease states. Metabolic diseases, whether specifically defined by a macroscopic indicator (as excess 
adiposity defines obesity), or by particular blood markers (as blood glucose levels define diabetes), 
have specific compositional signatures. Thus, human body composition provides powerful indicators 
of metabolic state and dynamics, and the study of body composition provides clinicians with tools to 
diagnose and monitor metabolic disease and treatments. 
2.1: History 
Conceptually, body composition dates back to ancient Greece around 400 BCE [46]. The 
Greeks believed that the human body was fundamentally made of the cosmic elements of fire, earth, 
air and water. Contemporary body composition research began with foundational research in the 
1850s identifying and relative amounts of protein, fat, salts, and water in the body. L.A.J. Quintlet 
in 1871 defined Quintlet’s index as body weight over height squared – the precursor to body mass 
index (BMI) as we know it today. Advancing technologies such as the development of stable and 
radioactive isotopes and conceptual metabolic models around the 1930s ushered in a “golden era” of 
body composition research. Underwater weighing, whole-body labeled potassium counting, and 
neutron activation analysis techniques were all introduced to measure body volume, fat and lean 
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mass, and protein. Body composition imaging techniques such as DXA, computed tomography 
(CT), and magnetic resonance imaging (MRI) were introduced in the 1970s and 1980s, providing 
not just quantification of total body composition, but also regional composition and rich 2D and 
3D visualizations of tissue distributions in the body. Many large studies such as the National Health 
and Nutrition Examination Survey in the United States have been created that include various body 
composition measurements [47]. Such studies provide reference data to establish normative 
compositional benchmarks and track overall population health over time. 
2.2: Multi-Component Models 
There exist several different conceptual models for human body composition. The body can be 
divided into elements, molecules, cells, tissues and organs, or regions [46], [48]. Shen and Wang 
summarized these models and their constituent components as shown in Table 2-1. Within each of 
these model levels there may be multiple different particular models with differing numbers of 
components. Models with fewer components necessarily group smaller components into larger ones 
– for example the two-component molecular model contains fat mass (FM) and fat free mass (FFM), 
where FFM contains protein, mineral, and carbohydrate. The two-component molecular model is 
widely used due to its simplicity and direct connection to metabolism: FFM encompasses “actively 
metabolizing” tissues and FM represents energy storage. 
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Table 2-1: Summary of multi-component body composition models. The components of each model sum to 
equal total body mass. Adapted from [46]. 
Model Level Components Number of 
Components 
Atomic Hydrogen, oxygen, nitrogen, carbon, sodium, potassium, chlorine, 
phosphorous, calcium, magnesium, sulphur 
11 
Molecular Lipid, water, protein, mineral, carbohydrate 2-6 
Cellular Cells (adipocytes and others), extracellular fluids, extracellular solids 3-4 
Tissue-Organ Adipose tissue, skeletal muscle, bone, visceral organs, other tissues 5 
Whole-Body Appendages, trunk, head 3 
 
The various model levels of body composition analysis have conceptual and historical 
underpinnings. While the different models and levels are closely related, it is not always possible to 
draw direct correspondences between components. For example, lipid and fat are often discussed 
interchangeably, but there is a small amount of lipid mass found in lean tissues. Furthermore, the 
term “lean tissue” is not equivalent to “fat free mass” despite similar conflicting usage in practice and 
in the literature [46]. Bazzocchi visualizes the subtle differences in these molecular body composition 
components graphically in Figure 2-1. Appropriate model selection is dependent upon the 
availability and practicality of measurement techniques, the outcome measurement of interest, and 
the overall purpose for composition analysis. 
Chemical analysis of human cadavers is perhaps the most precise way to quantify body 
composition [49], though this is for obvious reasons impractical for health assessment. Perhaps the 
first practical in vivo body composition analysis technique was Behnke’s two-component (2C) 
underwater weighing method introduced in 1942 [50]. This method relies on direct measurements 
of weight in and out of water to estimate body volume and density. Using assumed densities of fat 
and fat-free tissues, the relative masses of those components can be calculated [51]. This method is 
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simple and elegant, but it necessarily obfuscates much compositional detail in assuming fixed 
densities of summed “fat free” mass. 
 
Figure 2-1: Graphical representation of the various components of the molecular level model of body 
composition. Source: [52] 
The major components of fat free mass are water, protein, minerals, and glycogen. While in 
many cases, the relative composition of these components may be relatively stable, it has been shown 
that variability is observed depending on several factors including fasting status, growth, pregnancy, 
race, and disease [53]. To address this, Siri proposed a three-component (3C) model separating “fat 
free mass” into water and non-fat solids (protein, minerals, and glycogen). This was enabled in 1950 
by the introduction of isotopic water dilution techniques to measure total body water [54]. In these 
measurement, a subject consumes a small dose of stable isotopic water (e.g. deuterium). The dose is 
allowed to equilibrate over the course of a few hours. Water samples (either urine or saliva) are 
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collected throughout the process and analyzed for dose concentration to calculate the size of the total 
body water pool. 
The effort to further quantify specific “residual mass” components was boosted in 1963 with the 
introduction of single-photon absorptiometry (SPA) as a method for quantification of bone mineral 
mass [55]. This enabled a four-component (4C) model including fat, water, mineral, and residual 
protein (+glycogen) masses that was used by Selinger [56] to accurately quantify body composition 
in children, whose fat-free mass composition was not accurately represented by the stable 
assumptions calculated on adults.  
Notably, SPA bone mineral measurements were only reliable at bony sites free of significant 
overlying soft tissue. The development of dual-photon absorptiometry (DPA) [57] and then DXA 
[58] in the 1980s surmounted this issue by enabling simultaneous quantification of bone and soft 
tissue mass at different locations throughout the body. While it should be recognized that these dual-
energy techniques must assume fixed density of soft tissue, the density of bone mineral is so 
significantly higher that calculated bone mineral content is relatively insensitive to small changes in 
assumed soft tissue density. 
Fundamentally the development of these 2C, 3C, and 4C models rely upon accurate 
measurement of body mass and volume to attain density. Additional material-specific measurements 
(e.g. body water and mineral mass) are added to precisely fix certain components and allow for 
calculation of increasingly specific residual mass. Five- and six-component models were recently 
described by Wang [59] and others that separate mineral into osseous and soft tissue components, 
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then a separate glycogen component [53], but these models remain relatively limited in practice due 
to their inherent complexity. 
Over the past few decades there has been significant development in techniques for measuring 
molecular-level body composition for research, clinical, and even consumer applications [53]. While 
improved accessibility and availability of body composition analysis is undoubtedly positive for 
management of metabolic health and disease around the world, the proliferation of different 
techniques underscores the need for appropriate reference standards and calibration to ensure 
accurate risk assessment and clinical interpretation.  
2.3: Tissue Quality and Spatial Distribution 
Whole-body bone mineral density is known to be a significant predictor of bone fracture risk, 
but it is not utilized in clinical practice for diagnosis of osteoporosis. Rather, site-specific bone 
density at the hip, spine, and forearm are officially recommended by the International Society for 
Clinical Densitometry [60]. It is intuitive that site-specific bone structure and density would better 
predict fracture than whole-body metrics given that bone fractures are mechanical failure events that 
occur at specific locations where an applied force exceeds the capacity of a specific bone.  The local 
density of bone, as well as the spatial distribution of cortical and trabecular bone, each provide 
additional information towards prediction of fracture [61]–[64]. 
A growing body of evidence shows that local information about tissue quality and spatial 
distribution is similarly powerful for assessing metabolic risk from body composition. Muscle 
quality, as quantified by intra- and inter-muscular fat using Computed Tomography, is more 
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predictive of functional strength than muscle mass alone [65], [66]. This is particularly important 
because muscle strength, but not mass, has been shown to predict mortality in older adults [29], 
despite the fact that strength is notoriously difficult to measure with high precision [67]. Passive 
methods for assessment of muscle quantity and quality may offer stronger predictors of functional 
ability, fall risk, and mortality. The spatial distribution of fat tissues throughout the body has been 
shown to have a significant effect on metabolic risk. For example, visceral fat has been shown to 
predict mortality even after adjustment for subcutaneous fat and age [68]. Even more localized fat 
measurements such as pericardial fat and liver fat have been shown to be independent predictors of 
coronary artery calcification and insulin resistance, respectively [69]–[71]. At a higher level, android-
to-gynoid fat ratio is an independent  predictor of diabetes [72]. Trunk-to-leg volume ratio is a 
strong predictor of diabetes and mortality risk independent of other metrics of fat quantity and 
distribution [73]. The significance of these measures of fat distribution throughout the body are 
loosely captured by simple metrics such as waist circumference, waist-hip ratio, and “apple” vs. 
“pear” body shapes. Indeed, the diagnostic criterion of waist circumference in classifying the 
Metabolic Syndrome underscores the importance of body shape/tissue distribution over shape-
agnostic measurements such as body mass index. 
2.4: Technology Considerations 
It is clear that detailed metrics and models of body composition and distribution and quality 
hold key insight into metabolic status and disease risk. Ideally, all of the aforementioned metrics 
would be available when evaluating a clinical patient or research subject. However, detailed 
composition analyses, such as four-component body composition analysis or quantification of liver 
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fat, may be expensive or impractical. Clinicians and researchers must constantly weigh the costs of 
particular measurements versus the information benefits to be gained, with particular sensitivity to 
specific patient needs and available resources. Equipment accessibility, patient burden, use of 
ionizing radiation, and measurement invasiveness must all be considered when selecting body 
composition assessments. Because of these concerns, in many cases only simple metrics like weight, 
body mass index, and waist circumference may be used in practice. Several different body 
composition measurement techniques, and the strengths, applications, and limitations of each, will 
be discussed in the following chapter. 
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3 | Body Composition Analysis Techniques 
There are a variety of techniques used to measure body composition, from simple surrogate 
anthropometric measurements like BMI to high-resolution 3D whole-body computed tomography 
and magnetic resonance imaging. A summary of the primary tools used in body composition 
research is provided in Table 3-1. We detail each method in the following sections 
Table 3-1: Summary of body composition techniques and measurements. Cost, patient burden, accessibility, 
and specific diagnostic needs must be considered when selecting an appropriate measurement technique. 
Technique Measurements Measurement Level Cost  Notes 
Anthropometry Body Mass Index,  
Waist Circumference, 
Waist Hip Ratio 
Whole-Body, Regional Very Low  
Underwater Weighing 
(UWW) 
Total Body Volume, %Fat Whole-Body Moderate  
Air Displacement 
Plethysmography (ADP) 
Total Body Volume, %Fat Whole-Body Moderate  
Deuterium Dilution 
(D2O) 
Total Body Water, %Fat Whole-Body High  
Bioelectrical impedance 
Analysis (BIA) 
Total Body Water, %Fat Whole-Body, Regional Low  
Computed Tomography 
(CT) 
Volume, Fat, Muscle, Bone Whole-Body, Regional, 
Voxel 
High 
 
High Ionizing 
Radiation Dose 
Magnetic Resonance 
Imaging (MRI) 
Volume, Fat, Muscle Whole-Body, Regional, 
Voxel 
High  
Dual Energy X-ray 
Absorptiometry (DXA) 
Volume, Fat, Lean, Bone Whole-Body, Regional, 
Pixel 
Moderate 
 
Low Ionizing 
Radiation Dose 
3D Optical Surface 
Imaging 
Volume, Fat, Lean Whole-Body, Regional Low  
 
3.1: Classical Anthropometry 
Anthropometry, meaning “human measure” in Greek, encompasses a variety of simple 
measurements of the human body including lengths, circumferences, and mass. Because 
anthropometric measurements typical only require simple tools such as rods, tapes, calipers, and 
scales, these methods are highly accessible and easily acquired even in resource-limited environments 
[74]. As described previously, body mass index – or the Quintlet index – is perhaps one of the most 
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broadly-used anthropometric measurements available. Requiring only scale weight and a height 
measurement, BMI is highly appealing for population studies especially in low- and middle-income 
countries where access to clinics and health assessment tools may be limited. Indeed, despite the fact 
that obesity is defined specifically by an excess accumulation of adipose tissue, the diagnostic metric 
for overweight and obesity is BMI (which does not discriminate between body tissue types) [1], [75]. 
Keys noted in a 1972 review of various anthropometric indices that BMI, while not without its 
flaws, is a suitable indicator of obesity at the population level [76]. Despite its limitations for 
individual assessment (e.g. athletes with high muscle mass may be classified overweight or obese 
despite very low body fat levels), BMI in many cases continues to be the frontline metric for 
physician assessment of metabolic status [77].  
Waist circumference (WC) and waist-hip-ratio (WHR) are other simple anthropometrics that 
approximate central adiposity. There several other indices that have been developed such as waist 
height ratio (WHtR) [78] and a body shape index (ABSI) [79]. Several studies have shown that these 
metrics better predict adverse metabolic outcomes than BMI [80]–[83]. However these indices are 
still not direct measurements of body composition, and there can be significant variability in 
measurement depending on observer training and measurement site [84], [85]. While 
anthropometric measurements are highly useful and practical for health assessment, they remain 
surrogate measures of body composition. 
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3.2: Total Body Density 
Behnke and Siri’s two-component body composition models require accurate measurement of 
body density. Scale weight is simple to measure with high accuracy. There are two primary methods 
for measuring body volume, described below. 
3.2.1	Underwater	Weighing	
Underwater weighing (UWW, also known as hydrostatic weighing) is based on Archimedes’ 
principle that buoyant force exerted on an object is equal to the weight of fluid displaced by the 
object. The subject’s weight is measured in the open air (𝑊௔௜௥), then weighed underwater 
(𝑊௨௡ௗ௘௥௪௔௧௘௥) [86]. Underwater weight is acquired by having the subject sit on a seat connected to 
a force meter (Figure 3-1). The seat is lowered into a large tank of water until the subject is 
completely submerged, and weight is recorded. Volume of the body 𝑉஻ is then calculated as follows: 
𝑉஻ ൌ 𝑊௔௜௥ െ 𝑊௨௡ௗ௘௥௪௔௧௘௥𝐷௪௔௧௘௥ െ 𝑉ோ 
where 𝐷௪௔௧௘௥ is the density of water and 𝑉ோ is residual volume, which is dominated by lung volume. 
Subjects are typically encouraged to exhale completely before submersion. Residual volume can then 
be measured using gas dilution techniques or estimation equations based on subject sex, age, and 
height [86]. Body density is given by 𝐷஻ ൌ 𝑉஻/𝑊௔௜௥, which can be used with reference densities of 
fat and fat free mass to calculate two-component body composition, as described by Siri [51] and 
Brožek [87]. The Siri equation is reproduced below. 
%Fat ൌ ൬495𝐷஻ ൰ െ 450  
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Figure 3-1: Example of an underwater weighing apparatus. The subject rests on a seat connected to a force 
meter. The seat is lowered into the water until the subject is completely submerged, and her underwater weight 
is then measured. Image source: https://education.uky.edu/khp/laboratories/exercise-physiology-lab/ 
 
3.2.2	Air	Displacement	Plethysmography	
In 1995, Dempster and Atkins reported on the development of the BOD POD, a new device 
for body volume measurement that relies upon air displacement plethysmography (ADP) [88]. The 
technique had been proposed and researched for several decades, but this work marked the first 
implementation of ADP with sufficient accuracy and stability for commercial deployment [89]. 
A subject sits inside the enclosed chamber of the BOD POD (Figure 3-2) while wearing 
minimal, form-fitting clothing. The subject chamber is connected to a smaller chamber with a 
flexible diaphragm in between. The volumes of the two (empty) chambers are known precisely, and 
the diaphragm is actuated to induce small volume changes between the two chambers. 
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Using Boyle’s Law (𝑃ଵ𝑉ଵ ൌ 𝑃ଶ𝑉ଶ), the volume of the loaded subject chamber can be calculated. 
Subtracting this from the volume of the empty subject chamber yields the body volume of the 
subject. As with underwater weighing, the measured volume must be adjusted downward for residual 
lung volume – either from equation estimates or a direct measurement using a breathing tube that 
attaches to the system and employs the same ADP measurement principle.  
The same composition equations used to estimate body %Fat from UWW body volume 
measurements (such as the Siri equation in the preceding section) are used for ADP body volume 
measurements [88]. Due to its ease of use compared to UWW, ADP is now the primary tool for 
body volume measurement [53]. Specially-designed devices with smaller volume chambers such as 
the PEA POD have been developed for children and infants, and several studies have been 
performed to validate the accuracy of the technique in such individuals [90]. 
3.3: Total Body Water 
Accurate measurement of total body water (TBW) mass enabled four-component body 
composition measurement in the laboratory setting. This is particularly useful in individuals with 
variable hydration status (e.g. growing children and older adults) whose FFM composition may not 
be accurately predicted by reference adult norms. In normally-hydrated adults, TBW measurements 
alone can be used with reference fat free mass hydration (73.2%) [91] to estimate %Fat: 
𝐹𝐹𝑀 ൌ 𝑇𝐵𝑊/0.732 
%𝐹𝑎𝑡 ൌ 100 ∗ ൬1 െ 𝐹𝐹𝑀𝑇𝑜𝑡𝑀𝑎𝑠𝑠൰ 
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Figure 3-2: The BOD POD (COSMED, Rome, Italy) air displacement plethysmography device for measuring 
body volume. Image source: https://bit.ly/2KKrTZr 
3.3.1	Deuterium	Dilution	
Dilution measurement techniques for calculating total body water require a dose of isotopic 
water that mixes freely in the body water pool. The dose is administered, and the subject is 
instructed to refrain from strenuous activity or food/drink consumption for a period of 2-5 hours 
while the dose equilibrates. Body water samples (usually saliva or urine) are collected and analyzed 
using spectrometric techniques such as Fourier Transform Infrared Spectrometry (FTIR) to 
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determine the dose concentration within the body water pool. The size of the body water pool is 
then the administered dose amount divided by the equilibrated dose concentration [92]: 
𝑇𝐵𝑊 ሺ𝑘𝑔ሻ ൌ 𝜂 ∗ 𝐷𝑜𝑠𝑒 𝐷ଶ𝑂 ሾ𝑚𝑔ሿ
𝑒𝑛𝑟𝑖𝑐ℎ𝑚𝑒𝑛𝑡 𝐷 𝑖𝑛 𝑠𝑎𝑙𝑖𝑣𝑎 ൤𝑚𝑔𝑘𝑔 ൨
 
where 𝜂 is a dilution space correction factor, described below. 
Stable water isotopes of 2H2O (deuterium, also D2O) or H218O (O-18 water) are commonly 
used today for dilution protocols to measure total body water [53], [54]. These isotopes have largely 
supplanted the radioactive isotope 3H2O (tritium) [93] for this purpose. It must be noted that each 
of the isotopic molecules occur naturally, and thus trace amounts may be present in the body at 
baseline. In addition, each of the aforementioned water isotopes undergo exchange with non-
aqueous oxygen or hydrogen in the body [53]. Correction factors must be applied to account for 
these considerations. For deuterium dilution protocols, experimentally validated dilution space 
correction factor is 𝜂 ൌ 1.041 [92]. 
3.3.2	Bioelectrical	Impedance	Analysis	
Characterization of the electrical properties of tissues dates back to the 1870s, but the 
foundations of modern bioelectrical impedance analysis (BIA) were developed a century later [94]. 
In brief, the body is modeled as one or more homogeneous conductive cylinders. A tetrapolar array 
of electrodes is attached at distant points on the body (e.g. the ankle and wrist, see Figure 3-3) – a 
small current is passed between one pair of electrodes, and the voltage differential is measured across 
the other pair. Measurements are recorded at one or more frequencies to estimate the resistance and 
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reactance (together, impedance) of the body. At zero (or very low) frequency, the electrical signal is 
insulated by cell membranes and conducted only by extracellular water (ECW) in the body. At 
infinite (or very high) frequency, the signal is conducted through both intracellular (ICW) and 
extracellular water. These combined represent total body water [95].  
 
Figure 3-3: A clinical multifrequency segmental bioelectrical impedance analysis device with touch electrodes 
connected to the subject’s fingers and ankles. InBody S10 (InBody Co. Ltd., Seoul, South Korea). Image source: 
http://www.inbody.com/global/product/inbodys10.aspx 
BIA is an attractive tool for body composition analysis because it is relatively inexpensive, fast, 
and easy to use. The balance of ICW to ECW in the body can be used to estimate fat/lean 
composition using assumed hydration constants for those tissue types. Segmental BIA devices 
perform a series of measurements across different pairs of electrodes connected to each appendage to 
estimate regional body composition in the limbs and trunk. Many commercial products have been 
introduced at the consumer level that offer body fat estimates using BIA technology. It should be 
noted that BIA fat estimates are sensitive to fluctuations in hydration, and that the electrical 
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conductivity of the skin can introduce significant noise. Furthermore, the assumed cylinder model of 
the body may not hold for individuals with varying body shapes [96]. 
3.4: Dual Energy X-Ray Absorptiometry 
DXA was first introduced in the 1980s as a tool for measuring areal BMD [97]. DXA 
represented a significant advance over single- and dual-photon absorptiometry techniques as it 
allowed for wide field of view imaging of bone density, even in regions of the body with significant 
soft tissue. Today, DXA is the primary technique for diagnosis of osteopenia and osteoporosis. Body 
composition analysis is a second significant use of DXA technology. Subjects lie flat on the scanner 
bed (Figure 3-4) during a whole-body scan that takes about five minutes. The principles of DXA will 
be discussed in section 4.1.1 . 
The scan arm and table of the device move in a coordinated fashion to sweep the X-ray beams 
across the entire table. X-ray dose from a whole-body DXA scan is less than 5 microsieverts – an 
amount comparable to the dose received in one day due to natural background radiation. Scan data 
are processed on a connected computer. A certified technician analyzes the scan, and a report is 
generated that includes fat, bone, and lean masses for the total body as well as arm, leg, and trunk 
subregions [98]. 
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Figure 3-4: A dual energy X-ray absorptiometry scanner. GE iDXA (GE Healthcare, Madison, WI). Image source: 
https://bit.ly/2ws7DJ5 
DXA is appealing for body composition analysis because it provides regionalized 3-component 
body composition. DXA can also be used to estimate the relative amounts of subcutaneous and 
visceral fat in the abdomen using a projection method described by Kaul and colleagues [99]. The 
technology provides rich body composition information, but its use of ionizing radiation (albeit low 
dose) and high training requirements for technicians are limitations to broader use. 
3.5: Computed Tomography and Magnetic Resonance Imaging 
Quantitative Computed Tomography (QCT) is an X-ray based 3D imaging method that can be 
used to quantitatively image body composition in three dimensions [100]. By calibrating measured 
attenuation in Hounsfield Units (HU) to materials of known density, QCT provides quantitative 
density measurements. Notable body composition metrics include volumetric BMD, skeletal muscle 
volumes, organ volumes, visceral fat volume, and intermuscular adipose tissue (an indicator of 
muscle quality) [101]. QCT can provide richly-detailed full body 3D images of internal 
composition, but the high X-ray dose requirements limit its use to select research applications or 
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opportunistic screening [102]. In most cases, only specific cross-sections of interest within the body 
are imaged using CT in order to minimize dose. 
Magnetic resonance imaging (MRI) is another 3D technique that can provide high-resolution 
internal composition images. MRI can provide many of the same internal volume measurements 
that CT provides, without any ionizing radiation. Development of chemical shift imaging 
techniques has enabled isolation and relative quantification of fat and water signals in MR images, 
and recent work on ultra-short- and zero-time echo (UTE/ZTE) MR imaging has made it possible 
to image bones [103]. MRI has several advantages for detailed body composition imaging, but it is 
prohibitively expensive for clinical analysis of body composition, and unsuitable for individuals with 
BMI exceeding about 40 kg/m2 due to bore size and field of view limitations [104]. 
Both CT and MRI scanners feature a large circular bore that contains the imaging hardware. 
The subject lies flat on a table that is slowly moved through the bore during the imaging process. 
Imaging studies can be confined to small regions of interest, such as over a specific organ, or cover 
the whole-body (sometimes broken into several sequences). 
A highly-specialized imaging procedure involving simultaneous positron emission tomography 
(PET) and CT imaging has been developed to image metabolically-active brown adipose tissue 
(BAT), or “brown fat” [105]. There are significant research efforts to understand the genesis and 
activation of brown fat, as this type of adipose tissue converts stored energy into heat and is 
associated with improved glucose sensitivity, bone density, and overall metabolic health [106], [107]. 
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Because PET-CT imaging requires high X-ray dose in addition to a radioactive tracer, it use is even 
more limited to specialized research applications. 
3.6: Three-dimensional whole-body surface Imaging 
3.6.1	Background	
Initial development of 3D surface scanning of the human body was largely driven by military 
and commercial interests [108], [109]. The technology offers a rapid, noninvasive method for 
acquiring several anthropometric measurements from a large number of individuals, thus providing a 
scalable solution for custom fitting. 3D surface scan anthropometry supports multiple simultaneous 
measurements with high precision and repeatability [110]. In addition, 3D scans can be analyzed 
post-acquisition if new body measurements are desired. All of these features make 3D surface 
scanning a compelling tool for clinical use. 
3.6.2	Imaging	Technologies	
There are several different technologies and for 3D surface imaging. We describe the 
technologies suitable for whole-body scanning below.  
Laser line scanners sweep laser lines across a subject. Charge couple device (CCD) or 
complementary metal oxide semiconductor (CMOS) sensors are used to record the subject. Using 
fixed geometry between the laser source and image sensor, the deformation pattern of the recorded 
laser line is used to determine surface position in space. Line position information is assembled from 
all images in the sweep sequence to produce a full 3D model. 
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Structured light scanners utilize controlled illumination patterns across the imaging field of view 
to extract depth information. These include a projector to cast controlled bands of light across the 
field of view. “Light coding” scanners, such as the Kinect (Microsoft Corporation, Redmond, WA, 
USA), include an infrared (IR) emitter that casts a dot pattern across the field of view. In all cases, 
deformation of the known illumination pattern can be used to calculate depth throughout the scene. 
Stereophotogrammetry scanners reconstruct 3D images from multiple 2D photographs taken 
from different angles around the subject. Landmarks are co-registered between images, and the 
known positions of the image sensors are used to triangulate each pixel in space. This technology, 
which mimics the depth perception of the human visual system, has already been implemented in a 
few consumer devices such the Nintendo 3DS portable video game system. 
Time of flight (ToF) scanners also utilize coupled scene illumination (visible light or IR) and 
image recording (using CCD or CMOS sensors) [111]. However, instead of measuring pattern 
deformations, these scanners measure the round-trip time (RTT) for reflected photons to reach the 
image sensor in order to calculate depth information. The hardware in ToF scanners must be 
accurate to the picosecond scale to achieve millimeter precision. Previously used primarily for 
architectural and surveying purposes, ToF technology (for near-field applications) has been made 
more broadly accessible with the introduction of the second-generation Microsoft Kinect. 
Millimeter wave scanners utilize electromagnetic (EM) wave reflection patterns from the skin 
surface to construct a full 3D body image. Active scanners emit EM energy at the subject and 
measure reflected signals, while passive scanners only measure ambient/background EM radiation. 
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The advantage of millimeter wave technology is that the EM frequencies utilized freely penetrate 
most clothing materials. These scanners have seen broad adoption for security screening purposes at 
major airports. 
The software used to derive measurements from 3D scans accepts raw data from the scanners in 
the form of a list of unconnected sampled surface points in 3D space (called a point cloud). These 
points are used to reconstruct a closed surface [112]. Smoothing and template interpolation 
techniques [113] may be applied to correct holes or irregularities in a scan. A set of defined 
landmarks are algorithmically placed on the closed surface, and surface measurements are calculated 
between these landmarks [114]. 
3.6.3	Applications	and	Opportunities	
3D optical scanners provide a number of measurements that are useful in the clinical setting. 
These include various length, area, and volume measurements. Wells, et al. showed that 3D body 
surface scanning systems produced anthropometric measurements with precision within 0.5 cm 
[114]. The efficacy of these measures has been reported in various studies in both adult and youth 
populations [115]–[117]. 3D length and circumference measurements can be utilized to quickly 
calculate several established body shape indices, including waist-to-hip ratio (WHR), waist-to-height 
ratio (WHtR), a body shape index (ABSI), and body roundness index (BRI). These indices have 
been shown to be significant risk factors for all-cause mortality, cardiovascular disease, diabetes 
mellitus, hypertension, sleep apnea, and cancer [79], [118]–[121]. Wang, et al. [115] demonstrated 
that 3D surface scanning can measure whole-body volume with precision below 1%. Notably, 3D 
optical scanning offers the distinct advantage of regional volume assessment, which is not possible 
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with UWW or ADP. Regional body volume is of interest for the calculation of indices such as the 
trunk-to-leg volume ratio (TLVR), which has been shown to be an independent risk factor for 
diabetes and mortality, even for individuals within the “normal” BMI range [73]. 
Utilizing 3D scanners, national studies on population anthropometrics have been conducted in 
several countries including the UK, USA, China, Spain, Mexico, Thailand, France, Korea, and 
Taiwan [122], [123]. These studies have been used to identify longitudinal trends in population 
anthropometrics and differences between national and ethnic groups. 
 An emerging use of 3D optical surface scanners is joint detection and pose/posture assessment 
[124]. In particular, the broad release of the consumer-oriented Microsoft Kinect and its 
accompanying software development kit has provided an accessible tool for static and dynamic 
marker-free skeleton posture detection from 3D surface images [125], [126]. Reyes, et al. 
demonstrated that such a system can be used for static posture analysis, spine curvature analysis, and 
range of movement analysis, with sufficient accuracy for diagnosis of musculoskeletal disorders such 
as scoliosis, kyphosis and lordosis [127].  
 3D surface scanning offers an appealing method for body composition analysis. Lee, et al. 
derived models of total and regional fat and lean mass utilizing regional volume and circumference 
features derived from 3D optical scans [128]. The same group also demonstrated estimation of 
visceral fat area using similar measures [129]. 
3D body surface scanning is clearly appealing for its ease of use, lack of ionizing radiation, and 
commodity hardware. Validation of 3D body scan methods using commercial hardware would 
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provide direct translational applications suitable for clinical and personal use. While linear, areal, and 
volumetric measurements from 3D scanners have been used for a variety of applications described 
above, there is significant fine surface and texture detail not utilized by these metrics. More detailed 
3D body shape features may provide improved clinical health information at no extra cost or risk. 
3.7: Unmet Needs and Proposed Solutions 
Human body composition research has advanced tremendously over the past 70 years. There are 
several conceptual models for body composition with varying levels of complexity, and many 
different techniques available for body composition research. Our understanding of the biochemical 
processes and disorders of the human metabolic system continues to grow. However, despite these 
advances, simple surrogate measurements of body composition such as BMI or waist circumference 
remain the de facto standards in many clinical settings and epidemiological studies around the 
world. While valuable as population metrics, these measurements have limited accuracy for 
individual tracking, and often require increasingly-cumbersome adjustments for different sexes, 
ethnicities, and regions. There is an unmet need for accessible tools for detailed individual body 
composition analysis in the clinic and in the field. 
To address this need, we propose several solutions built upon 3D optical (3DO) body surface 
scanning and DXA technology: 
1. Validation of commercially-available 3D body scanners for rapid clinical anthropometric 
assessment that obviates the need for laborious tape and caliper measurements. 
2. Development of statistical shape models that capture detailed features of 3D body shape 
and provide simple descriptors for the complexities of body shape and composition.  
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3. Development of statistical appearance models of DXA composition images to identify 
features of fat and lean tissue distribution that are uniquely associated to disease risk. 
4. Integration and validation of BIA and DXA imaging to provide rapid, accurate, and 
practical 4C body composition.  
5. Integration of 3DO and DXA technology to provide high resolution three- and four-
component composition across the whole body.  
Collectively these solutions would enable richer and more detailed body composition 
assessments in the clinical setting that may allow doctors to better predict disease risk and develop 
personalized treatment recommendations. They can also enable individuals to use accessible 
consumer imaging devices to better understand and monitor their own health. 
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4 | Advanced Techniques in DXA Body Composition 
4.1: High-resolution 3-component DXA image separation 
4.1.1	DXA	Physics	
The core principle of DXA is that different materials have unique X-ray attenuation properties. 
Measured beam attenuation at two different X-ray energy levels due to photoelectric and Compton 
scattering effects provides two independent measurements of tissue thickness at each pixel [130]. 
Using calibrated mass attenuation coefficients, it is possible to determine the masses of two different 
materials at a given pixel (Figure 4-1). 
 
Figure 4-1: Principle of DXA. High and low energy X-ray attenuation profiles 𝑨𝒉𝒊𝒈𝒉 and 𝑨𝒍𝒐𝒘 are measured 
simultaneously. Different materials have different attenuation profiles by X-ray energy level. The ratio of 
specific mass attenuation coefficients (in cm2/g) at low and high energies are used to determine 𝒌𝒃𝒐𝒏𝒆 and 𝒌𝒔𝒐𝒇𝒕 
coefficients that allow for isolation of bone and soft tissue masses, respectively. Adapted from [131]. 
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The innovation of DXA and DPA over single-photon absorptiometry allowed for subtraction of 
soft tissue thickness over a bony structure, thus enabling accurate measurement of bone density even 
in regions of the body with significant soft tissue. However, the composition of soft tissue can vary 
significantly across the body and across different people. To address this, the “R-factor”, or ratio of 
high to low energy attenuation 𝑅 ൌ 𝐴௟௢௪/𝐴௛௜௚௛, can be used to determine the fat/lean composition 
of soft tissue in the absence of bone. A higher R value indicates higher lean content and a lower R 
value indicates higher fat content. The numerical relationship between R-factor and percent fat can 
be calibrated empirically, but for polychromatic X-ray systems such as DXA, that relationship varies 
with total thickness due to beam hardening, as shown in Figure 4-2. DXA soft tissue calibration thus 
requires nonlinear mapping to a phantom with multiple different fat/lean combinations at multiple 
different thicknesses [130].  
 
Figure 4-2: The “R-factor” ratio between low- and high-energy X-ray attenuation can be used to estimate 
fat/lean composition of soft tissue. For DXA, beam hardening effects with increased thickness produce a 
nonlinear relationship which requires multi-point calibration using soft tissue phantoms. Adapted from [130]. 
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4.1.2	Three	Component	Spatial	Assumptions	
Although DXA reports contain fat, lean, and bone masses, DXA technology can be used to 
measure two different materials at a given pixel. As described above, bone mass and combined soft 
tissue mass can be calculated at a given pixel, but the composition of the soft tissue must be known. 
Fat/lean soft tissue composition can be estimated using the R-factor, but only in pixels that do not 
contain bone. Spatial assumptions about soft tissue composition must be made to produce 3C 
output from DXA. Specifically, the soft tissue composition over pixels with bone is assumed to be 
equal to the average soft tissue composition across neighboring pixels without bone. In practice, this 
approximation is performed at each line on a DXA scan, and thresholding is used to determine the 
presence of bone in a pixel [130]. 
While spatial approximation of soft tissue is likely robust in the appendages (where there is a 
large area of relatively homogeneous soft tissue only compared to a small area of bone), the 
abdominal region presents a particular challenge due to increased variability in fat distribution and 
limited lateral area free of bone. In whole-body scans, approximately 60% of body area may require 
spatial interpolation (Figure 4-3). 
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Figure 4-3: Example of soft tissue interpolation required in DXA scans. The image on the left from a GE scanner 
and the image on the right is from a Hologic scanner (courtesy of Joseph P. Wilson). 
4.1.3	DXA	Calibration	and	Image	Processing	
Accurate quantitative body composition measurements from DXA rely on careful calibration of 
the densitometer. Densitometers from Hologic, Inc. (Marlborough, MA) employ a continuous 
“internal reference system” calibration mechanism consisting of a wheel or drum of known 
thicknesses of different phantom materials approximating bone, soft tissue, and air that rotates in 
synchronization with the input power supply (60 Hz in the US). By measuring the differences in 
attenuations through each of the internal reference system, soft tissue mass attenuation coefficients 
can be determined in real-time. This allows the system to automatically adjust for beam hardening 
effects that occur with increased tissue thickness. 
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Figure 4-4: High-energy air-phase images extracted from a whole-body DXA scan. The image on the left is the 
raw data extracted from the scan file, and the image on the right is an interleaved, upscaled version that uses 
all three bone/soft tissue/air phase images from the Hologic internal reference system. 
In addition to the bone/soft tissue/air phases of the internal reference system, the X-ray source 
oscillates between high and low energies such that there is a total of six transmission measurements 
in sequence [130]. These measurements are made in a continuous, sequential cycle throughout the 
duration of the scan, and each group of six measurements is collected into a single pixel. In actuality 
the sequential measurements are made at immediately adjacent to each other. We developed 
algorithms to linearly match and interleave the bone, soft tissue, and air phase images to provide 
increased resolution (Figure 4-4).  
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We used these high-resolution images from raw DXA scan files along with the bone and soft 
tissue calculation techniques described by Blake and Fogelman. Further improvements included 
areal sampling of adjacent soft tissue-only pixels for estimation of soft tissue composition (as opposed 
to line-by-line sampling) and use of a 2-dimensional second order polynomial surface for soft tissue 
composition estimation at each pixel. The soft tissue composition equation was calibrated to 
measurements of the official Hologic Tissue Bar (or TBAR) phantom – a six-step acrylic and 
aluminum phantom designed to approximate different fat/lean compositions at different thicknesses. 
The processing algorithms were developed in MATLAB R2016b (The MathWorks, Inc., Natick, 
MA) and are available in the ‘3c_dxa’ repository of the Shepherd Lab GitHub (see Appendix: Code 
Availability). They allow for generation of quantitative, high-resolution fat, lean, and bone images 
from any standard Hologic DXA scan (Figure 4-5). The algorithms support all major scan types, but 
the focus of this development was whole-body scans for body composition analysis. 
 
Figure 4-5: Quantitative 2C and 3C image extraction from whole-body DXA scan files. High- and low-energy 
X-ray attenuation maps are extracted from Hologic scan files (left group). Simple 2C subtraction assuming 
fixed soft tissue composition produces detailed bone and soft tissue mass images (middle group). 3C modeling 
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of variable soft tissue composition using the Hologic internal reference system enables calculation of bone, fat, 
and lean mass images. 
As of this writing, the current stable version of the 3c_dxa code is tagged “mec2000_08.08.17”.  
This version of the code was used to process images from the Multiethnic Cohort (MEC) Obesity, 
Body Fat Distribution, and Cancer Risk study as will be described in section 4.3: . Total mass was 
calculated from the derived 3c bone/fat/lean images from this study of older adult men and women 
(n=1,851) and compared with corresponding mass values on the Hologic DXA report. Regression 
plots are shown in Figure 4-6. Coefficients of determination were R2 = 0.94, 0.90, and 0.64 for fat, 
lean, and bone mass, respectively. This present version of the 3c_dxa algorithm on the whole 
underreports fat and lean mass, but overreports bone mass relative to Hologic report values. Further 
refinement and calibration of the 3c_dxa code, potentially in conjunction additional understanding 
of the manufacturer’s software and whole-body scan processing algorithms, would improve 
agreement with tabulated Hologic report mass measurements. 
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Figure 4-6: Regression plots for whole-body fat, lean, and bone mass as measured by the 3c_dxa algorithms (y-
axes) compared with Hologic report values (x-axis). Hologic fat and lean values were calculated with the 
NHANES calibration enabled [132]. 
Images generated using this 3C pixel-by-pixel image processing approach, as well as the pixel-by-
pixel total thickness estimation described by Wilson, allow for analysis and modeling of detailed 
spatial distribution of body tissues that is not captured in standard DXA reports. In the following 
sections, we describe the construction such detailed DXA “statistical appearance models”, and their 
metabolic significance in terms of disease and mortality risk. 
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4.2: Statistical Appearance Models of 3D Body Shape and Mortality Risk 
4.2.1	Introduction	
Global prevalence of diabetes has more than doubled over the past 30 years, affecting nearly 
1 in 10 adults, and increasing numbers of children [133], [134]. The largest contributor is type 2 
diabetes, linked to dyslipidemia, hypertension, and insulin resistance, collectively referred to as 
“metabolic syndrome.” Metabolic syndrome accounts for approximately 6-7% of all-cause mortality, 
12-17% of cardiovascular disease, and 30-52% of diabetes [135]. Higher Body Mass Index (BMI), a 
measure of excess weight, was associated with mortality in early studies [136], [137] but is now 
controversial [138], [139] because more recent work has shown that higher BMI at older age is 
protective against mortality.  However, measures of body shape and central adiposity have been 
shown to be associated with increased mortality risk. Waist circumference (WC) and its ratio to the 
hips are more closely related to adverse outcomes than BMI [80], [81], [118], [140]–[142]. The 
ratio of trunk-to-leg volume is a strong indicator of diabetes (fifth-to-first quintile odds ratio 6.8) 
and mortality risk (odds ratio 1.8), independent of BMI and WC [73], showing that more advanced 
descriptors of body shape accurately indicate metabolic risk beyond traditional measures. We 
hypothesize that statistical models of the shape and thickness of the whole body will better determine 
metabolic status and thus mortality risk than existing body shape measures. 
 Statistical appearance modeling (SAM) [143] has several successful applications including 
manufacturing [144], handwriting recognition [145], facial recognition [146], and medical imaging 
of the brain [147], heart [148], eye, liver, lung, kidney, prostate, knees [149], and proximal femur 
[62], [150]. To date, this powerful technique has not been applied to quantitative DXA body 
47 
composition scans. We have developed SAM algorithms to analyze pixel-based shape and 
composition from whole-body dual-energy X-ray absorptiometry (DXA) scans [151], [152]. 
Statistical appearance models from reanalyzed DXA images provide dominant modes of variance of 
body shape and thickness across a population. The statistical appearance models can be used to 
investigate associations of body shape and tissue density distribution and demographic (i.e. sex, race, 
etc.) and clinically-relevant disease outcomes (diabetes, sarcopenia, mortality) to identify those at 
high disease risk.  
In this study, we present the methods to prepare DXA data for analysis, the challenges 
associated with image registration, and application of the resulting statistical appearance models to 
estimate mortality risk as a function of body shape. 
4.2.2	Methods		
Here we detail the DXA acquisition and image processing algorithms, as well as the statistical 
appearance modeling techniques. We then describe the statistical analysis of the models to identify 
and visualize SAM modes strongly associated with clinical variables such as sex and race, as well as 
mortality status in a sample of older adults. 
DXA	Scan	Analysis	
In commercial DXA systems, the X-ray attenuation values are used to directly solve for the 
mass of fat and lean soft tissue. We previously derived relationships from calibration phantom X-ray 
attenuations to quantify tissue volume and mass at each pixel in whole-body DXA scans [151]. 
Using custom software developed by the authors in MATLAB (MathWorks, Inc., Natick, MA), we 
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processed the raw low- and high-energy (HE) X-ray attenuation values from a Hologic QDR 4500A 
densitometer (Hologic, Inc., Bedford, MA) to produce three types of images for this study: (1) total 
thickness images, capturing the sum thicknesses all tissues in the body; (2) leanness images, defined 
as the ratio of fat-free (i.e. lean + bone) tissue thickness to total tissue thickness; and (3) R-value 
images, defined as the ratio of low-energy attenuation to high-energy attenuation. R-value decreases 
as thickness increases [130] and is used to calculate soft tissue composition (i.e. percent fat). Note 
that we define thickness here as tissue thickness projected onto the image plane (tissue thickness = 
tissue mass / tissue density * pixel area). Total thickness is thus generally the sum of the tissue 
thickness excluding air cavities. It is equivalent to linear path length an X-ray takes through the 
body.  
Raw X-ray attenuation images from the DXA scanner had a resolution of 327 x 150 pixels, at 
16-bit pixel depth. Each pixel had spatial dimensions of 2mm x 13mm. All images were upscaled by 
a factor of 6.5 in the y-direction to have a resulting resolution of 327 x 975 square (2mm x 2mm) 
pixels. Output thickness and R-value images were exported with 8-bit depth to be compatible with 
some of the annotation software. 
Image	Annotation	
We defined 82 points on the skin edges as well as bony and soft tissue landmarks. A subset of 
available images were used to build an semi-automated annotation algorithm based on Constrained 
Local Model (CLM) methods [153], [154]. The annotator was blinded to participant data. This 
CLM was then run on each of the remaining R-file training images. Point placements by the 
algorithm were manually reviewed and corrected by the human annotator where necessary. 
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Differences in patient positioning led to variations in the extremities, which are of limited 
importance when examining body composition. Thus, we created a 52-point extended torso model, 
which includes the torso, the upper arms and upper legs, but not the forelimbs. 
Statistical	Appearance	Modeling	
Statistical shape and appearance models were constructed from the annotated images. Details 
of the approach can be found in [143]. In summary: (1) A shape model is built by (i) translating 
each set of annotation points so that they have a common center of gravity, (ii) applying Principal 
Component Analysis (PCA) to vectors containing the 2D annotation point coordinates that 
represent the aligned shapes for each image. (2) Shape variation is removed by warping each image to 
a reference frame defined by the mean body shape. Specifically, each image is deformed using a 
piece-wise affine transformation defined by a triangle mesh (see Figure 4-7 and Figure 4-8). (3) A 
“texture” model is built by applying PCA to vectors defined by the pixel-by-pixel grayscale intensity 
of these warped images. Texture models contain no 2D (in-plane) shape variation – only grayscale 
intensity differences due to varying X-ray attenuation measurements for each participant. (4) An 
“appearance” model is built by applying PCA to vectors formed by concatenating the shape and 
texture parameters. Appearance models thus capture both shape and texture information and reveal 
the ways in which shape and texture are correlated. 
Concretely, a completed appearance model represents both (in-plane) shape and texture 
using the linked linear models 
𝑥 ൌ ?̅? ൅ 𝑄௫𝑐 
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𝑔 ൌ ?̅? ൅ 𝑄௚𝑐 
where 𝑥 is a vector containing the annotation point coordinates, ?̅? is the mean shape vector, 𝑔 is 
a vector containing the grayscale pixel intensities in the mean shape reference frame, ?̅? is the mean 
grayscale intensity vector, the columns of 𝑄௫ and 𝑄௚ are the ordered eigenvectors that span the 
variance in shape and texture across the images, and 𝑐 is the vector of appearance model parameters. 
We refer to each eigenvector as a mode of shape and texture variation. These modes linearly map the 
compact parameter vector 𝑐 to the shape and texture vectors 𝑥 and 𝑔.  
    
(a) 82-point 
annotation 
(b) Triangles used 
(82pt) 
(c) 52-point 
annotation 
(d) Triangles used 
(52pt) 
Figure 4-7: Annotation schemes and triangulations for texture warping. A full-body shape model containing 82 
annotation points was initially developed. To eliminate spatial noise introduced by pose variation, a 52-point 
subset model was created that excludes the forelimbs and head. 
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(a) Aligning with 
translation 
(b) Aligning with affine (c) Warping using 
triangles 
Figure 4-8: Mean images created with the 200 R-value images. Images were calculated using alignment with 
(a) translation, (b) translation, rotation, and scaling (affine), and (c) piecewise warping using the triangle 
model in Figure 4-7. Each successive mean image is visually sharper than the last, indicating that the more 
advanced alignment techniques are more effective at eliminating noise from shape and pose variation. 
The appearance model allows new images with different shapes and textures to be generated by 
selecting new values for the parameters in 𝑐. Each image can then be compactly encoded by a vector 
of parameters, 𝑐, obtained by fitting a parameter vector 𝑐 that synthesizes an image as close as 
possible to the original [143]. 
Proof	of	Concept	Sample	
A total sample of 400 older adults (ages 70-79) was selected from the longitudinal Health, 
Aging and Body Composition (Health ABC) study [29], [30], [155]. Two sets of 100 cases 
(participants who died during the first six years of follow-up) and 100 BMI-, sex-, and age-matched 
controls were selected. One set was used for model calibration and the other was used for validation. 
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Selection was stratified by sex and race (black and white). The Health ABC study was initiated in 
1997 by the National Institute on Aging to examine the impact of changes in body composition and 
health conditions on age-related physiologic and functional status. At baseline, each participant 
received numerous clinical evaluations including whole-body DXA scans acquired using Hologic 
QDR 4500A systems (Hologic, Inc., Bedford, MA) and software version 9.03, located at two study 
sites. Validity of fan-beam DXA for measuring fat-free mass and leg muscle mass has been previously 
reported [156]. 
Statistical appearance models were trained on the calibration dataset and validated on the 
validation dataset. We investigated the bivariate association of the SAM parameter vectors to 
continuous variables of BMI and age using general linear regression models (proc GLM), and 
categorical variables of mortality status, sex, and race using logistic regression (proc LOGISTIC). 
Stepwise selection for the most significant SAM parameters, i.e. the number the explained 95% of 
the variance, were used to select parameters at a significance of 𝑝 ൑ 0.05 to estimate each outcome 
variable. All statistical analysis was done using SAS software, version 9.2 (SAS Institute, Inc., Cary, 
NC). This study and all included analyses were approved by Health ABC and the UCSF Committee 
on Human Research. 
4.2.3	Results	
Statistical	Appearance	Model	Training	
Figure 4-7 (a) shows the 82 points used to describe the outline of the body and some key 
landmarks on the skeleton. Figure 4-7 (b) shows the associated triangulation scheme used to warp 
the image to a reference frame. Figure 4-7 (c) shows the 52-point subset that excludes the points 
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associated with the lower arms and legs. Figure 4-7 (d) shows the associated triangles to the 52 
points. Wherever possible, the triangles in the 52-point annotation are unchanged from the 82-point 
annotation. This demonstrates how our algorithm can select how the image is warped by manually 
defining the triangle relationships. Table 4-1shows the relevant demographic and anthropometric 
markers for the sample participants included in this study. Figure 4-8 shows the mean image of the 
200 calibration participants with progressively more sophisticated registration: (a) translating the 
images so that the centres of gravity coincide, (b) applying an affine transformation so that the 
bounding boxes coincide, and (c) using the full piece-wise affine transformation from triangulated 
mesh. The final registration has corrected for a range of body positions and shapes to bring all the 
pixels into approximate correspondence, allowing analysis of equivalent structures to be done easily. 
The images are displayed using the histogram equalised R-images. The models are built from 200 
examples and their reflections (400 samples in total). 
We found that 23 shape modes explained 95% of the shape variance defined by our markers. 
The first 6 shape modes are shown in Figure 4-9. Furthermore, after registering all images to the 
average shape, we found that 261 texture modes explained 95% of the variance in X-ray attenuation 
(represented as greyscale.) Six texture modes are shown in Figure 4-10. Figure 4-11 shows the 
combination of the shape and texture variances to form the full statistical appearance model. The 
first 237 SAM modes explained 95% of the combined shape and texture appearance. The model is 
capable of synthesizing both in-plane shape changes and intensity changes, and shows the main 
correlations between the two. 
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Table 4-1: Demographic characteristics of selected participants in HealthABC study. 
Variable White Men Black Men White Women Black Women P-value 
Calibration set N = 51 N = 49 N = 50 N = 50  
Age at baseline (yrs) 75.7 (3.0) 73.3 (2.7) 74.3 (3.0) 74.2 (3.1) <0.01 
Height (cm) 172.8 (5.8) 172.1 (5.8) 158.9 (5.2) 158.9 (6.6) <0.01 
Weight (kg) 80.7 (12.8) 77.5 (17.0) 66.0 (12.6) 71.6 (13.1) <0.01 
BMI (kg/m2) 27.1 (4.3) 26.1 (5.3) 26.2 (5.0) 28.4 (4.9) 0.07 
BMI Category (n)  
     Underweight 1 5 4 0  
     Normal 16 16 14 10  
     Overweight 22 16 26 26  
     Obese 12 12 6 14  
6-year status (n)  
     Living 26 24 25 25  
     Deceased 25 25 25 25  
Sagittal diameter (cm) 22.8 (3.2) 21.9 (3.7) 21.1 (2.8) 22.7 (2.8) 0.03 
Abdominal circ. (cm) 101.1 (10.7) 96.4 (14.8) 96.4 (11.2) 97.7 (12.3) 0.18 
Validation set N = 50 N = 50 N = 50 N = 50  
Age at baseline (yrs) 74.7 (3.2) 72.4 (2.6) 74.0 (2.5) 74.1 (2.8) <0.01 
Height (cm) 172.2 (5.4) 172.7 (7.3) 159.8 (5.4) 159.8 (6.2) <0.01 
Weight (kg) 76.6 (9.8) 78.7 (14.7) 65.4 (13.5) 72.6 (11.9) <0.01 
BMI (kg/m2) 25.8 (2.9) 26.3 (4.3) 25.7 (5.6) 28.5 (4.9) 0.08 
BMI Category (n)  
     Underweight 0 0 2 0  
     Normal 24 20 22 14  
     Overweight 20 22 16 20  
     Obese 6 8 10 16  
6-year status (n)  
     Living 25 25 25 25  
     Deceased 25 25 25 25  
Sagittal diameter (cm) 21.8 (2.6) 22.2 (3.3) 20.6 (3.4) 22.4 (3.3) 0.02 
Abdominal circ. (cm) 98.9 (9.2) 97.1 (12.5) 97.2 (14.7) 97.1 (11.9) 0.86 
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Mode 1 Mode 2 Mode 3 
Mode 4 Mode 5 Mode 6 
Figure 4-9: Shape only modes (first 6). For each mode, the ±3 standard deviation (left and right respectively) 
images are shown. 23 modes were required to explain 95% of shape variance. At a high level, we see that body 
height is captured in Mode 1, width in Mode 5, and android/gynoid shape variation in Mode 2. Note that 
several modes capture variation in subject pose. 
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Mode 1 Mode 2 Mode 3 
Mode 4 Mode 5 Mode 6 
Figure 4-10: Texture only modes (first 6). For each mode, the ±3 standard deviation (left and right respectively) 
images are shown. 261 modes explained 99% of the variance. Since this model captures only texture 
information, all images have the same shape, but differing grayscale intensity indicating different 
distributions of tissues throughout the regions of the body. 
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Mode 1 Mode 2 Mode 3 
Mode 4 Mode 5 Mode 6 
Figure 4-11: Combined appearance modes (first 6). For each mode, the ±3 standard deviation (left and right 
respectively) images are shown. 237 modes explained 99% of the variance. This model captures dominant 
modes of variation in both texture and shape. 
Alternative	Representations	of	the	Statistical	Appearance	Model	
Several examples are given of how different appearance models can be created from different 
texture information found in the DXA images. Figure 4-11 shows the first 6 modes of the R-value 
images where white represents higher density. Figure 4-12 shows the first 8 modes of an appearance 
model of shape and body thickness, using a 52-point annotation excluding the forelimbs. Figure 
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4-13 shows a combined appearance model of shape, thickness, and leanness, where thickness is 
encoded as green and leanness is encoded as red in an RGB image. Linear scaling was applied to 
ensure the data range was in 0 to 255 range. The blue channel was not used. 
   
Mode 1 Mode 2 Mode 3 Mode 4 
Mode 5 Mode 6 Mode 7 Mode 8 
Figure 4-12: The first 8 appearance modes for a SAM of solid body thickness (lean + fat thickness) and 52-
point annotation. (±3 SD). We see significant differences in body shape roughly corresponding to weight, 
height, and sex in Modes 1, 2, and 3, respectively. Again, pose variation is captured in multiple modes. 
    
Mode 1 Mode 2 Mode 3 Mode 4 
    
Mode 5 Mode 6 Mode 7 Mode 8 
Figure 4-13: Hybrid model of shape, thickness, and leanness including bone. Total thickness is represented by 
green intensity and %lean by red intensity. (±3 SD). Mode 1 captures dramatic body shape and composition 
variance ranging from a high-lean, low-thickness (thin) phenotype to a low-lean, high-thickness phenotype. 
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Sex Race 
Figure 4-14: Linear regression models of sex and ethnicity using the combined appearance model of Leanness 
+ Thickness images (±3 S.D.s). There were 3 appearance modes used in the sex model that achieved an AUROC 
of 0.99. There were 6 appearance modes used in the Race model that achieved an AUROC of 0.91. These 
models show that statistical appearance of body shape, thickness, and leanness accurately identifies sex and 
race differences in the sample population. 
Descriptive	Models	
Bivariate correlation coefficients between demographic and anthropometric variables and 
shape modes are found in Table 5-2. Of these variables, we found that only height predicted sex 
(AUC = 0.95). Body thickness and leanness, however, was more strongly predictive of sex - the final 
logistic model includes three shape modes (Table 5-3) and achieved AUC = 0.99. No combination 
of the following anthropometric or demographic variables (of sex, BMI, height, weight, sagittal 
diameter, nor abdominal circumference) predicted race even though this may not be universally true 
in all datasets.  However, body thickness and leanness was a strong predictor of race – the final 
logistic model includes six shape modes (Table 5-3) and achieved AUC = 0.91. Visualizations of sex 
and race models are shown in Figure 4-14. Using a statistical appearance model of body thickness on 
the calibration dataset, we found that a logistic model with three SAM parameters predicted 
mortality with AUC = 0.66. Example images of low- and high-risk body appearances are shown in 
Figure 4-15. Note that the primary differences between the low and high risk were the apparent lung 
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volume and waist shape. The mortality model had an AUC = 0.62 when applied to the validation 
dataset. Regression equations for sex, race, and mortality are provided in Table 5-3. 
Table 4-2: Correlation coefficients for each principal component of the shape model versus demographic and 
anthropometric variables 
 PC1  PC2  PC3  PC4  PC5  PC6  PC9  PC10 
Age           
Sex  ‐0.19  0.69  ‐0.39    0.35      
Race    0.23  0.37     0.22  ‐0.21  ‐0.26 
BMI   0.93  0.27         
Height  0.22  ‐0.89  0.29        
Weight  0.95  ‐0.24       0.18   
Sagittal diameter   0.89  0.16    ‐0.16      ‐0.16 
Abdominal circ.  0.86     ‐0.24       
These components correspond to the images in Figure 4-9. Only correlations with 𝑷 ൑ 𝟎. 𝟎𝟓 are shown. Bold 
denotes 𝑷 ൑ 𝟎. 𝟎𝟏 and shading denotes 𝑷 ൑ 𝟎. 𝟎𝟎𝟏. 
 
Table 4-3: Logistic regression equations for sex, race, and mortality 
Model Type Outcome Equation 𝛼 Train AUC 
Thickness + 
leanness* 
Sex P(male) = (1+e-α)-1 -0.178 - 0.0026pc1 + 0.0041pc2 + 0.0027pc3 0.99 
Race P(white) = (1+e-α)-1 0.130 - 0.0019pc3 - 0.0008pc4 - 0.0019pc6 - 0.0009pc7 - 0.0013pc8 + 
0.0042pc16 
0.91 
Thickness** Mortality P(deceased) = (1+e-α)-1 0.0336 - 0.0015pc10 + 0.0014pc11 - 0.0026pc23 0.66 
Parameters for each model were selected using stepwise regression with a required P-value of 0.05 to stay in 
the model. *Visual representations of the first 8 thickness + leanness appearance modes are shown in Figure 
4-14. ** Figure 4-13 shows the first 8 thickness appearance modes. 
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Low mortality 
risk 
High mortality 
risk 
Difference 
Figure 4-15: Linear regression model of mortality status using the combined appearance model of Thickness 
images (±3 S.D.s). There were three appearance modes used in the model that achieved training AUC of 0.66 
and validation AUC of 0.62. In the difference image, green indicates greater thickness in the low-risk image 
and red indicates greater thickness in the high-risk image. 
4.2.4	Discussion	
We have developed methods to describe and analyze the rich regional body shape and 
composition information captured in whole-body DXA images. We applied statistical appearance 
modeling techniques to body thickness and leanness images derived from raw DXA attenuation data. 
The resulting SAM principal components describing holistic body shape were shown to be highly 
predictive of race and sex, indicating that this technique is capable of distinguishing the unique 
shape characteristics of each group. Importantly, appearance modes of body thickness were 
predictive of mortality status. Inspection of the body shape differences captured by the appearance 
model (Figure 4-15) reveals interesting features such as apparent lung volume that differ by mortality 
status. These results suggest that this technique could be used to elucidate body shape and 
composition phenotypes that may be strongly associated with health status, provide new metrics for 
risk assessment in individuals, and reveal body features worthy of further research. 
Previous work in this area was performed by Wilson in his PhD dissertation [157]. Wilson 
created whole-body principal component models that used only rigid affine-aligned thickness 
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images. This work did not include piecewise registration, or other image types. The preliminary 
models had a blurry appearance, similar to Figure 4-8(b), due to the lack of precise registration. 
Nonetheless, Wilson was still able to show strong correlations to patient demographic variables. 
Later, Wilson showed that body shape was related to mortality using trunk to leg volume ratios from 
DXA images [73]. In his fully adjusted models for mortality, he demonstrated strong AUC values of 
0.83. Besides the representation of body shape, the Wilson study design differed from our design in 
population (Wilson: NHANES 1999-2004, ages 20 to 85 years; Health ABC: 75 years at baseline) 
and adjustments (Wilson: Age, gender, race, BMI, waist circumference, activity level, poverty index; 
Health ABC: none). Further future evaluations are planned in the NHANES population Wilson 
used to directly compare the SAM methods directly to simple measures like trunk to leg volume 
ratio. 
Shape and appearance modeling has been applied to proximal femur DXA scans with success  
[150], [158], [159]. Goodyear et al. [159] showed that the combination of shape and appearance 
models with bone density produced the best AUC = 0.65 compared to any single measure for 
predicting hip fracture risk. To our knowledge, this is the first application of SAM techniques to 
whole-body DXA images. The models for sex, race, and mortality risk derived herein demonstrate 
the potential of this approach to provide novel and significant image features from standard DXA 
data.  
This study had notable strengths. First, there was a similar number of men and women, and 
black and white participants. This is important because the models derived are equally weighted by 
sex and ethnicity. Second, because of our case and control design, we were able to increase the signal 
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present in the model for mortality over what would be expected in a prospective study of the same 
number of participants. However, this study had some limitations. First, the DXA data was acquired 
on one make of DXA system (Hologic). Our statistical appearance models would not be applicable 
to other makes without further validation. Additionally, the study population was limited to a 
narrow age range. A more complete analysis of body shape and appearance in a broader, 
representative sample of adults is warranted to ensure generalizability. Another issue was the limited 
data available for training the constrained local model for automatic annotation of the DXA images. 
All images required some degree of manual annotation point adjustment where the automated 
placement algorithm did not accurately detect body landmarks. Given sufficient high-quality 
training data, though, the automated CLM technique has been shown to achieve very good accuracy 
[153]. We expect that a large training dataset of DXA images across a wide range of body shapes and 
compositions would yield a precise and accurate active appearance model for fully-automated 
annotation. 
Detailed models of the body shape and tissue distribution offer significantly more 
information than standard DXA analyses. This study demonstrates a method for describing holistic 
body shape, thickness, and leanness that reveals unique features by sex, race, and also predicts 
mortality risk. Further study is warranted to investigate body shape associations to other outcome 
variables of interest, across different populations. As this technique utilizes standard whole-body 
DXA image data, it is readily applicable to several existing study databases of DXA scans. In 
addition, supervised methods of feature selection beyond principal component analysis may yield 
more sensitive and specific predictors for clinical outcomes. 
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4.3: Body Composition Appearance and Metabolic Disease across Ethnicities 
4.3.1	Introduction	
 Simple anthropometric measurements of body size such as body mass index (BMI) and waist 
circumference have long been shown to be significant indicators of metabolic risk for cardiovascular 
disease and diabetes [81], [82]. Trunk-leg-volume-ratio, a metric that assesses the general shape of 
the body, is a strong predictor of diabetes and mortality risk independent of BMI [73]. Body 
composition measurements, including holistic percent fat/lean and the quantification of visceral 
versus subcutaneous fat are even stronger predictors of metabolic risk [68], [160], [161]. It is evident 
that body size, shape, and regional composition offer significant insight into metabolic status and 
health risk. Whole-body Dual energy X-ray absorptiometry (DXA) imaging is a proven clinical 
method for total and regional body composition assessment [156], [162]–[164]. DXA provides a 
detailed 2D image of fat, lean, and bone mass throughout the body, however measurements are only 
reported for coarse regions (arms, legs, trunk). We developed statistical appearance models (SAMs) 
to capture 95% of the imaged variance in fat and lean tissue distribution. We hypothesized that 
detailed SAM descriptors of the distribution of adipose and lean tissues throughout the body would 
strongly predict metabolic status, across a range of different ethnicities. 
4.3.2	Methods	
Data from a sample of 2,000 older adult men and women across five different ethnicities 
were used in this analysis. We directly processed and analyzed whole-body DXA image data to 
construct SAMs of fat, lean, and bone tissue. Logistic regression equations were derived to predict 
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metabolic syndrome (MetS) status and diabetes status. We describe the details of each component of 
the study below. 
Participants	
The present analysis was performed as part of the cross-sectional Multiethnic Cohort (MEC) 
Obesity, Body Fat Distribution, and Cancer Risk study (NIH NCI 1P01CA168530). This study 
involved re-contacting 2,000 participants from the parent population-based Multiethnic Cohort 
study of 215,000 men and women across five different ethnicities (African American, Japanese, 
Latino, Native Hawaiian, and Caucasian). Re-contacted participants in the MEC Obesity study were 
selected to have an age between 60-72 years. Enrollment was stratified by sex, ethnicity, and six BMI 
categories (18.5-21.9, 22-24.9, 25-26.9, 27-29.9, 30-34.9, and 35-40 kg/m2). 
Enrolled participants underwent whole-body DXA and abdominal magnetic resonance 
imaging, blood and stool specimen collection, as well as health and lifestyle questionnaires. 
Recruitment was performed at the University of Hawaii Cancer Center (UHCC, Honolulu, HI) and 
the University of Southern California (USC, Los Angeles, CA). Participants were scanned between 
May 2013 and April 2016. All participants provided informed consent, and the study protocol was 
approved by Institutional Review Boards at USC (#HS-12-00623), UHCC (CHS#17200), and 
UCSF (IRB#12-10255). 
Dual	Energy	X‐Ray	Absorptiometry	
Whole-body DXA scans were acquired on a Hologic Discovery/A system (Hologic Inc., 
Marlborough, MA, USA). All scans from both study sites were analyzed at the University of 
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California, San Francisco (UCSF) by a single International Society for Clinical Densitometry 
(ISCD) certified technologist using Hologic APEX software (version 3.3). Participants were clothed 
in examination gowns, without shoes, and positioned on the scanner table with arms out to the side, 
hands flat on table and feet in planarflex position, in accordance with the manufacturer’s standard 
protocols. Participants with a high BMI (men >32kg/m2, women >31kg/m2) were systematically 
measured with a hemi-scan, where the participant is offset on the table such that the torso and right 
arm are within the scan region, and the left arm is extended off the table. For hemi scans, analysis is 
performed assuming symmetry of the arms. 
DXA scanners were cross-calibrated using in vivo data of 12 individuals who underwent 
scans at both sites within 3 days. Each scanner was kept in regular calibration using phantom 
scanning protocols and according to ISCD guidelines. 
DXA	Image	Processing	
Using custom algorithms developed in consultation with the device manufacturer, we 
process each scan file produced by the Hologic system into separate images of bone mass, fat mass, 
and lean mass. These algorithms follow the method described by Blake, Wahner, and Fogelman 
[130]. Utilizing calibration information from known phantom scans, we quantified the mass of each 
tissue type at each pixel in a 654x300 whole-body image. Images were linearly scaled to a resolution 
of 654x1914 to have square pixels of length 1.02 cm on each side. DXA scan files have a native 16-
bit depth. Processed tissue images were saved in maximum-quality JPEG format with 8-bit depth. 
To maximize dynamic range in the processed tissue images, we calculated the 98th percentile of tissue 
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mass observed at any pixel across all images. Those values were mapped to the maximum 8-bit 
intensity (255) for each tissue type (fat, lean, and bone). 
Statistical	Appearance	Modeling	
 
Figure 4-16: Schematic representation of the Statistical Appearance Modeling approach utilized in the present 
study.  
Statistical shape and appearance models for the processed DXA images were constructed for 
each sex using the method described by Cootes [143] and am_tools version 3 software (University of 
Manchester, UK). A visual representation of the SAM method is shown in Figure 4-16. In brief, an 
87-point shape model outlining the head, trunk, upper legs, spine, pelvis, and femurs was annotated 
on each image. The specific list of point definitions can be found in the shepherd-lab/dxa_sam 
repository (see Appendix: Code Availability). Note that this point set differs from the prior set 
defined in the pilot study (see section 4.2.2 ). Annotation was performed in a semi-automated 
manner using a random forest regression voting model [153] in conjunction with human review. A 
vector of the two-dimensional coordinates of the 87 annotation points define the “shape” of each 
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image. Triangles defined between these points are used to perform piecewise affine transformations 
to warp each image to the calculated average (mean) shape. A vector of grayscale pixel values in the 
warped reference frame define the “texture” of each image. “Appearance” is defined as the 
concatenation of shape and texture vectors. Each participant DXA image is thus processed into three 
different vector representations (shape, texture, appearance) for each of three different tissue types 
(fat, lean, and bone). 
Principal component analysis was performed to reduce the high dimensionality of the shape, 
texture, and appearance data to a compact orthogonal space that captures 95% of the original image 
variance. The resulting principal components linearly define the modes of greatest variance in body 
shape and tissue distribution. Each image can be represented in this principal component space as a 
vector of principal component coefficients. These components compactly describe rich variation in 
body shape. 
Statistical	Analysis	
Analyses were performed using SAS version 9.4 (SAS Institute, Cary, NC), R version 3.4.2 
(The R Foundation), and MATLAB R2016a (The MathWorks Inc., Natick, MA). Mean principal 
component coefficient vectors were calculated for each sex and ethnicity subgroup. These mean 
vectors were used to synthesize the average fat and lean shape, texture, and appearance for each 
subgroup. 
Metabolic syndrome was classified using the National Cholesterol Education Program 
(NCEP) Adult Treatment Panel III as described in section 1.2: [165]. Diabetes was classified as 
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fasting plasma glucose at or above of 126 mg/dL or A1C at or above 6.5 percent, in accordance with 
American Diabetes Association guidelines [166], or if the participant is currently taking antidiabetic 
medication. Separate models were derived for men and women.  
Predictive equations were derived for metabolic syndrome and diabetes status using logistic 
regression with LASSO selection (cv.glmnet in R package glmnet version 2.0-13). Candidate 
variables for model selection were the principal components that explained up to 95% of variance in 
shape, texture, or appearance for whole-body fat and lean tissue. Models were trained on a random 
subset of 80% of the available data and validated on the remaining 20%. 5-fold cross validation was 
applied during model selection on the training set. Relative performance of the models was assessed 
by comparing area under the receiver operating characteristic curve (AUROC). 
Mean shape, texture, and appearance for each sex/ethnicity subgroup was calculated. The 
derived MetS prediction models were applied to the mean images to estimate prevalence of MetS 
within each subgroup. For comparison, equivalent logistic regression models were derived using 
BMI as a predictor and applied to the subgroup means.  
The derived logistic regression equations were used to predict risk for MetS and diabetes for 
the calculated mean fat appearance for each sex and ethnicity subgroup. The resulting risk estimates 
were compared against the observed prevalence of MetS and diabetes in the dataset. 
4.3.3	Results	
1,861 participants completed the study protocol. Of these, six were excluded from the 
present analysis due to significant DXA scan artifacts (e.g. metal implants). Statistical appearance 
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models were generated for each of lean and fat tissue using the 1,855 valid DXA images at a 
resolution of 64,000 pixels. A summary of included participant characteristics is provided in Table 
4-4. Body mass index, fat mass index, and lean mass index for each subgroup are shown in Figure 
4-17. 95% of body shape variance for males and females was compactly captured in 23 and 21 
principal components, respectively. More modes were required to capture 95% of variance in fat and 
lean appearance, and over 150 were required to capture 95% of fat and lean texture. Correlations 
between shape, texture, and appearance principal components and metabolic markers of interest are 
shown in Table 4-5 and Table 4-6 for males and females, respectively. 
 
Figure 4-17: Mean body mass index and fat/lean composition by sex/ethnicity subgroup. 
Mean fat texture by sex (across all ethnicities), and by sex and ethnicity subgroup were 
calculated. Subgroup images were subtracted from the overall sex mean and plotted in Figure 4-18. 
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Marked differences, particularly in the trunk versus leg regions, are apparent. For example, 
Caucasian individuals exhibit greater-than-average adipose deposition in the legs, but lower-than-
average deposition in the trunk. The converse is apparent in the mean images for Latino individuals. 
Hawaiian men and women appear to have greater-than-average adipose deposition around the hips, 
but do not otherwise appear significantly different than the mean fat distribution. Notably, the 
characteristic fat distributions for each ethnicity appear consistent across sexes. Corresponding 
analysis was performed for the lean tissue texture. The resulting images are shown in Figure 4-19. 
The logistic regression models derived to predict MetS and diabetes status as a function of fat 
appearance modes are shown in Table 4-7. In general, models seem to perform better (in terms of 
higher AUROC) in the male sample than the female sample. BMI unsurprisingly remains a strong 
predictor of MetS (overall body size, measured by waist circumference, is one of the diagnostic 
criteria for MetS); it is not immediately clear that SAM analysis provides better insight. However, 
shape and appearance models significantly outperform BMI as predictors for diabetes status. 
The derived logistic models were applied to the synthesized mean fat appearance of each 
sex/ethnicity subgroup, thus predicting risk of MetS for each subgroup. Risk estimates were 
normalized to the estimates for each sex, across all ethnicities, and compared to the actual observed 
prevalence of MetS in the sample population. These results are shown in Figure 4-20. 
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Figure 4-18: Weighted mean statistical texture of whole-body DXA fat by sex and ethnicity. The mean fat 
texture of each subgroup is shown relative to the overall means across all ethnicities. Marked differences, 
particularly in the trunk and leg regions, are apparent. Notably, fat distributions for each ethnicity are 
consistent across sexes.  
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Figure 4-19: Weighted mean statistical texture of whole-body DXA lean by sex and ethnicity. The mean lean 
texture of each subgroup is shown relative to the overall means across all ethnicities. 
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Table 4-7: Logistic regression equation performance for MetS and diabetes status as a function of fat shape, 
texture, and appearance modes. Data were randomly assigned to training (80%) or validation (20%) sets. 
Outcome Variable Sex Model Type # of selected 
PCs 
Training 
AUC 
Validation 
AUC 
Metabolic 
Syndrome 
Male Shape 41 0.86 0.82 
Fat Texture 69 0.89 0.84 
Fat Appearance 63 0.90 0.83 
Lean Texture 60 0.89 0.85 
Lean Appearance 47 0.89 0.85 
Combined 29 0.87 0.87 
Female Shape 26 0.83 0.78 
Fat Texture 13 0.84 0.80 
Fat Appearance 30 0.86 0.80 
Lean Texture 43 0.88 0.81 
Lean Appearance 46 0.88 0.82 
Combined 7 0.84 0.82 
Diabetes Male Shape 31 0.74 0.69 
Fat Texture 43 0.78 0.70 
Fat Appearance 76 0.80 0.70 
Lean Texture 2. 0.74 0.71 
Lean Appearance 49 0.79 0.73 
Combined 29 0.77 0.75 
Female Shape 38 0.76 0.66 
Fat Texture 22 0.75 0.63 
Fat Appearance 7 0.70 0.66 
Lean Texture 79 0.82 0.67 
Lean Appearance 65 0.82 0.68 
Combined 47 0.80 0.68 
Parameters for each model were selected using stepwise regression subject to minimization of the Schwarz-
Bayesian Information Criterion 
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4.3.4	Discussion	
In this work we demonstrate statistical appearance modeling of whole-body fat and lean 
distribution from whole-body DXA images. Using unsupervised principal component analysis, we 
identify metabolically-significant modes of variation in fat and lean distribution. These models reveal 
sex- and ethnicity-specific fat distribution phenotypes that are likely the product of genetic and 
lifestyle characteristics. Further analysis against other -omic variables may provide insight into the 
complex mechanisms that dictate the macroscopic manifestation of body shape and composition. 
That these unsupervised models produce predictive indicators of metabolic syndrome and diabetes 
status suggests that the spatial distribution of body tissues is metabolically significant. This supports 
several previous works that have demonstrated the significance of visceral fat versus subcutaneous fat, 
as well as android adiposity versus gynoid adiposity. Holistic analysis of high-resolution whole-body 
compositional images provides a means of identifying new markers for metabolic health. 
This study had a few limitations. First, the recruitment was limited to a narrow age range and 
was not evenly distributed across sex and ethnicity subgroups. Analysis of a larger distribution of 
ages, ethnicities, and BMIs would produce models that better represent the wide variation in body 
shapes and size. Further investigation of special populations such as those affected by sarcopenia or 
lymphedema would yield valuable insight into unusual body compositions and metabolic states. A 
second issue was slight pose variations in the DXA images. This introduced positioning noise that 
could be seen in a number of statistical appearance modes. Careful positioning at the time of 
scanning, as well as careful image registration should ameliorate this issue. In future studies we plan 
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to investigate the metabolic significance of specific sub-regions of the body, registered across all 
individuals in the sample. 
A significant advantage of the presented technique is that it utilizes conventional whole-body 
DXA data. No additional measurements are required to perform this analysis. Thus, it is possible to 
apply this technique to numerous large DXA datasets from various studies on numerous 
populations. Coupled with advanced methods of supervised learning and computer vision, this 
provides a platform for identifying new biomarkers from established imaging techniques. 
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5 | 3D Surface Scanning for Metabolic Health Assessment 
5.1: Clinical Anthropometrics from Commercial 3D Body Scanners 
5.1.1	Introduction	
Regional body shape and composition provide stronger indicators of obesity-related metabolic 
risk than body mass index (BMI). Goodpaster et al. showed that normal weight men with high 
visceral adipose levels were twice as likely to have metabolic syndrome [167]. Wilson et al. showed 
that the individuals in the highest quintile of trunk to leg volume ratio are at 6.8 times greater risk 
for diabetes [73]. Common methods for body composition assessment include bioelectrical 
impedance analysis (BIA), air displacement plethysmography (ADP), and dual-energy X-ray 
absorptiometry (DXA). Of these, DXA is the only method that provides regional information, but 
DXA is not suitable for large populations due to its relatively high cost and use of ionizing radiation. 
There is an unmet need for accessible tools for accurate regional body composition assessment.  
We investigated the use of 3D whole-body surface scanning for clinical anthropometry as well as 
total and regional body composition measurement. These systems generate surface renderings and 
automated circumference and length measurements across the entire body. Several studies have 
assessed their ability to accurately and precisely quantify clinically-relevant measures. Wells, et al. 
reported 0.5 cm precision on body circumferences (chest, waist, hips, etc.) using a six-camera 
structured light scanner [114]. Wang, et al. reported precise (%CV=0.38) whole-body volume 
measurements using a four-camera laser-triangulation scanner [115]. Lin, et al. reported correlations 
between 3D anthropometric measures and metabolic risk factors [168], [169]. Lee, et al. 
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demonstrated accurate prediction of whole-body and regional fat mass and percent fat from regional 
volume and length measures from an eight-camera structured illumination scanner [128]. 
Development of low-cost light-coding technology has enabled more affordable 3D scanners such as 
the TC2 KX-16 (Cary, NC) [170] and the Fit3D ProScanner (Redwood City, CA). 
In summary, 3D body surface scanning is a compelling tool for metabolic status assessment that 
offers inexpensive, radiation-free, and automated collection of hundreds of measurements that would 
otherwise require significant time and personnel resources to collect. The objective of this study was 
to validate direct anthropometric and derived body composition measurements from 3D whole-body 
surface scans against criterion methods. 
5.1.2	Methods	
We conducted a cross-sectional stratified study of healthy adults. 3D scan measurements 
(circumferences, surface areas, and volumes) were systematically compared to manual 
anthropometry, DXA, and ADP. Predictive equations were derived to estimate DXA body 
composition using 3D scan measurements. 
Participants	
There were two participant groups: a calibration group and field validation group. Calibration 
participants were recruited using flyers posted around UCSF between January 2014 and May 2015. 
Calibration group recruitment was stratified by age (20-40, 40-60, 60+ years), sex, and BMI (normal 
< 25 kg/m2, 25 kg/m2 ≥ overweight < 30 kg/m2, obese ≥ 30 kg/m2). Eligible participants were 
identified as ambulatory individuals within the study strata. Exclusion criteria included current 
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pregnancy, missing limbs, non-removable metal in the body (e.g. joint replacements), a history of 
body-altering surgery (e.g. liposuction), and significant hair that cannot be contained within a swim 
cap. Each calibration participant underwent a whole-body DXA scan and two 3D optical scans, with 
repositioning. Weight, height, and waist and hip circumferences (each in duplicate) were recorded. 
All measures were acquired at the UCSF Clinical and Translational Science Institute (CTSI) Body 
Composition, Exercise Physiology and Energy Metabolism Laboratory (San Francisco, CA). 
Calibration participants gave informed consent and the study protocol was approved by the UCSF 
Committee on Human Research.  
Participants in the field validation group were scanned at one of eight fitness centers in the 
United States and Australia for body shape self-assessment purposes between July and November 
2014. Each participant had a BIA percent fat measurement and a 3D body scan on the same day. 
Validation participants were selected to have height, weight, BMI, and age measurements within the 
minimum-maximum ranges of the calibration dataset. It should be noted that BIA measurements 
were user-reported, and the BIA hardware and acquisition protocols were uncontrolled. All field 
validation participants signed a waiver of consent authorizing the use of their anonymized scans by 
the investigators. 
3D	surface	scans	
3D surface scans were acquired on a Fit3D ProScanner (Fit3D Inc., Redwood City, CA) 
according to a standard protocol. The device consists of a rotating platform and a 3D optical light-
coding camera mounted in a tower two meters from the center of the platform. Users grasp 
adjustable handles mounted on the platform such that their arms are straight and relaxed, abducted 
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from the body. When buttons on the scanner handles are depressed by the user, a 360-degree 3D 
image is acquired while the platform rotates once around in approximately 40 seconds. Although 
only 11 circumferences (chest, waist, and hips; as well as left/right biceps, forearm, thigh, and calf) 
are reported to end users, 476 anthropometric measurements from the neck down to the ankles and 
wrists are automatically derived and stored in a proprietary database. In general, the head, hands, 
and feet are excluded from all circumference, surface area, and volume calculations. The Fit3D 
system was chosen for this study over other models because approximately 100 of these systems are 
available to the public at fitness centers across the US. 
Each calibration participant was scanned twice, with repositioning. Form-fitting boxer briefs 
and a swim cap were provided for each participant. Male participants were scanned topless while 
female participants wore a sports bra. Each validation participant was scanned once, in personal 
form-fitting clothing, with long hair tied above the neck. 3D scan data and measurements were 
transferred securely from Fit3D to UCSF. 
For quality control we performed 41 scans of a female mannequin (part #DSPEFAMW, Display 
Warehouse, San Diego, CA) with repositioning over a two-month period (data not included). Chest, 
hip, thigh, and waist circumference as well as total body volume showed high long-term stability 
with coefficients of variation between 0.25 and 1.2%. 
DXA	
Only calibration participants received a DXA scan as the criterion method for body 
composition. Whole-body scans were acquired on a Hologic Discovery/W or Horizon/A system 
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(Hologic Inc., Marlborough, MA). All scans were centrally analyzed at UCSF by a single ISCD-
certified technologist using Hologic Apex software (version 13.5.2.1) and NHANES calibration 
[132]. Participants were scanned in examination gowns, without shoes. Participants were centered 
on the scanner table with arms out to the side, hands flat on table, and feet in planarflex position, in 
accordance with the manufacturer’s standard protocols. The standard DXA output includes percent 
fat, fat mass, lean mass, and total mass for the whole body as well as the arms, legs, torso, and head. 
In addition, total and regional body volumes were derived for each region on the DXA report (arms, 
legs, trunk, whole body) using the equations of Wilson et al. [151]. 
ADP	
Only calibration participants received an ADP measurement as the criterion method for total 
body volume. Measurements were performed using a Bod Pod (COSMED USA, Inc., Chicago, IL). 
Before each measurement, the instrument was calibrated by placing a hollow cylinder with known 
volume into the Bod Pod. Participants wore the same outfit for the ADP measure as for the 3D 
optical scan (swim cap, boxer briefs, and a sports bra for females). Body volume is measured by the 
body’s air displacement with corrections for residual lung volume and surface area artifacts. Details 
of the standard ADP protocol are described elsewhere [90].  
Statistical	Methods	
All analyses were performed using SAS version 9.4 (SAS Institute, Cary, NC). Univariate linear 
regressions were performed to assess agreement of selected clinically-relevant anthropometric 
measurements acquired on the 3D scanner versus criterion methods: hip and waist circumference 
tape measurements, body surface area estimated using the Du Bois model (12), and whole/regional 
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body volumes calculated from ADP and DXA, respectively. Student’s t-tests were performed to 
detect significant measurement biases between 3D measurements and criterion methods. 
Measurements were assumed to be normally distributed. A critical P-value of 0.05 was considered 
significant. Coefficients of variation (%CV) and root mean square error (RMSE) were calculated for 
the matched test-retest measurements from the 3D optical scanner. Coefficients of determination 
(R2) reported in this study are adjusted for multiple variables where applicable. 
Predictive equations were derived for whole-body and regional DXA body composition 
variables, including percent fat, fat mass, and visceral fat mass. Where available, we derived linear 
regression equations using the parameters described by Lee [128], [171]. The ratio of waist girth to 
waist width was used as a surrogate for “central obesity depth” defined by Lee. Waist girth and width 
were likewise used as surrogates for “central obesity width” as defined by Lee. We further derived 
predictive equations for fat free mass in each compartment (whole body, legs, and trunk) using the 
same parameters as the fat mass equations. Equations were derived using linear regression (proc 
GLM). Additional equations were derived for fat and lean mass in the arms, by using stepwise linear 
regression (proc GLMSELECT, selection=STEPWISE) and over 18 length, area, and volume 
measurements of the arms and trunk. Selection was performed subject to minimization of the 
Schwarz-Bayesian Information Criterion, with 5-fold cross validation on the calibration data.  
Since DXA scans were acquired on two different systems (Horizon/A and Discovery/W), we 
performed covariate analysis on each equation to determine whether cross calibration was necessary. 
Adjusting for age, height, and weight, no significant differences were found between the two 
scanners for all predicted variables except visceral fat. Consequently, all measurements except visceral 
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fat were pooled directly between the two scanners. Visceral fat measurements acquired on the 
Discovery/W were calibrated to the Horizon/A using a linear calibration equation derived from a 
separate study of 13 participants who underwent sequential whole-body scans on the two scanners 
(unpublished work). 
Whole-body prediction equations were applied to the field validation data. Estimated whole-
body percent fat, fat mass, and fat free mass were compared to the reported values from bioelectrical 
impedance analysis using simple linear regression. 
5.1.3	Results	
39 individuals (20 male) completed the calibration study. 37 individuals (18 male) were 
included in the validation group. Summary statistics of the calibration and validation populations are 
provided in Table 5-1. Example 3D optical and DXA images are shown in Figure 5-1. 
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Figure 5-1: 3D scanner body circumferences and surface area vs. criterion methods. Clockwise from top left: hip 
circumference, waist circumference, and body surface area comparisons, then sample matched DXA and 3D 
optical images with annotated landmarks. 3D circumferences and surface area show high correlation with 
manual tape measures. Biases may be the result of non-identical landmark positioning between the methods. 
Of note, body surface area shows significant bias that may be explained by the fact that the 3D scanner 
software does not report surface area of the head and neck. This omission is not a technical shortcoming, but a 
design decision by the manufacturer to avoid inaccuracies introduced by voluminous hair. 
Regression plots are shown in Figure 5-1 for 3D optical measurements against tape measure 
circumferences and Du Bois-estimated body surface area. Figure 5-2 shows 3D measurements 
against DXA and ADP whole-body volumes, and DXA regional volumes. Strong association was 
observed for waist and hip circumferences (R2=0.95 and 0.92, respectively). T-tests showed 
significant mean differences of 1.75 cm (95% CI: [0.58, 2.91]) for waist circumference and 3.17 cm 
(95% CI: [1.93, 4.41]) for hip circumference between the 3D scanner and tape measurements.  
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Figure 5-2: 3D scanner body volume vs. criterion methods. Clockwise from top left: total volume vs. ADP and 
DXA, arms vs. DXA, legs vs. DXA, and trunk vs. DXA. High precision and accuracy is observed for whole-body 
volume. Due to differences in partition locations, regional measurements are not directly comparable between 
the 3D scanner and DXA. For instance, the legs are partitioned horizontally at the crotch in the 3D optical 
system, but diagonally from the crotch up to the top of the hip in the DXA system. Consequently, reported leg 
volumes are lower on the 3D system than the DXA system. Refinement of the regional partitions is necessary 
before cross-modality comparisons can be performed. 
Surface area and volume measurements from the 3D scanner showed high test-retest precision 
(Table 5-2). Strong association to the Du Bois model was observed for whole-body surface area 
(R2=0.97), although this 3D system significantly underreports surface area (mean difference -0.38 
m2, 95% CI: [-0.40, -0.36]). Similarly, strong associations to ADP- and DXA-measured whole-body 
volumes were observed (R2=0.99 and 0.97, respectively) with a significantly smaller 3D scan 
measured volume relative to ADP (mean difference -4.15 L, 95% CI: [-5.13, -3.17]). Regional 3D 
scan volume estimates were highly correlated to similar measures derived from the DXA scans 
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(R2=0.73 - 0.97). In general, the 3D scanner includes less volume in the arm and leg compartments 
than DXA, and correspondingly more volume in the trunk compartment (all P < 0.001). 
Table 5-1: Summary statistics of the model calibration population and validation groups. Reported 
circumferences, areas, and volumes were derived from the 3D optical scans. Unpaired two-tailed t-tests were 
performed to detect significant mean differences in the direct 3D measurements between the two groups (P-
values shown in the right-most column, * denotes P≤0.05). Note that body composition was measured using 
DXA on the calibration group and BIA on the validation group. 
  Calibration (N=39, 20 male) Validation (N=37, 18 male) P-val. 
Variable Mean (SD) Min Max Mean (SD) Min Max  
   Age (years) 44.3 (15.5) 21.6 72.5 42.6 (11.5) 23.1 62.9 0.60 
   Height (cm) 169.5 (9.7) 152.4 190.5 174.1 (8.3) 160.0 190.5 0.03* 
   Mass (kg) 78.0 (17.6) 46.8 123.6 80.0 (10.5) 61.0 100.0 0.56 
   BMI (kg/m2) 27.5 (6.5) 20.3 51.0 26.4 (3.2) 22.2 34.2 0.36 
   3D Optical Measures        
Circumferences (cm)        
   Waist 94.4 (13.6) 66.8 132.4 92.5 (7.2) 80.0 106.8 0.45 
   Hips 106.2 (11.8) 89.7 149.3 105.3 (7.1) 94.6 122.2 0.70 
   Biceps 34.3 (4.4) 26.6 45.2 35.0 (3.1) 28.9 41.8 0.44 
   Forearm 27.9 (2.7) 23.0 34.4 28.3 (2.5) 23.9 36.7 0.49 
   Thigh 61.8 (6.3) 53.1 80.4 62.4 (5.9) 53.4 80.4 0.67 
   Calf 39.6 (3.5) 32.0 49.7 39.5 (2.2) 34.3 44.6 0.87 
Areas (m2)        
   Torso 0.662 (0.095) 0.453 0.834 0.669 (0.076) 0.513 0.839 0.75 
   Left arm 0.129 (0.016) 0.102 0.153 0.135 (0.019) 0.068 0.164 0.11 
   Right arm 0.129 (0.015) 0.100 0.159 0.137 (0.013) 0.116 0.154 0.02* 
   Left leg 0.268 (0.029) 0.217 0.335 0.281 (0.027) 0.235 0.359 0.05* 
   Right leg 0.270 (0.029) 0.212 0.340 0.282 (0.028) 0.233 0.358 0.06 
Volumes (L)        
   Whole-body 75.8 (17.1) 43.7 124.3 76.9 (10.1) 57.6 98.5 0.74 
   Left arm 3.59 (0.87) 2.27 5.96 3.71 (0.68) 2.27 4.82 0.49 
   Right arm 3.50 (0.77) 2.27 5.39 3.74 (0.58) 2.55 4.82 0.12 
   Left leg 8.83 (1.56) 6.53 12.77 9.28 (1.52) 7.10 14.76 0.20 
   Right leg 8.82 (1.58) 6.24 12.77 9.35 (1.47) 7.10 14.47 0.14 
Obesity indices        
   Waist-Hip Ratio 0.89 (0.07) 0.73 1.00 0.88 (0.05) 0.76 0.99 0.56 
   Waist-Height Ratio 0.56 (0.08) 0.43 0.84 0.53 (0.05) 0.47 0.65 0.11 
Body composition        
   FMI (kg/m2) 9.0 (4.4) 3.9 25.1 6.4 (3.1) 2.1 13.5 <0.01* 
   FFMI (kg/m2) 18.4 (3.0) 12.9 26.8 20.0 (2.1) 15.7 24.5 0.01* 
   %Fat 31.7 (7.8) 17.8 50.0 23.7 (9.4) 8.0 39.5 <0.01* 
The derived body composition equations for percent fat, fat mass, lean mass, and visceral fat 
mass are shown in Table 5-3. Validation results for the whole-body measurements is included. Fat 
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and fat free mass models exhibited strong fit to the calibration data (R2=0.95 and 0.96) and a 
reasonable fit to the validation data (R2=0.76 and 0.85). The visceral fat prediction equation showed 
moderately strong association (R2=0.75). Predictive models for regional fat and lean mass showed 
generally strong associations on the calibration set (R2=0.79-0.94), however no validation data was 
available for these regional models. 
Table 5-2: Test-retest precision of measurements derived from the 3D optical scanner. Each participant in the 
calibration data set was scanned twice, with repositioning. 
Measurement Type Variable %CV RMSE 
Circumference [cm] Waist 1.50 1.41 
Hips 0.75 0.79 
Biceps 2.24 0.77 
Forearm 1.93 0.54 
Thigh 0.95 0.59 
Calf 0.92 0.36 
Area [m2] Whole-body surface 1.38 0.0168 
Volume [L] Whole-body 0.74 0.57 
Average (L/R) arm 4.49 0.16 
Average (L/R) leg 2.61 0.23 
Trunk 0.99 0.51 
Derived fat / fat free 
mass [kg] 
Whole-body fat 1.96 0.50 
Whole-body fat free 0.94 0.50 
Whole-body percent 
fat [%] 
2.16 0.68 
Visceral fat mass 6.69 0.03 
Trunk fat 2.38 0.30 
Trunk fat free 0.50 0.13 
Arms fat 11.63 0.34 
Arms fat free 6.67 0.42 
Legs fat 1.25 0.11 
Legs fat free 1.99 0.36 
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Table 5-3: Derived fat mass, fat free mass, and percent fat prediction equations from 3D optical 
measurements. Models were trained using gold-standard measurements from whole-body DXA scans. Whole-
body models were validated against an external dataset that included scale weight and bioelectrical 
impedance measurements. Parameters were selected to validate previous work by Lee, et al. (11, 18). 
Region Variable Prediction equation Train 
R2adj 
Train 
RMSE 
Valid 
R2adj 
Valid 
RMSE 
Whole 
body 
Fat mass 
[kg] 
-19.06 + 4.05 (waist circumference / waist 
width) – 11.78 (average leg volume) - 
10.48 (is male) + 22.29 (torso volume) 
0.95 2.36 0.76 3.72 
Fat free 
mass [kg] 
(measured mass) - (predicted fat mass) 0.96 2.24 0.85 3.14 
Percent Fat (predicted fat mass) / (measured mass) 0.84 3.06 0.72 3.75 
Fat mass 
index 
[kg/m2] 
(predicted fat mass) / (measured height)2 0.95 0.90 0.83 1.13 
Fat free 
mass index 
[kg/m2] 
(predicted fat free mass) / (measured 
height)2 
0.93 0.84 0.64 1.04 
Visceral fat 
mass [kg] 
9.93 - 0.10 (is male) – 3.93 (waist circ / 
waist width) - 0.91 (waist width) + 1.31 
(waist circumference / hip circumference) 
+ 0.33 (waist circumference) 
0.75 0.11   
Trunk Fat mass 
[kg] 
-22.49 + 5.67 (waist circ / waist width) + 
11.71 (torso volume) - 4.71 (is male) 
0.94 1.49   
Fat free 
mass [kg] 
11.00 - 0.65 (waist circ / waist width) + 
7.31 (torso volume) + 5.31 (is male) 
0.88 1.72   
Arms Fat mass 
[kg] 
0.54 - 1.01 (is male) - 0.0097 (torso 
surface area) + 6.25 (torso volume) + 
47.92 (arm volume / body volume) 
0.90 0.53   
Fat free 
mass [kg] 
-1.44 + 2.93 (is male) + 0.46 (average 
upper arm circumference) 
0.92 0.55   
Legs Fat mass 
[kg] 
-3.72 + 0.51 (waist circ / waist width) + 
8.61*(average leg volume) - 3.90 (is male) 
+ 5.82 (torso volume) 
0.79 1.69   
Fat free 
mass [kg] 
-8.46 + 3.26 (waist circ / waist width) + 
44.17 (average leg volume) + 0.55 (is 
male) + 0.39 (torso volume) 
0.84 1.60   
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5.1.4	Discussion	
In this study of automated anthropometric measures from 3D whole body surface scans, we 
found strong associations of waist and hip circumference to tape measured-values, body surface area 
to the Du Bois model, and body volumes to DXA volume estimates. 3D measures were used to 
derive whole-body and regional body composition estimates for both sexes across a wide range of 
ages and BMI values. The accuracy of these body composition estimates was validated in a separate 
dataset using BIA. Although some biases were found in the anthropometric measures, this study 
supports the use of 3D surface scanning as an accurate, precise, and automated substitute to other 
methods such as measuring tape, ADP, and DXA.  
Notably, 3D scanning is a more direct measure of surface area than the criterion method 
(height/weight equation) available. In practice, there is no established gold standard for body surface 
area measurement. We found strong correlation between surface area measurements from the present 
3D scanner and the clinically-prevalent Du Bois model (R2=0.97). Tikuisis reported high precision 
and accuracy of a 3D laser scanner to six different height and weight equations for body surface area 
[172], but again, no gold standard comparison method was available. This measure is clinically 
relevant for modeling evaporative water loss, in particular for burn injuries [173] and calculating 
chemotherapeutic medication dosages [174].  
Whole-body volume measurements from 3D scans exhibited high precision (%CV=0.74) 
comparable to ADP (%CV=0.10) [175]. Differences in landmark and partition positioning in the 
3D surface scan analysis algorithms led to significant biases in regional volume measurements 
compared to DXA. For example, the present trunk/leg partition defined by the ProScanner is a 
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horizontal plane at the crotch. Whereas on a standard Hologic DXA, the trunk/leg partitions run 
diagonally from the crotch to the hips, such that the femur is completely in the leg compartment. 
Calibration to DXA compartments would enable direct assessment of trunk-to-leg volume ratio (2), 
a strong independent indicator of metabolic health and disease risk. 
Body composition models from 3D features calibrated using DXA data validated well, similar to 
those reported by Lee [128], [129], especially in light of the different body composition 
measurement methods employed (DXA calibration data and BIA validation data in our study, and 
DXA and MRI data in Lee’s studies). In particular, our whole-body fat mass prediction model 
showed strong fit to the calibration data (R2=0.95), matching the equivalent Lee model (R2=0.95) 
[128]. Our visceral fat prediction model showed moderately strong association (R2=0.75), similar to 
Lee (R2=0.72) [171]. 
This study had a few limitations. Small sample size (n=39) limits the statistical power of our 
models. However, all age/BMI/sex strata defined for this study were represented. Another issue was 
that the validation data contained only BIA body composition data rather than DXA data. This BIA 
data was reported by users rather than trained technicians with a defined protocol. Despite these 
limitations, the strong validation results suggest good predictive model stability across a range of 
body shapes in a real consumer environment. Lastly, our findings were derived from a healthy 
population without any known conditions that may alter the relationship between 3D body shape 
and body composition such as sarcopenia, anorexia, or malnutrition. 
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We conclude that 3D surface scanning presents a compelling modality for clinical 
anthropometry. This method provides an accessible platform for rapid body measurement as well as 
total and regional body composition analysis. Due to low cost, high precision, and a lack of ionizing 
radiation, 3D surface scanning is uniquely suitable for routine clinical use to monitor longitudinal 
metabolic health. This study shows feasibility of broad clinical use of 3D surface scanning to 
estimate body composition in a wide range of body shapes. Larger follow-up studies are justified to 
better understand the relationships of 3D body shape and composition across various sex, BMI, age, 
and ethnicity groups, as well as in special populations with metabolic conditions and potentially 
abnormal body composition. 
5.2: The Shape Up! Studies 
The pilot investigation reported in the preceding section formed the preliminary results that 
were submitted as part of the Shape Up! Adults and Shape Up! Kids studies (funded by NIH R01 
DK109008 and R01 DK111698, respectively). These studies are currently underway to measure 3D 
body shape and a variety of metabolic markers in 1440 children and adults from age 18-80. Some of 
the first findings from this study are reported below. 
5.2.1	Introduction	
Excess adiposity plays a central role in the development of type 2 diabetes, cardiovascular 
disease, and several cancers [140], [176], [177]. Distinguishing between adipose tissue and 
functional lean tissues is vital to understanding overall health and the risk of developing chronic 
diseases. Body mass index (BMI) is a widely used proxy for body composition that fails to 
independently estimate the two major body compartments, fat mass (FM) and fat-free mass (FFM) 
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[178]. Clinicians and investigators have long used anthropometric assessments to estimate body fat 
mass and FFM. A typical assessment may include manual measurement of height, weight, waist, 
trunk, and extremity circumferences, and multiple skin-fold thicknesses [74].These measurements 
provide information about the regional distribution of tissues across the body to more accurately 
separate body mass into fat and fat-free mass components.  
In practice, manual anthropometry assessment relies on well-trained technicians to produce 
accurate results. Tests can be time-consuming and data may not be comparable between clinical sites 
or measurement protocols [84]. Dual-energy X-ray absorptiometry (DXA) is commonly used in 
clinical research settings to estimate body composition as it allows precise measurement of regional 
and total body fat, bone mineral, and lean soft tissue mass [98]. However, the cost, radiation 
exposure, and relative inconvenience of DXA make it unsuitable for regular clinical visits and 
unrealistic for home use. 
Recently, three-dimensional (3D) laser and optical (3DO) scanners have been investigated as an 
alternative to manual anthropometry for health assessment [179]. Three-dimensional optical 
scanners are becoming widely available in clinics, recreational facilities, and even in the home setting. 
Lengths, girths, and circumferences can be extracted automatically from 3DO scans, allowing direct 
comparison to the manual measurements traditionally used to quantify human body shape and size. 
Several studies have investigated the use of 3D body shape to estimate body composition [128], 
[168], [171], [179]–[181]. However, the simplification of rich 3D body scan data into a few coarse 
measurements results in the loss of high-fidelity shape features that offer additional information 
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about tissue composition. Thus, a more advanced approach to 3D body shape modeling may 
provide superior estimates of body composition. 
Statistical shape modeling using Principal Component Analysis (PCA), a technique for 
dimensionality reduction, can capture complex shape features from 3D scans that may better 
correlate to actual body composition than traditional approaches. The aim of this study was to first 
develop body composition prediction models based on 3D body shape PCA and to then compare 
the predictive accuracy of these models to those developed using the traditional regression modeling 
approach. A secondary aim was to determine the test-retest precision and 3D PCA and DXA body 
composition estimates. 
5.2.2	Methods	
Experimental	Design	
This analysis is part of Shape Up! Adults, an ongoing stratified cross-sectional observational 
study supported by the National Institutes of Health (R01 DK109008). Participants underwent two 
whole-body DXA and 3DO scans, each with repositioning. Statistical shape models were built from 
3DO surface scans and compared to previously-published automated anthropometry techniques 
[180], using DXA as the criterion body composition method. Test-retest precision for body 
composition variables were determined from the duplicate DXA and 3D optical scans. 
Participants	
Recruitment for this sample took place between October 2015 and March 2017. Participants 
were stratified by age (18-40, 40-60, >60 years), ethnicity (non-Hispanic (NH) white, NH black, 
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Hispanic, and Asian), sex, BMI (<18, 18-25, 25-30, >30 kg/m2), and geographic location (San 
Francisco, CA or Baton Rouge, LA). Participants were excluded if they could not stand without aid 
for two minutes, could not lie flat for 10 minutes without movement, had metal objects in their 
body, or had significant body-shape-altering procedures (liposuction, amputations, etc.). Female 
participants were also excluded if they were pregnant or breast feeding. All participants were 
examined at either the University of California, San Francisco (UCSF) Clinical and Translational 
Science Institute (CTSI) Body Composition, Exercise Physiology, and Energy Metabolism 
Laboratory or the Pennington Biomedical Research Center (PBRC). The study protocol was 
approved by the UCSF Committee on Human Research and the PBRC Institutional Review Board. 
All participants gave written informed consent. 
Dual‐energy	X‐ray	Absorptiometry	
Each participant underwent two whole-body DXA on either a Hologic Horizon/A system at 
UCSF or a Discovery/A system at PBRC (Hologic Inc., Marlborough, MA, USA). Participants were 
scanned according to the manufacturer’s guidelines. The DXA scans were analyzed at UCSF by an 
ISCD-certified technologist using Hologic Apex version 5.6 with the National Health and Nutrition 
Examination Survey (NHANES) Body Composition Analysis (BCA) calibration option disabled. 
DXA systems were cross-calibrated according to standard Hologic procedures [182]. Body 
composition measurements from DXA included total body mass, total and regional (trunk, arms, 
legs) fat mass, bone mineral content, and FFM. 
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Whole‐body	surface	3DO	scanning	
Each participant underwent two 3DO whole-body surface scans on a Fit3D ProScanner v1.0 
(Fit3D, Inc., Redwood City, CA, USA). Participants followed a standard positioning protocol and 
wore skin-tight undergarments to minimize the effects of clothing on observed body shape. The 
ProScanner v1.0 uses a single light-coding PrimeSense Carmine 1.08 depth sensor that oscillates 
vertically as participants rotate 360 degrees horizontally on a moving platform. Each scan takes 
approximately 40 seconds to complete. The Iterative Closest Point (ICP) algorithm was used to 
spatially align point clouds captured by the sensor as the subject rotates [183]. The final point cloud 
was converted to a triangle mesh with approximately 300,000 vertices and 900,000 faces 
representing the human body shape. All 3D scan data were transferred securely from Fit3D to UCSF 
for statistical analysis. 
Statistical	Analysis	
The goal of this study was to derive prediction equations for body composition from detailed 
shape measured by 3DO. To achieve this, statistical models of 3D body shape were constructed as 
follows. A standardized 60,000-vertex body template was warped to fit each participant 3DO scan 
using the methods of Allen et al. [113]. This registration process ensures vertex correspondence to 
specific anatomic locations across the dataset, allowing for direct 3D body shape comparison across 
the whole sample. To initialize registration, seventy-five markers were manually placed on 
physiological landmarks defined by the Civilian American and European Surface Anthropometry 
Resource Project (CAESAR) [184]. The landmarks used are described in section 5.2.5 . Marker 
placement was performed by a licensed exercise physiologist using MeshLab version 1.3.2 (Consiglio 
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Nazionale delle Ricerche, Rome, Italy). The template marker locations were transformed to align 
with the participant mesh markers, then the remaining template mesh vertices were warped to the 
participant mesh surface using a minimization process that preserved overall smoothness [113]. After 
registration, PCA was performed to produce a statistical shape model that captured 95% of shape 
variation in the 60,000-vertex template space with only a small number of principal components 
(PCs). Each detailed 3D body scan could be then represented in the 3D PC space as a short vector of 
weights.  
The 3D principal components were used as input variables for stepwise linear regressions to 
predict DXA-measured total and regional body composition measurements. Regressions were 
performed subject to minimization of the Schwarz-Bayesian Information Criterion, with five-fold 
cross validation. PCA and mesh processing were performed using Python version 2.7 (Python 
Software Foundation, DE, USA). Regression analysis was performed in R version 3.3.3 (R Core 
Team, Vienna, Austria).  
Measurement accuracy was assessed using coefficient of determination (R2) and root mean 
square error (RMSE). Measurement precision was quantified using RMSE and coefficient of 
variation (%CV). To benchmark the performance of body composition estimation equations using 
the 3D PCs, body composition was also estimated using previously-published equations that use 
3DO-derived traditional anthropometrics (e.g. lengths, circumferences, and volumes) [180]. 
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5.2.3	Results	
Participants	
Two hundred and four healthy adults were recruited at the time of this analysis. Thirty-two 
participants were excluded for invalid DXA scans (17 missing sub regional results, 7 too large for 
scan area, 7 high density object in scan area, 1 movement artifact) and 14 participants were excluded 
for invalid 3DO scans (10 non-form fitting attire, 2 scanner malfunction, 1 positioning error, 1 
movement artifact). Thus, complete data were available on 158 healthy adults (67 males and 91 
females). Summary demographics of the sample participants can be found in Table 5-4.  
Table 5-4: Subject Characteristics.  
 Male (N=67) Female (N= 91) 
 Mean (SD) Min Max Mean (SD) Min Max 
Age [years] 41.1 (15.8) 19 77 45.5 (14.8) 20 74 
Height [cm] 176 (6) 163 187 163 (7) 149 181 
Mass [kg] 85.3 (18.3) 56.7 148.7 69.3 (14.2) 45.0 118.0 
BMI [kg/m2] 27.5 (5.4) 19.4 49.4 26.1 (5.5) 16.7 46.3 
Percent Fat 22.2 (6.1) 10.5 38.8 34.3 (6.2) 21.3 48.3 
FMI [kg/m2] 6.3 (2.7) 2.2 14.7 9.2 (3.5) 4.0 19.3 
FFMI [kg/m2] 21.2 (3.3) 15.2 36.3 16.9 (2.5) 12.2 27.0 
Fat Mass [kg] 19.6 (8.7) 6.9 47.5 24.4 (8.7) 11.5 49.5 
Fat Free Mass [kg] 65.9 (11.8) 43.7 108.6 45.0 (6.9) 28.8 69.2 
Visceral Fat [kg] 0.43 (0.26) 0.19 1.60 0.42 (0.27) 0.09 1.53 
BMI = Body Mass Index, FFM = Fat Free Mass, FMI = Fat Mass Index, FFMI = Fat Free Mass Index 
 
Shape	Models	
PCA on registered 3D scans produced unique statistical shape models for males and females. 
Twelve components captured 95% of the variance in male body shape while nine components 
captured 95% of the variance in female body shape. Visualizations of the principal component 
modes of body shape variation (±3 standard deviations for each) are shown in Figure 5-3 and 
Figure 5-4 for males and females, respectively. Univariate correlations of principal components to 
102 
body composition measurements are presented in Table 5-5 and Table 5-6 for males and females, 
respectively. For men, PC3 significantly correlated (p<0.001) with all 12 body composition measures 
presented while PC8 and PC12 significantly correlated (p<0.05) with 7 out of the 12 measures. For 
women, PC3 significantly correlated (p<0.001) with all 12 measures while PC4 significantly 
correlated (p<0.05) 10 out of the 12 measures.  
Table 5-5: Correlation of principal modes to measurements, male. 
 PC1 PC3 PC6 PC7 PC8 PC9 PC11 PC12 
Percent Fat (%)  0.53**  0.27 -0.43**    
Fat Mass (kg) 0.24 0.75**   -0.30   0.24 
FFM (kg) 0.56** 0.71**      0.56** 
FMI (kg/m2)  0.77**   -0.31    
FFMI (kg/m2) 0.25 0.83**      0.25 
Visceral Fat Mass (kg)  0.46** 0.30 0.27 -0.33*    
Trunk Fat Mass (kg)  0.76** 0.26  -0.32*    
Trunk Fat Free Mass (kg) 0.55** 0.74**      0.55** 
Arms Fat Mass (kg)  0.73**   -0.27    
Arms Fat Free Mass (kg) 0.47** 0.62**      0.47** 
Legs Fat Mass (kg) 0.30 0.63**   -0.21  0.25 0.30 
Legs Fat Free Mass (kg) 0.55** 0.62**      0.55** 
Only significant correlations are shown, p<0.05. * denotes p<0.01, ** denotes p<0.001. FFM = Fat Free Mass, 
FMI = Fat Mass Index, FFMI = Fat Free Mass Index, PC = principal component. 
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Figure 5-3: The first 12 principal components that captured 95% of shape variance in males. Each component 
displays -3 SD to the left and +3 SD to the right. 
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Figure 5-4: The first 9 principal components that captured 95% of shape variance in females. Each component 
displays -3 SD to the left and +3 SD to the right. 
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Table 5-6. Correlation of principal modes to measurements, female 
 PC1 PC3 PC4 PC5 PC6 
Percent Fat (%) 0.23 0.64** -0.25   
Fat Mass (kg)  0.87** -0.32*   
Fat Free Mass (kg) -0.36** 0.72** -0.26   
FMI (kg/m2) 0.23 0.84** -0.31*   
FFMI (kg/m2)  0.79** -0.27*   
Visceral Fat Mass (kg)  0.77** -0.31*   
Trunk Fat Mass (kg)  0.87** -0.33*   
Trunk Fat Free Mass (kg) -0.32* 0.72** -0.33* -0.27*  
Arms Fat Mass (kg)  0.86** -0.27   
Arms Fat Free Mass (kg) -0.26 0.68**    
Legs Fat Mass (kg)  0.71** -0.28*  0.23 
Legs Fat Free Mass (kg) -0.43** 0.64**    
Only significant correlations are shown, p≤0.05. Bold denotes correlations significant with the Bonferroni 
correction, P≤0.00029. * denotes p<0.01, ** denotes p<0.001. FFM = Fat Free Mass, FMI = Fat Mass Index, 
FFMI = Fat Free Mass Index, PC = principal component. 
 
Linear models selected from the 3D PCA stepwise regressions are shown in Table 5-7. The lists 
of PCs in each model are provided, along with the sex-combined R2 and RMSE accuracy metrics to 
DXA reference values. For total body models, we directly regressed to predict fat mass, then used 
that equation along with scale weight and measured height to produce predictions of fat free mass, 
FMI, and FFMI. R2 and RMSE metrics for the simple anthropometric model [180] are provided as a 
benchmark. Coefficients of determination for the 3D PCA models ranged from R2 = 0.71 for 
visceral fat to R2 = 0.95 for total body fat free mass. For the simple anthropometric model, the 
corresponding values were R2 = 0.56 and 0.91, respectively. Across all variables tested, the 3D PCA 
models outperformed (i.e. had greater coefficients of determination and lower RMSEs) than 
corresponding simple anthropometric models. Generally, fat free mass prediction models had higher 
106 
coefficients of determination than corresponding fat mass prediction models, likely since FFM 
typically represents a larger component of mass within each region than FM. 
Repeatability	
Test-retest precision was calculated in subsets of 30 males and 30 females for whom complete 
duplicate DXA and 3DO scan analysis was available. Precision metrics for male and female models 
are presented in   
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Table 5-8. RMSE in total body percent fat was 1.11 units for males and 0.92 units for females. 
Precision was generally better (lower coefficients of variation, %CV) for female 3D PCA models 
than for male models. FFM measurements had lower coefficients of variation than corresponding fat 
mass measurements at both total body and regional levels. 3D PCA measurement precision metrics 
were generally about 3-4x larger than corresponding DXA metrics.  
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Table 5-7. Predictions of body composition from 3D scans. Linear models were trained using 5-fold cross 
validation.  
 3D PCA and Stepwise Regression Simple Anthropometric 
Model 
   R2 RMSE R2 RMSE 
Fat Mass (kg) Male PC1, 3, 5, 6, 7, 8, 12 0.89 2.80 0.84 4.06 Female PC3, 4, 5, 6, 7, 9 
Fat Free Mass (kg) Male (scale weight) - (predicted 
FM) 0.95 3.02 0.91 4.22 Female 
Percent Fat (%) Male ((predicted FM) / (scale 
weight)) * 100 0.80 3.58 0.67 5.14 Female 
Fat Mass Index 
(kg/m2) 
Male (predicted FM) / (height)^2 0.91 0.99 0.86 1.44 Female 
Fat Free Mass Index 
(kg/m2) 
Male (predicted FFM) / 
(height)^2 0.91 1.04 0.83 1.51 Female 
Visceral Fat Mass 
(kg) 
Male PC3, 4, 6, 7, 8, 9 0.71 0.12 0.56 0.19 Female PC1, 3, 4, 5 
Trunk Fat Mass (kg) Male PC1, 3, 4, 5, 6, 7, 8, 11, 12 0.90 1.43 0.83 2.07 Female PC1, 3, 4, 5, 7, 9 
Trunk Fat Free Mass 
(kg) 
Male PC1, 3, 5, 11 0.94 1.52 0.88 2.17 Female PC1, 3, 4, 5, 6 
Arms Fat Mass (kg) Male PC1, 3, 5, 7, 8, 12 0.83 0.51 0.46 0.90 Female PC1, 3, 4, 5, 6, 7, 8, 9 
Arms Fat Free Mass 
(kg) 
Male PC1, 3, 4, 5, 10 0.89 0.79 0.55 1.70 Female PC1, 3, 6, 8 
Legs Fat Mass (kg) Male PC1, 3, 5, 7, 8, 9, 12 0.73 1.50 0.70 1.94 Female PC1, 3, 4, 5, 6, 7, 9 
Legs Fat Free Mass 
(kg) 
Male PC1, 3, 4, 5, 10, 11 0.88 1.60 0.47 3.55 Female PC1, 3, 4, 9 
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Table 5-8. Test-retest precision of body composition predictions from 3D scans 
 3D PCA DXA 
 Male (n=30) Female (n=30) Male (n=29) Female (n=30) 
 RMSE %CV  RMSE %CV  RMSE %CV  RMSE %CV  
Fat Mass [kg] 1.02 5.0 0.67 2.7 0.30 1.42 0.23 0.86 
Fat Free Mass [kg] 1.02 1.5 0.67 1.5 0.28 0.42 0.28 0.63 
Percent Fat [%] 1.11 -- 0.92 -- 0.30 -- 0.31 -- 
Fat Mass Index [kg/m2] 0.33 5.0 0.26 2.7 0.10 1.42 0.08 0.83 
Fat Free Mass Index [kg/m2] 0.33 1.5 0.26 1.5 0.09 0.43 0.11 0.63 
Visceral Fat Mass [kg] 0.05 12.3 0.01 3.2 0.03 6.38 0.03 5.88 
Trunk Fat Mass [kg] 0.53 5.5 0.26 2.3 0.25 2.47 0.28 2.37 
Trunk Fat Free Mass [kg] 0.34 1.1 0.37 1.6 0.32 1.00 0.20 0.91 
Arms Fat Mass [kg] 0.17 6.7 0.12 3.6 0.08 3.12 0.07 2.02 
Arms Fat Free Mass [kg] 0.25 2.8 0.12 2.5 0.17 1.85 0.10 2.21 
Legs Fat Mass [kg] 0.43 6.1 0.38 4.2 0.17 2.33 0.11 1.12 
Legs Fat Free Mass [kg] 0.62 2.8 0.24 1.7 0.23 1.03 0.11 0.80 
3D and DXA scans were each performed with repositioning. 30 participants per sex, 2 scans per participant. 
One male participant had only one DXA scan available and was excluded from this precision analysis. 
%CV: coefficient of variation. RMSE: root-mean-square error. 
 
5.2.4	Discussion	
In this study, we found that shape information extracted from 3D optical scans by PCA 
provided moderately strong estimates of DXA body composition measurements in healthy adults. 
We demonstrated the feasibility of an advanced statistical shape modeling technique for relating 
shape components from whole-body surface 3D scans to body composition without relying on 
traditional anthropometric measurements. Across whole-body and regional body composition 
measurements, statistical shape analysis outperformed the previous best method of body composition 
assessment from 3D scans that utilizes simple anthropometrics. The R2 of 0.91 for estimating fat 
mass index from the 3D shape model also compares favorably to both skinfold anthropometry (SFA) 
and bioelectrical impedance analysis (BIA), as a 2013 study by Hronek et al. comparing DXA to 
SFA (R2 = 0.86) and DXA to BIA (R2 = 0.88) [185]. 
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Previous studies report that 3D optical scanners offer precise measurements of body shape and 
composition. Lee, et al. reported accurate prediction of total fat mass (training R2 = 0.95, RMSE = 
3.39 kg) using one length and two volumes from a custom-built 3D optical scanner, along with sex 
[128]. Ng et al. demonstrated accurate prediction of total body composition (fat mass validation R2 
= 0.76, RMSE = 3.72 kg; fat free mass validation R2 = 0.85, RMSE = 3.14 kg) using a combination 
of four length and volume measurements from a commercial 3D optical scanner, along with sex as a 
covariate [180]. These previous studies have been limited to linear, circumferential, volumetric, and 
surface area measurements extracted from scans using scanner manufacturers’ proprietary, often non-
standard, algorithms. This limitation can lead to incompatibility between datasets and fragile 
statistical models that apply only to specific scanner hardware/software combinations.  By contrast, 
our study used the entire 3D space of human shape data to create PCA-based body shape models. 
This technique eliminates the need for inconsistent anthropometry measures for prediction of health 
status. With proper preprocessing and registration, 3D body shape models can be agnostic to 
scanning technology, allowing comparison across a wide array of 3D body scanning systems. Further 
studies may use more advanced supervised statistical shape modelling techniques to investigate health 
predictions that require more localized or fine-grained shape characteristics not captured by PCA, 
such as those caused by edema or cellulite. 
This study had a few limitations. The study population was restricted to healthy adults, in 
whom body shape is relatively stable over time. Children, by contrast, undergo significant skeletal 
and overall body shape changes as they grow. The adult shape models derived here may not 
accurately interpret the unique body shapes and shape dynamics observed in children. Shape 
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variation of children is an active area of research, and child-specific body shape models are currently 
under development in the Shape Up! Kids study (NIH R01DK111698). Another limitation of this 
study was the requirement for manual landmark placement. There are significant research efforts to 
and accurately register point sets without the need for picked landmarks, and robust to variations in 
pose [186]–[188]. Validation of a robust landmark-free registration method would automate the 
analysis process and enable broad implementation of these modeling techniques.  
In conclusion, PCA of 3DO scans provides compact shape features that describe detailed 
individual body shape. These 3D PCs and can be used to predict body composition with greater 
accuracy than traditional anthropometric modeling approaches and good repeatability. 3DO body 
scanning is safe, accessible, and increasingly affordable. Consequently, this technology is uniquely 
attractive for longitudinal body shape and composition monitoring at the individual level. 
5.2.5	Supplement:	Descriptions	of	75	Body	Landmarks	for	3D	Shape	Registration	
 
Figure 5-5: Annotated 3D body scan with 75 landmarks shown. Mesh annotation and visualization was 
performed in MeshLab version 1.3.2. 
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A set of 75 markers is annotated on each 3D body scan, based on the protocol defined for the 
CAESAR study [184]. The list of markers is reproduced in Table 5-9 and visualized in Figure 5-5. 
These points are used to initialize registration of a standardized 3D body mesh template to fit each 
target participant 3D body scan. 
Table 5-9: List of markers for 3D body scans. Adapted from [184]. 
1_sellion 26_iliac_spine_posterior_superior_right 51_ulnar_styloid_left 
2_infraorbitale_right 27_iliac_spine_posterior_superior_left 52_metacarpal_phalangeal_V_left 
3_infraorbitale_left 28_waist_preferred_posterior 53_knee_crease_right 
4_supramenton 29_acromion_right 54_femoral_epicondyle_lateral_right 
5_tragion_right 30_axilla_point_anterior_right 55_femoral_epicondyle_medial_right 
6_gonion_right 31_radial_styloid_right 56_metatarsal_phalangeal_V_right 
7_tragion_left 32_axilla_point_posterior_right 57_malleolus_lateral_right 
8_gonion_left 33_olecranon_right 58_malleolus_medial_right 
9_nuchale 34_humeral_epicondyle_lateral_right 59_sphyrion_right 
10_clavicle_right 35_humeral_epicondyle_medial_right 60_metatarsal_phalangeal_I_right 
11_suprasternale 36_radiale_right 61_calcaneus_posterior_right 
12_clavicle_left 37_metacarpal_phalangeal_II_right 62_digit_II_right 
13_thelion_bustpoint_right 38_dactylion_right 63_knee_crease_left 
14_thelion_bustpoint_left 39_ulnar_styloid_right 64_femoral_epicondyle_lateral_left 
15_substernale 40_metacarpal_phalangeal_V_right 65_femoral_epicondyle_medial_left 
16_tenth_rib_right 41_acromion_left 66_metatarsal_phalangeal_V_left 
17_iliac_spine_anterior_superior_right 42_axilla_point_anterior_left 67_malleolus_lateral_left 
18_tenth_rib_left 43_radial_styloid_left 68_malleolus_lateral_right 
19_iliac_spine_anterior_superior_left 44_axilla_point_posterior_left 69_sphyrion_left 
20_ilioicristale_right 45_olecranon_left 70_metatarsal_phalangeal_I_left 
21_trochanterion_right 46_humeral_epicondyle_lateral_left 71_calcaneus_posterior_left 
22_iliocristale_left 47_humeral_epicondyle_medial_left 72_digit_II_left 
23_trochanterion_left 48_radiale_left 73_crotch 
24_cervicale 49_metacarpal_phalangeal_II_left 74_navel 
25_tenth_rib_midspine 50_dactylion_left 75_nose_tip 
 
5.3: Manifold Regression to Predict Compositional Shape Change 
Over half of all participants discontinue diet and exercise programs within one year. Value 
placed on personal aesthetics is a powerful predictor of compliance to weight-loss regimes [189]. 
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Thus, providing a realistic target for body shape may improve treatment compliance. Whereas 
simple body shape models may attempt to vary body circumferences uniformly, or shrink the body 
along one dimension, we used the Shape Up! 3D optical and DXA information to create data-driven 
models for predicting realistic body shape changes in response to specific gains and losses in fat and 
lean mass. 
In order to generate shape changes for specific body composition adjustments (i.e. decrease in fat 
mass with fixed lean mass), we performed multivariate manifold regression over the set of principal 
component representations of body shape. As described by Allen [190], this is performed by 
preparing an attribute matrix 𝐴 and a PCA weight matrix 𝑊. Each vector 𝑎௜ in 𝐴 contains to the 
measured variables of interest (here: fat mass, lean mass, height, and age) for participant 𝑖. Each 
vector 𝑤௜ in 𝑊 contains the specific PC weights that define participant 𝑖’s body shape in the PCA 
body shape model. We then calculate the relationship 𝑀 between attributes and body shape as: 
𝑀 ൌ 𝑊𝐴ା 
where 𝐴ାis the pseudoinverse of 𝐴. For a given vector of attributes 𝑎, we can then calculate a 
probable body shape using the weights 𝑤 ൌ 𝑀𝑎. We can also calculate differential changes in body 
shape for differential changes in attributes as Δ𝑤 ൌ 𝑀Δ𝑎. These Δ𝑤 vector can be added to a 
participant shape vector 𝑤 to visualize body shape changes for that specific person.  
For this analysis, variables included in the manifold regression were fat mass, fat free mass, age 
and height. Age and height were held fixed while fat mass and fat free mass were adjusted 
independently. Regression was performed in Python 2.7 (Python Software Foundation, DE, USA) 
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and scikit-learn version 0.19.0 [191]. Synthesized body meshes were created and visualized in 3D 
using Blender version 2.78 (Blender Foundation, Amsterdam, Netherlands). 
We performed separate regressions for the male and female datasets. Example male and female 
participants at their current shape and fat and lean mass increases and decreases of up to ±20 kg 
(male) and ±10 kg (female) are shown in Figure 5-6. These predicted bodies represent a BMI range 
of 16 to 40 kg/m2. 
 
Figure 5-6: Predicted 3D body shape changes for individual male (left) and female (right) participants. Actual 
participant scans are shown in the middle of each set. Height and age were held constant while fat mass and 
lean mass, were varied independently using manifold regression. Numbers next to each body represent BMI. 
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6 | Novel Multi-Modality Clinical Assessment Techniques 
6.1: Validation of DXA + BIA for Clinical 4C Body Composition Assessment 
6.1.1	Introduction	
 Over 1.9 billion adults worldwide are overweight, and of those some 650 million are obese. 
Obesity now affects about 13% of the world’s population – a figure that has nearly tripled since 
1975 [192]. Low- and middle-income countries that have historically faced challenges of 
undernutrition now increasingly face a double burden of malnutrition marked by simultaneous 
prevalence of obesity and undernutrition [193], [194]. These conditions are associated variety of 
metabolic diseases and stunted growth in children. Malnutrition leads to altered states of body 
composition. Accurate measurement of body composition is important for the diagnosis of 
nutritional and metabolic disorders and monitoring of associated treatments [53].  
Four component (4C) models of body composition – those that divide the body into fat, 
water, protein, and mineral masses – are considered the reference within the research community. 
Importantly, 4C models do not assume a fixed hydration as is the case in simpler body composition 
models [195]. This is important for assessment of undernutrition in children, which is often 
associated with dehydration [196], as well as assessment of lean mass in older adults, which has been 
shown to have significantly different hydration than found in younger adults [197]. Altered lean 
mass hydration in older adults may explain why DXA-measured lean mass (which assumes fixed 
hydration) is a poor predictor of mortality and functional strength compared to simple handgrip 
strength [29]. Direct measurement of lean mass water and protein content is therefore particularly 
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useful in the presence of wasting conditions associated with aging such as sarcopenia and cachexia 
[198]. 
Despite its advantages, 4C body composition is seldom used in the clinic because it requires 
several different measurements that are time consuming and costly. The Lohman 4C model, for 
example, includes bone mineral measurements from DXA, body mass from a scale, total body 
volume, and total body water from labeled water dilution [199]. Wilson proposed a simplified 
model for clinically-viable 4C body composition that uses DXA-calculated body volume in place of 
ADP and BIA-calculated total body water in place of labeled water dilution [200]. We sought to 
validate this rapid, simplified 4C method against the reference Lohman method as well as to 2-
component (BIA, ADP, and TBW) and 3-component models (DXA) of percent fat.  
6.1.2	Methods	
A cross-sectional convenience sample of healthy adults underwent whole-body DXA, 
multifrequency BIA, air displacement plethysmography (ADP), height and weight, and total body 
water deuterium dilution measurements. Four-component body composition was calculated using 
the Lohman method [201] and the simplified DXA+BIA approach of Wilson [200]. Linear 
regression analysis was performed to determine agreement between body composition methods. We 
describe the details of each part of the study below. 
Participants	
Thirty-one healthy adults over the age of eighteen were enrolled in a prospective open 
recruitment during the time period of November 2016 and April 2017. Each participant received 
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duplicate measures with repositioning for whole-body DXA and segmented multifrequency BIA 
scans, and singleton measures of deuterium dilution and air-displacement plethysmography (due to 
time considerations for these techniques). Exclusion criteria included a history of body-altering 
surgery, significant non-removable metallic implants, height over 73 inches (185 cm) and weight 
over 250 pounds (113 kg) (to ensure whole-body fit within the dimensions of the DXA scan table). 
Recruitment was performed using flyers posted around the UCSF Parnassus campus. All participants 
provided informed consent. The study protocol was approved by the UCSF Committee on Human 
Research (IRB #16-19342). 
Dual	Energy	X‐Ray	Absorptiometry	
Whole-body DXA scans were acquired on a Hologic Discovery/W system (Hologic Inc., 
Marlborough, MA, USA). All scans were analyzed at Hologic, Inc. by a single International Society 
for Clinical Densitometry (ISCD) certified technologist using Hologic APEX software (version 
4.6.0.4) with NHANES body composition correction disabled. Participants were clothed in form-
fitting undergarments, without shoes, and positioned on the scanner table with arms out to the side, 
hands flat on table and feet in planarflex position, in accordance with the manufacturer’s standard 
protocols. The scanner was kept in regular calibration using daily and weekly quality control 
protocols scanning spine and soft tissue phantoms according to ISCD guidelines. 
Bioelectrical	Impedance	Analysis	
Whole-body segmented multifrequency BIA measurements were acquired on an InBody S10 
system (InBody Inc., Cerritos, CA, USA). Measurements were performed with the participant in 
supine position immediately after DXA scans. Contact sites on the fingers and ankles were cleaned 
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prior to measurement with a sterile antimicrobial tissue provided by the manufacturer. Touch type 
electrodes were used in accordance with standard protocols. Participants were scanned a total of 
three times to allow for assessment of measurement precision with and without repositioning. TBW 
and %Fat measurements were recorded directly from the device. The average of two TBW 
measurements (with repositioning) was used for 4C analysis.  
Air	Displacement	Plethysmography	
 Whole-body volume measurements were taken using air displacement plethysmography 
(ADP) in a BodPod (v5.4.1, COSMED USA, Inc., Concord, CA). Measurements were taken using 
the manufacturer’s standard protocol. Participants were clothed in form-fitting clothing and a swim 
cap. Lung volume was measured directly using the built-in breathing tube system. The BodPod was 
regularly calibrated using a known-volume cylinder and known-mass weights in accordance with 
manufacturer guidelines. The BodPod provided body volume measurements for the 4C models as 
well as its own estimate of %Fat. 
Deuterium	Dilution	
Total Body Water was assessed using a four-hour deuterium (D2O) dilution protocol as 
defined in the International Atomic Energy Agency standards by Schoeller, et al. [92]. In summary, 
participants were provided with a measured dose of deuterium in local drinking water (100 mL total 
volume) to achieve 0.05 grams of excess 2H per kilogram of body weight. Three 2.5 mL saliva 
samples were collected – one at baseline (before dose consumption), one 3 hours post dosing, and 
one 4 hours post dosing. Participants were allowed to void and/or drink small amounts (< 500 mL) 
of water during the four-hour protocol; all fluid changes were measured and recorded as change in 
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body weight using a high precision scale. Total body water was calculated by measuring deuterium 
enrichment in the saliva samples versus baseline dose and drinking water samples [92] which 
included the correction factor of 1.041 for non-aqueous exchange of deuterium. Fat mass was 
estimated from TBW using a fixed hydration constant of 0.732 for lean mass: 𝐹𝑎𝑡𝑀𝑎𝑠𝑠 ൌ
𝑇𝑜𝑡𝑀𝑎𝑠𝑠 െ 𝑇𝐵𝑊/0.732. All samples were analyzed at the University of Wisconsin Biotechnology 
Center. 
4‐Component	Models		
Four component models divide the body into fat, water, protein, and mineral masses. We 
calculated 4C composition using the model of Lohman, et al. [53], [199], [202], reproduced below. 
𝐹𝑎𝑡𝑀𝑎𝑠𝑠ସ஼௅௢௛௠௔௡ ൌ 2.747𝑇𝑜𝑡𝑉𝑜𝑙𝑢𝑚𝑒 െ 0.714𝑇𝐵𝑊 ൅ 1.146𝑇𝑜𝑡𝑀𝑖𝑛𝑒𝑟𝑎𝑙 െ 2.0503𝑇𝑜𝑡𝑀𝑎𝑠𝑠 
𝑇𝑜𝑡𝑀𝑖𝑛𝑒𝑟𝑎𝑙 ൌ 𝐵𝑜𝑛𝑒𝑀𝑖𝑛𝑒𝑟𝑎𝑙 ൅ 𝑆𝑜𝑓𝑡𝑇𝑖𝑠𝑠𝑢𝑒𝑀𝑖𝑛𝑒𝑟𝑎𝑙 
𝑇𝑜𝑡𝑀𝑖𝑛𝑒𝑟𝑎𝑙 ൌ 𝐵𝑀𝐶 ൅ 0.0105𝑇𝑜𝑡𝑀𝑎𝑠𝑠 
𝑃𝑟𝑜𝑡𝑒𝑖𝑛𝑀𝑎𝑠𝑠ସ஼௅௢௛௠௔௡ ൌ 𝑇𝑜𝑡𝑀𝑎𝑠𝑠 െ ሺ𝐹𝑎𝑡𝑀𝑎𝑠𝑠ସ஼௅௢௛௠௔௡ ൅ 𝑇𝐵𝑊 ൅ 𝐵𝑀𝐶ሻ 
ADP, D2O dilution, DXA, and scale weight measurements were used for TotVolume, TBW, 
BMC, and TotMass, respectively. The Lohman model served as criterion method for fat and protein 
measurements. It may be noted that this model is often misrepresented to include only bone mineral 
mass instead of total mineral mass, which includes mineral in both bone and soft tissues. Bartok-
Olson described the discrepancy and its implications here [202]. Note also that the residual mass 
(𝑃𝑟𝑜𝑡𝑒𝑖𝑛𝑀𝑎𝑠𝑠ସ஼௅௢௛௠௔௡) contains a small amount of carbohydrate in addition to protein.  
120 
The simplified DXA+BIA 4C model described by Wilson [200] uses the same form as the 
Lohman 4C model, but body volume calculated from DXA instead of ADP, and water mass 
measured by BIA instead of D2O. Specifically, Wilson showed that body volume could be accurately 
calculated using calibrated fat, lean, and bone densities along with the measured masses from whole-
body DXA scans [152]. 
𝑇𝑜𝑡𝑉𝑜𝑙𝑢𝑚𝑒஽௑஺ ൌ 𝜈௟௘௔௡𝐿𝑒𝑎𝑛𝑀𝑎𝑠𝑠஽௑஺ ൅ 𝜈௙௔௧𝐹𝑎𝑡𝑀𝑎𝑠𝑠஽௑஺ ൅ 𝜈஻ெ஼𝐵𝑀𝐶஽௑஺ ൅ 𝜈௥௘௦௜ௗ௨௔௟ 
where inverse density coefficients 𝜈 are calibrated for each make of DXA scanner. These 
coefficients were published in earlier cross-sectional studies with matched DXA and ADP 
measurements using multiple linear regression with the three-component DXA masses as input and 
ADP volume as output. Wilson derived separate volume coefficients for Hologic [152] and GE 
DXA systems [200], and reported test-retest precision of RMS-%CV = 1.1 in total body DXA-
volume. In the present study, Hologic calibration values were used (𝜈௟௘௔௡ ൌ 0.95, 𝜈௙௔௧ ൌ
1.14, 𝜈஻ெ஼ ൌ 0.21, 𝜈௥௘௦௜ௗ௨௔௟ ൌ 0.01). We sought to validate Wilson’s DXA+BIA 4C model and 
demonstrate hardware independence by using an independent recruitment and different devices 
(Hologic DXA and InBody BIA, versus GE DXA and Impedimed BIA). 
Statistical	Analysis	
Linear regressions were performed to assess agreement between different modalities. Total 
body water from BIA was compared against deuterium dilution criterion measurement. Percent 
body fat was compared between DXA, ADP, BIA, D2O, and the proposed 4C DXA+BIA model 
against the 4C Lohman criterion method. Constant intercepts were included in linear models only if 
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significant at P < 0.05. Test-retest precision was quantified using root mean square coefficient of 
variation (%CV) for mass and volume measurements, and root mean square standard deviation 
(RMS-SD) for percent fat measurements as described elsewhere [203]. Outlier detection thresholds 
for test-retest measurements were conservatively defined at six standard deviations 𝜎 away from zero, 
where 𝜎 was estimated by the sample median absolute difference (MAD) between repeat 
measurements [204]. Statistical analyses were performed using pandas 0.20.1 (Python Software 
Foundation, Wilmington, DE), SAS version 9.4 (SAS Institute, Cary, NC), and MATLAB R2017a 
(The MathWorks Inc., Natick, MA).  
6.1.3	Results	
Table 6-1: Summary demographic statistics of the 23 participants included in the present analysis (11 male). 
Total BMC, TBW, and Body Volume measures are reported from DXA, deuterium dilution, and air displacement 
plethysmography, respectively. 
Variable Mean (SD) Min Max 
Age [years] 33.8 (12.3) 22 63 
Height [cm] 168.4 (11.0) 148.7 188.6 
Mass [kg] 73.2 (12.6) 54.1 104.1 
Body Mass Index [kg/m2] 25.6 (4.1) 20.2 36.9 
Total Bone Mineral Content (DXA) [kg] 2.40 (0.43) 1.57 3.29 
Intracellular Water (BIA) [kg] 25.1 (5.7) 15.5 39.0 
Extracellular Water (BIA) [kg] 14.9 (3.1) 9.7 22.5 
Total Body Volume [L]    
    ADP 70.4 (12.0) 56.9 104.9 
    DXA 70.9 (12.1) 57.4 104.7 
Total Body Water [kg]    
    D2O 38.4 (7.9) 26.1 53.9 
    BIA 40.0 (8.8) 25.1 61.5 
Percent Fat    
    DXA 26.9 (10.7) 9.9 45.1 
    ADP 26.0 (11.2) 13.0 50.0 
    BIA 25.1 (11.8) 8.9 52.3 
    D2O 27.9 (10.0) 11.2 47.0 
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Of the 31 participants that completed the study protocol, 23 had complete valid measurements. 
There was an error in the dose preparation for the first batch of 8 participants that invalidated 
measurements; these participants’ data were used for precision analysis only. Summary demographics 
of the participants included in the analysis are shown in Table 6-1.  
 
Figure 6-1: Linear regression between body volume measurements from DXA and ADP (n=23). High correlation 
was observed, though a slope significantly different from 1 was detected. These data were used to determine a 
linear correction equation for body volume from DXA: BVADP = 0.993 BVDXA (95% CI: [0.990, 0.996]). The 
dashed line is the line of identity. 
Body volume measurements calculated from DXA showed excellent agreement with ADP 
(Figure 6-1), BVADP = 0.993 BVDXA (95% CI: [0.990, 0.996]). Total body water measurements from 
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BIA also showed strong agreement to criterion measurements from D2O (Figure 6-2), TBWD2O = 
0.956 TBWBIA (95% CI: [0.932, 0.979]). 
Whole-body percent fat was calculated using the 4C Lohman model as presented above after 
correcting for the small biases in the DXA volume and BIA water measures using the equations in 
Figure 6-1 and Figure 6-2. Regression results for the 2-, 3-, and 4-component methods are shown in 
Figure 6-3. Each of DXA, BIA, ADP, and D2O estimates of percent fat showed strong agreement 
with the Lohman model, with R2 ≥ 0.90. D2O dilution was the only modality to exhibit a significant 
bias. BIA exhibited the highest RMSE at 3.83 percentage units, while ADP had the lowest at 1.71; 
however, this is likely due to the fact that 4C Lohman %Fat equation is dominated by body volume 
(here measured by ADP). Note that the Hologic DXA percent fat results were calculated with 
NHANES correction [132] disabled. Enabling the NHANES correction resulted in overestimated 
DXA fat values compared to the 4C Lohman model (see 6.1.5 Supplement).  
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Figure 6-2: Linear regression between total body water measurements from BIA and D2O (n=23). High 
correlation was observed, though a slope significantly different from 1 was detected. These data were used to 
determine a linear correction equation for total body water from BIA: TBWD2O = 0.956 TBWBIA (95% CI: [0.932, 
0.979]). The dashed line is the line of identity. 
The simplified 4C DXA+BIA model closely agreed with the Lohman 4C reference. The 4C 
DXA+BIA model can be generalized using the equation below. 
𝐹𝑎𝑡𝑀𝑎𝑠𝑠ସ஼ ൌ 2.747 ∗ 𝐷𝑋𝐴௖௢௥௥൫𝜈௟௘௔௡𝐿𝑒𝑎𝑛𝑀𝑎𝑠𝑠஽௑஺ ൅ 𝜈௙௔௧𝐹𝑎𝑡𝑀𝑎𝑠𝑠஽௑஺ ൅  𝜈஻ெ஼𝐵𝑀𝐶஽௑஺൯
െ 0.714 ∗ 𝐵𝐼𝐴௖௢௥௥ሺ𝑇𝐵𝑊஻ூ஺ሻ ൅ 1.146ሺ𝐵𝑀𝐶஽௑஺ ൅ 0.0105𝑇𝑜𝑡𝑀𝑎𝑠𝑠ሻെ 2.0503𝑇𝑜𝑡𝑀𝑎𝑠𝑠 
 
where 𝜈௟௘௔௡ ൌ 0.95, 𝜈௙௔௧ ൌ 1.14, 𝜈஻ெ஼ ൌ 0.21, and 𝐷𝑋𝐴௖௢௥௥ ൌ 0.993 for the present Hologic DXA 
system, and 𝐵𝐼𝐴஼௢௥௥ ൌ 0.956 for the present InBody BIA system. 
 
Residual protein measurements from the 4C DXA+BIA model versus the Lohman model are 
shown in Figure 6-4. Whole-body 4C protein measured by DXA+BIA closely approximates the 
Lohman reference method.  
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Method Slope [95% CI] Intercept [95% CI] R2 RMSE 
DXA 0.98 [0.94, 1.03] n.s. 0.93 2.97 
ADP 0.96 [0.94, 0.99] n.s. 0.98 1.71 
BIA 0.94 [0.88, 0.99] n.s. 0.90 3.83 
D2O 0.90 [0.82, 0.97] 3.56 [1.45, 5.68] 0.97 1.80 
4C DXA + BIA 1.01 [0.97, 1.04] n.s. 0.96 2.33 
Figure 6-3: Linear regression between whole-body percent fat from the 2-, 3-, and 4-component body 
composition assessment methods in this study versus the reference 4C Lohman model (n=23). “n.s.” indicates 
that the regression intercept was non-significant (P > 0.05) and set to zero. 
 
0
10
20
30
40
50
60
0 10 20 30 40 50 60
Pe
rce
nt 
Fat
 by
 Ca
nd
ida
te
Percent Fat by Lohman 4C
Whole-Body %Fat by Method
DXA ADP 4C_DXA+BIA BIA D2O Linear (Identity)
126 
 
Figure 6-4: Linear regression of whole-body 4C residual protein measured by DXA+BIA method versus Lohman 
reference method (n=23). The equation for the line of best fit is ProtDXA+BIA 4C = 0.99 ProtLohman 4C (95% CI: [0.93, 
1.05]). The dashed line is the line of identity. 
Duplicate DXA and BIA measurements were available for all 31 participants. Test-retest 
precision results for BIA total body water and fat mass, DXA fat mass and volume, and 4C 
DXA+BIA fat mass and protein mass are shown in Table 6-2. Repeat TBWBIA measurements (with 
immediate repositioning) showed a coefficient of variation of %CV = 5.2. The median absolute 
difference (MAD) in the test-retest data was 0.3 kg. Outliers were defined conservatively as the test-
retest difference exceeding six times the MAD, or 1.8 kg. Four outlier pairs were identified in the set 
of 31 test-retest measurements. Excluding these outliers results in %CV = 1.1. As shown in Table 
6-2, precision in TBWBIA significantly affects the precision of 4C DXA+BIA fat and protein 
measurements. Observed test-retest RMS-SD for BIA, DXA, and 4C DXA+BIA percent fat (after 
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BIA TBW outlier removal) were 0.9, 0.6, and 0.8 percentage units, respectively. Least significant 
changes implied by these intra-method errors (approximately 2.77 times the test-retest precision, per 
[205]) are smaller than the corresponding inter-method errors versus Lohman 4C percent fat of 
3.83, 2.97, and 2.33 percentage units, respectively (Figure 6-3). 
Table 6-2: Test-retest precision for the BIA and DXA measurements utilized in the study. Duplicate 
measurements were collected using each modality, with repositioning. High variability in BIA Total Body 
Water measurements leads to imprecision in BIA fat mass and 4C DXA+BIA fat and protein masses. Removal 
of outlier BIA TBW measurements as described in the text results in significantly improved precision for each 
of those measurements. 
Variable Before BIA Outlier 
Removal (n=31) 
After BIA Outlier 
Removal (n=27) 
BIA Total Body Water (%CV) 5.2 1.1 
DXA Total Body Volume (%CV) 0.2 0.3 
BIA Percent Fat (RMS-SD) 3.8 0.9 
DXA Percent Fat (RMS-SD) 0.6 0.6 
4C DXA+BIA Percent Fat (RMS-SD) 1.9 0.8 
4C DXA+BIA Protein Mass (%CV) 6.1 4.4 
Lean mass hydration was calculated as 𝑇𝐵𝑊/𝐿𝑒𝑎𝑛𝑀𝑎𝑠𝑠஽௑஺ where TBW was measured 
using either D2O or BIA. Histograms of participants’ lean mass hydration levels are shown in Figure 
6-5. Greater mean lean mass hydration was observed when using TBWBIA (mean = 0.755) than 
TBWD2O (mean = 0.726). Greater spread in lean mass hydration levels was observed in TBWBIA (SD 
= 0.047) than TBWD2O (SD = 0.027). Hydration results generally agree well with a review of cadaver 
studies by Wang, et al. [195] in which the hydration mean and standard deviation was found to be 
0.737 ± 0.036. The range of D2O hydration values is relatively narrow, with only a single data point 
more than one standard deviation away from the 0.737 mean reported by Wang. However, the 
range of BIA hydration values was much larger, with five data points more than one standard 
deviation away from 0.737. 
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Figure 6-5: Histograms of fat-free mass hydration (defined as total body water divided by fat-free mass from 
DXA) (n=23). More variance was observed when using BIA for TBW than when using D2O for TBW. The 
observed range of hydration values extends beyond physiological bounds for healthy adults in the sample; 
definition of thresholds on plausible hydration levels may provide criteria to validate BIA TBW measurements. 
 
6.1.4	Discussion	
Four-component body composition is a well-established method for assessment of metabolic 
status and health. In this study we found that percent fat measurements from several different 
technologies using both 2-component (ADP, BIA, and D2O) and 3-component (DXA) models 
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agreed well with the criterion 4C Lohman model. Each of these devices should provide accurate, 
reliable measurements of adiposity in the clinical setting when normal hydration is expected. The 
best agreement with the Lohman model for both %Fat and protein measures was found to be with 
the rapid 4C DXA+BIA method. 
The agreement between the two 4C methods relies on the agreement of BVDXA with BVADP, 
and TBWBIA with TBWD2O. Although we found high agreement between the two BV measurements, 
a small but significant difference was observed (TBWD2O/TBWBIA = 0.993). BV is highly weighted in 
the Lohman 4C model, so it is important that BV measures are accurately calibrated. The two 
methods have very different underlying assumptions and it is unclear which method most accurately 
measures volume in an individual. The BodPod is calibrated using a reference object periodically so 
that accuracy on solid volumes is assured. However, in vivo error sources include uncertainty in the 
lung and gastric volumes. DXA systems only measure solid volume and are unaffected by lung and 
gastric voids. Potential errors in the DXA volume include the extrapolation of the lean and soft tissue 
masses over regions containing bone and the lack of existing quality assurance methods to validate 
soft tissue mass accuracy (standard phantoms and protocols exist only for calibration of bone mineral 
mass). Clearly, a quality control method for DXA that assures mass accuracies to better than 0.5% is 
warranted to ensure agreement between DXA systems in the field.  
In a similar but larger study, Smith-Ryan, et al. [206] re-derived coefficients for BVDXA 
calibrated to BVADP using the same make and model DXA system. Smith-Ryan also did not use the 
NHANES correction, and found coefficients (𝜈௟௘௔௡ ൌ 0.971, 𝜈௙௔௧ ൌ 1.19, 𝜈௕௢௡௘ ൌ 0.086 ) 
similar to those originally published by Wilson: ሺ𝜈௟௘௔௡ ൌ 0.95, 𝜈௙௔௧ ൌ 1.14, 𝜈஻ெ஼ ൌ 0.21ሻ . In this 
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study, we found that BVDXA derived using Wilson’s coefficients agreed with BVADP within 0.3%. The 
difference seen by Smith-Ryan were likely due to slight calibration differences in the DXA systems 
and could have been corrected using a reference quality control phantom for soft tissue masses.  
We found high agreement between the two TBW measurements with a small but significant 
difference (TBWD2O/TBWBIA = 0.956). Although we used a trained laboratory for D2O spectroscopy 
and clinical staff to measure and administer the doses, there was still one measurement that appeared 
outside realistic biological bounds. Potential errors in D2O TBW measurements include subject 
noncompliance with the fasting and resting requirements before and during the protocol. Strenuous 
activity or significant food and drink consumption, particularly in the hours immediately before dose 
consumption and sample collection, can significantly affect accuracy of D2O TBW measurements 
[92]. Potential sources of BIA error include electrode placement inaccuracy, poor electrode contact, 
and significant variability in body shape [207]. Nonetheless, BIA is an appealing method for clinical 
TBW measurement due to its low cost, rapid results, and amenability to field calibration using stable 
phantoms. Significant outliers in TBWBIA can be detected by applying thresholds of agreement 
between duplicate TBWBIA measurements, or comparison to reference physiological hydration ranges 
for singleton measurements. Using these outlier exclusion methods, the TBWBIA test-retest precision 
was 1.1%. If the difference between the two measurements exceeds 1.8 kg, we recommend collecting 
a third measurement and averaging of the two closest measurements. Further validation of TBWBIA 
precision in different models and using different electrodes (adhesive gel pads vs. touch type) might 
be useful to expand the utility of this method. Without these outlier detection methods, the 
observed TBWBIA test-retest precision was 5.2%. Vaché et al. reported precision of 4.1 %CV for test-
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retest measurements collected eight hours apart [208]. Further precision studies would be needed to 
assess the long-term precision of BIA for TBW. 
Precision of %Fat measurements from the 4C DXA+BIA method (RMS-SD = 0.8 percent 
units after BIA outlier removal) was found to be comparable to that of DXA (RMS-SD = 0.6 percent 
units), suggesting that the method may be suitable for monitoring individual percent fat in 
longitudinal studies. Precision of 4C DXA+BIA protein measurements was somewhat lower (%CV = 
4.4) since protein is a smaller fraction of total body mass. This suggests that 4C DXA+BIA protein 
may be more suitable for population analysis and individual classification than monitoring of 
individual protein mass changes. 
Our results on the accuracy of 4C DXA+BIA protein measurements versus a reference 
Lohman model (R2 = 0.76, RMSE = 1.8 kg) are nearly identical to the results found of Wilson [200] 
who compared 4C DXA+BIA protein versus neutron activation analysis (R2 = 0.77, RMSE = 1.8 
kg).  
This study had several strengths. To our knowledge, our study is the first to validate the use 
of BIA for total body water measurements in a 4-component model, and the first to quantify test-
retest precision of 4C DXA+BIA measurements. Notably, the present study validates the use of 
specific DXA and BIA systems (from Hologic and InBody) whereas Wilson’s seminal study used 
systems from different manufacturers (GE and Impedimed). Smith-Ryan used a Hologic DXA 
system and Impedimed BIA system. While the equations presented herein are specifically calibrated 
to the particular devices (Hologic DXA and InBody BIA) in this study, the success of this validation 
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demonstrates the hardware agnosticism of the 4C DXA+BIA approach. Second, we showed how BIA 
and DXA can be combined to measure hydration. Third, we showed how total body protein can be 
estimated independently of water status.  
However, there were also limitations. Namely, the limited sample of participants included 
only healthy and normally hydrated individuals. Recruitment was not stratified to target a wide 
range of body sizes, ethnicities, and ages. We also did not include strength metrics that could have 
shown if protein is a superior estimate of function than DXA lean mass. Future studies may 
investigate the robustness of the 4C DXA+BIA model in populations with impaired metabolic and 
functional profiles, older ages, and abnormal hydration status.  
In summary, this work validates the accuracy and precision of a clinically-viable technique 
incorporating DXA and BIA technology for 4C body composition. Translation to clinical practice 
would enable fast, accessible 4C assessment including fat, protein, and hydration status - measures 
important for monitoring of wide variety of conditions including dieting, sarcopenia, cachexia, and 
performance training. Validation in such special populations is warranted.  
6.1.5	Supplement:	Effect	of	the	NHANES	calibration	on	DXA	%Fat	accuracy		
We evaluated percent fat results from DXA with and without the NHANES calibration setting 
enabled. This calibration was implemented in response to a 2005 publication by Schoeller, et al. that 
found that DXA underestimated fat mass compared to a few criterion methods (TBW dilution, 
densitometry, and 4-component analysis) across 7 different studies [132]. The recommendation of 
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this report was that DXA lean mass measurements be reduced by 5.4% and that fat mass 
measurements be increased by a corresponding amount of mass. 
 In the present study, NHANES calibrated-DXA measurements did not agree well with the 
criterion Lohman 4C model (Figure 6-6). Specifically, NHANES-calibrated DXA percent fat was 
significantly higher than the Lohman 4C criterion measurement, particularly in leaner individuals: 
[PFATDXA, NHANES = 0.89 * PFATLohman 4C + 6.45]. Disabling the NHANES calibration resulted in 
higher accuracy with the criterion Lohman 4C model: [PFATDXA = 0.98 * PFATLohman 4C]. 
 It may be noted that D2O dilution in the present study, similar to the NHANES-calibrated 
%Fat, was the only other percent fat measurement that produced a significant bias (P < 0.05) versus 
the Lohman 4C. Four of the seven studies that were used to derive the NHANES calibration used 
D2O as the criterion measurment. This is consistent with the present finding of a significant bias in 
NHANES-calibrated DXA percent fat. However, NHANES-calibrated DXA overestimated percent 
fat even relative to D2O (dashed red and solid purple lines inFigure 6-6, respectively). 
 The small sample size of this study limits the strength of conclusions that can be drawn from 
these data, however the finding that DXA agrees with the Lohmann 4C and other methods except 
when the NHANES-calibration is applied, is unexpected.  The NHANES-calibrated DXA 
overestimates fat versus all other methods, including D2O. These results support re-evaluation of 
DXA body composition calibration standards to optimize the accuracy of the method. 
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Method Slope [95% CI] Intercept [95% CI] R2 RMSE 
DXA (NHANES) 0.89 [0.78, 1.00] 6.45 [3.11, 9.78] 0.93 2.83 
DXA 0.98 [0.94, 1.03] n.s. 0.93 2.97 
ADP 0.96 [0.94, 0.99] n.s. 0.98 1.71 
BIA 0.94 [0.88, 0.99] n.s. 0.90 3.83 
D2O 0.90 [0.82, 0.97] 3.56 [1.45, 5.68] 0.97 1.80 
4C DXA + BIA 1.01 [0.97, 1.04] n.s. 0.96 2.33 
Figure 6-6: Whole-body percent fat from various body composition assessment methods versus the reference 
4C Lohman model. “n.s.” indicates that the regression intercept was non-significant and set to zero. This figure 
matches Figure 3 but includes DXA percent fat with NHANES correction enabled. It can be seen that DXA 
(NHANES) significantly overestimates percent fat versus all other methods tested, particularly in leaner 
individuals. 
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6.2: Ultra DXA + 3D Optical Imaging for True 3C and 4C Whole-Body Imaging 
6.2.1	Motivation	
 As previously mentioned, DXA technology cannot simultaneously resolve more than two 
tissue types. Lean/fat soft tissue composition is thus estimated at all pixels containing bone by 
inferring composition from the nearest bone-free pixels. This results in significant interpolation in 
up to about 60% of all pixels in a whole-body image (Figure 6-7). Because of this significant 
interpolation, DXA measurements of all three compartments (3C: bone, fat, lean) are highly 
sensitive to positioning. This limits accuracy and precision of the method and prohibits true 
measurement of the spatial distribution of fat over the ribcage within the torso. 
 
Figure 6-7: DXA can simultaneously resolve two tissue compartments (bone and homogenous soft tissue, left), 
but not three (bone, lean, and fat). Consequently, soft tissue composition must be interpolated in all pixels 
containing bone (right). 
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6.2.2	Theory	
To overcome the two-compartment limitation of DXA, body thickness at each pixel will be 
directly measured using 3D surface scanning. Specifically, body thickness will be measured using a 
set of 3D depth sensing cameras mounted adjacent to the X-ray detector array and source of the 
DXA system. To facilitate imaging of the subject’s posterior surface, the scanner table will be 
replaced with an optically-transparent acrylic tabletop. Depth streams from the cameras will be 
processed using temporal fusion to construct a high-resolution 3D model of the patient’s body as the 
C-arm sweeps across the table [209]. The assembled 3D depth data allows for independent 
estimation of X-ray path lengths corresponding to each DXA pixel. 
Using the low-energy (100 kVp) and high-energy (140 kVp) X-ray attenuation measurements 
𝐴௅ா and 𝐴ுா, along with total thickness 𝑇, three-compartment (bone/fat/lean) composition at each 
pixel can be estimated using the following monochromatic model (Equation 6-1), where 𝜇௝,௞ is the 
linear attenuation coefficient and 𝑡௝ is single-compartment thickness for material 𝑗 at energy level 𝑘. 
Here 𝑦 is the vector of measurements used to estimate 𝑥, the vector of component tissue thicknesses. 
𝐴 ൌ ቈ
𝜇ୠ୭୬ୣ,୐୉ 𝜇୪ୣୟ୬,୐୉ 𝜇୤ୟ୲,୐୉𝜇ୠ୭୬ୣ,ୌ୉ 𝜇୪ୣୟ୬,ୌ୉ 𝜇୤ୟ୲,ୌ୉
1 1 1
቉        𝑥 ൌ ൥
𝑡ୠ୭୬ୣ𝑡୪ୣୟ୬𝑡୤ୟ୲
൩        𝑦 ൌ ൥
𝐴௅ா𝐴ுா𝑇
൩ 
𝑦 ൌ 𝐴𝑥 
Equation 6-1: Monochromatic model for 3-compartment estimation at each pixel. 
For accurate measurement, corrections for beam hardening introduced by the polychromatic 
nature of the tungsten X-ray source in the DXA scanner must be implemented. This will be achieved 
by utilizing a polynomial approximation of the power series relationship (Equation 6-2) between 
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tissue thickness and polychromatic attenuation as defined previously for 3-compartment breast 
imaging [210]. We expect this technique to scale to whole-body composition assessment because 
target thicknesses are larger in a whole-body scan than a breast scan, and the primary components of 
interest (bone, lean, and fat) have greater separation in X-ray attenuation characteristics than do the 
components separated from breast images (water, protein, and fat).  
𝑡௝ ൌ ෍ 𝑎ఈఉఊ,௝𝐴ுாఈ 𝑅ఉ𝑇ఊ
ሺఈ,ఉ,ఊሻ∈ே
 
𝑡௝ ൌ 𝑎ଵ,௝ ൅ 𝑎ଶ,௝𝐴ுா ൅ 𝑎ଷ,௝𝑅 ൅ 𝑎ସ,௝𝑇 ൅ 𝑎ହ,௝𝐴ுாଶ ൅ 𝑎଺,௝𝑅ଶ ൅ 𝑎଻,௝𝑇ଶ ൅ 𝑎଼,௝𝐴ுா𝑅 ൅ 𝑎ଽ,௝𝐴ுா𝑇
൅ 𝑎ଵ଴,௝𝑅𝑇 
Equation 6-2: Power series relationship (upper) between tissue thickness and measured X-ray attenuations and 
thickness. Here the ratio value 𝑹 ൌ 𝑨𝑳𝑬/𝑨𝑯𝑬. Taylor series polynomial approximations (quadratic shown, 
lower) were calibrated to provide tissue thickness measurements adjusted for polychromatic beam hardening. 
Malkov showed conceptual phantom results using a GE Lunar Prodigy densitometer (GE 
Healthcare, Madison, WI, USA) and Microsoft Kinect (Microsoft, Inc., Redmond, WA, USA) 
suitable for whole-body imaging [211]. Imaging a phantom with 2, 4, and 6 cm steps, Malkov used 
experimental DXA attenuation measurements ሼ𝐴ுா, 𝐴௅ாሽ and known total thickness 𝑇 to estimate 
phantom water, lipid, and protein thicknesses. Malkov found errors (standard deviations) of 0.09 cm 
(1.6 %), 0.08 cm (1.4 %), and 0.05 cm (4.1 %) for water, lipid, and protein, respectively. He then 
simulated errors of ±0.1 cm in 𝑇 and found that estimated 3C errors increased to 0.19 cm (3.2 %), 
0.16 cm (2.7 %), and 0.3 cm (22 %), respectively. Malkov’s results demonstrate feasibility and 
underscore the importance of highly accurate total thickness measurements to the accuracy of this 
method. 
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If successful, the Ultra DXA technique could provide true 3C imaging across the whole body, 
including regions with bone, to allow accurate imaging of fat and lean tissue distribution in the 
torso. It could also enable interpolated 4C imaging, using the same spatial approximations used to 
derive 3C composition from two DXA attenuation signals.  
6.2.3	Prototype	Device	and	Phantom	Studies	
We developed a prototype Ultra DXA device (Figure 6-8) by integrating three 3D optical 
cameras (Kinect, Microsoft, Redmond, WA) above and below a custom optically-transparent 
tabletop installed on a Hologic Discovery/W densitometer (Hologic, Marlborough, MA). Depth 
images from the cameras were collected in serial, cycling once every three seconds throughout the 
duration of the whole-body DXA scan. Measurements were performed in serial to avoid illumination 
pattern interference between cameras. 3D meshes were assembled using KScan3D software (LMI 
Technologies, Vancouver Canada) and analyzed in MATLAB R2017a (The MathWorks, Inc., 
Natick, MA) to estimate X-ray path lengths corresponding to each DXA pixel. 
Material separation was demonstrated using multiple scans on a 6-cm step phantom of materials 
biologically equivalent to fat (machinable wax, McMaster-Carr, Inc., Elmhurst, IL, USA), water 
(Plastic Water LR, CIRS, Norfolk, VA, USA), and protein (Delrin acetal resin sheets, McMaster-
Carr, Inc., Elmhurst, IL, USA). The step phantom is shown in Figure 6-9. The steps were 2, 4, and 
6 cm high, at 0, 50, and 100% fat compositions. The total footprint of the step phantom is 12 cm x 
12 cm. Five thicknesses of Delrin sheet (0, 3.175, 6.8, 13.5, and 20 mm) were placed under the step 
phantom. Including an air region of zero thickness adjacent to the step phantom, a total of 46 
fat/water/protein thickness combinations were used. 
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Figure 6-8: Prototype Ultra DXA system with integrated transparent acrylic tabletop and 3D depth cameras. 
 
Figure 6-9: Blue wax/plastic water step phantom on Delrin sheets used to approximate water, lipid, and 
protein, respectively.  
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Calibration	and	3C	Separation	
DXA scans were acquired of the step phantom with each of the five Delrin thicknesses. A special 
high-resolution scan mode was used that produced images with a resolution of 2151 x 126 pixels at a 
pixel size of approximately 0.08 x 0.90 mm. Regions of at least 33 x 20 pixels were selected in the 
middle of each step of the phantom object. 𝐴ுா and 𝐴௅ா were averaged in each region and recorded 
for each of the 46 unique thickness combinations. These measurements were used with known 
(measured) thickness values 𝑇 to calibrate the 𝑎 coefficients in quadratic and cubic Taylor series 
polynomials as shown in Equation 6-2 (regress in MATLAB). Root mean square errors (RMSE) in 
thickness estimates across the calibration set using a cubic model were 0.97, 0.87, and 0.91 mm for 
water, lipid, and protein, respectively. These errors are 5.4, 4.8, and 12.3% of the average phantom 
thicknesses of water (18 mm), lipid (18 mm), and protein (7.4 mm), respectively. 
The calibrated cubic polynomial calibration equation was used to create separate material images 
of the step phantom fat, water, and protein components (Figure 6-10). Thicknesses were calculated 
on a per-pixel basis. Median filtering with a window size of 5 pixels was applied (medfilt2 in 
MATLAB) to suppress edge artifacts. Cross-sectional thickness profiles across the step phantom for 
an average of 10 columns are shown in the middle of Figure 6-10. Actual protein (Delrin) thickness 
in the image shown is 6.35 mm.  
Further experiments with increased thicknesses and different materials (including a bone-
equivalent phantom such as hydroxyapatite) are warranted to better approximate target materials 
expected in a whole-body scan, and to determine whether accuracy varies with thickness. 
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Region A B C D E F G H J 
True 
Thickness 
(mm) 
20 40 60 20 40 60 6.35 6.35 6.35 
Estimated 
Thickness 
(mm) 
20.4 40.0 59.7 19.0 38.6 59.0 6.97 8.01 6.17 
Figure 6-10: Isolated water, lipid, and protein images of the step phantom generated using the 3C “Ultra DXA” 
technique. High-resolution DXA attenuation measurements and known thicknesses were used to derive cubic 
polynomials to estimate water, fat, and protein composition. Cross-sectional thickness profiles are shown 
below each image, showing good agreement to the actual dimensions of the step phantom. 
3D	Mesh	Assembly	and	Thickness	Measurements	
Total thickness of the 3D step phantom was measured with the depth cameras in a fixed 
position above and below the phantom. 500 consecutive exposures were collected in this static 
configuration to assess noise characteristics and quantify the effect of averaging multiple thickness 
measurements on measurement error. The cameras were connected to a single computer and images 
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were captured using a KScan3D script. (All relevant scripts for this project can be found in the 
shepherd-lab/ultradxa repository; see Appendix: Code Availability). 
Acquired point cloud images are meshed and exported in PLY polygon file format. Each image 
is captured in the frame of the camera. Images from the three cameras must be rotated and translated 
in 3D space to align images into a single, all-around 3D point cloud of the target phantom object. 
Transformation matrices for each camera are generated by using the Align tool in MeshLab. Un-
aligned images from each of the three cameras are loaded into a single MeshLab workspace, and 
common points are selected on each image. One image is selected (“glued”) as the reference frame, 
and then successive images are aligned to that image using the selected points. In this phantom 
study, these camera-to-camera translations are the only required alignment transformations. On the 
other hand, in a whole-body scan, the motion of the system must be considered. 
Once the camera-to-camera transformation matrices are derived, those camera-specific 
transformations are applied to all images from each camera. The transformed point clouds are loaded 
and merged in MATLAB. Mean  𝑥 and standard deviation 𝑠 of estimated thickness is calculated at 
each level of the step phantom (2, 4, and 6 cm) for a single combined/aligned image (one point 
cloud from each camera). Mean, standard deviation, and standard error of the mean 𝑆𝐸𝑀 ൌ 𝑠/√𝑖 
are calculated for 𝑖 ൌ 1 → 500 images.  
Results for SEM of measured thickness are shown in (Figure 6-11). Using one exposure from 
each camera produced depth images with average thickness errors (SD) of approximately 2.3 mm at 
each step. Adding additional measurements reduced the SEM continuously. Averaging of 20 
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complete aligned images reduced error below 0.5 mm. While single exposures from commodity 
depth cameras such as the Kinect are noisy, multiple exposures can be collected with little additional 
cost. Provided the hardware supporting the 3D depth cameras is sufficiently powerful, video-rate 
(30Hz or greater) depth streams can be captured from each camera to easily acquire hundreds of 
samples in a matter of seconds. 
 
Figure 6-11: Effect of averaging multiple 3D optical depth measurements. We found that averaging of 
approximately 20 depth measurements reduced error below 0.5 mm. 
With this phantom study we demonstrated the feasibility of 3C separation using the Ultra DXA 
prototype scanner. In the following section we describe a pilot study of human subjects scanned on 
the system and the progress in image processing as of the writing of this document. 
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6.2.4	In	Vivo	Pilot	Study	
To demonstrate the Ultra DXA technique for whole-body imaging, thirty-one healthy adults 
over the age of eighteen were enrolled in a prospective open recruitment as described in 6.1.2 . All 
provided informed consent and the study protocol was approved by the UCSF Committee on 
Human Research (IRB #16-19342).  
Each participant was imaged on the prototype Ultra DXA system a total of six times: twice 
without repositioning and once again with repositioning, at each of two different X-ray energy 
settings (100/140 kVp standard configuration and 80/140 kVp research configuration). During each 
scan, depth images were collected from each of the three Kinect cameras mounted on the 
densitometer. Depth images were acquired in series using a KScan3D script, with a new cycle 
beginning every three seconds. After acquisition, each captured point cloud was converted to a 
connected mesh. Meshes were then aligned by camera (1-3) and pass (1-7) to create 21 groups of 
meshes. KScan3D features meshing and alignment tools for these operations, as well as combining 
and finalizing tools to clean, smooth, and simplify meshes for export. Alignment in KScan3D uses 
iterative closest point matching [183]. We provide example aligned and exported images from a 
single camera over the course of a single pass of the densitometer scan arm in Figure 6-12. 
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Figure 6-12: Two examples of assembled 3D meshes from depth images collected from a single depth camera 
over a single pass of the densitometer C arm. Images were collected approximately every 3 seconds and 
assembled using the Iterative Closest Point algorithm. The presence of many well-defined depth features (e.g. 
corners and ridges) is necessary for ICP to produce reliable alignments. Smaller participants with less shape 
features or smaller bodies may prove more problematic for alignment particularly near the feet end of the 
scanner and between scan passes. 
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As of this writing, significant effort has been devoted to processing the 3D depth images 
collected throughout all seven passes of the whole-body scans. However, we have not yet 
implemented robust alignment across all cameras and all passes of a scan, and as a result 
compositional images are yet to be calculated. While single-camera, single-pass alignment works 
reliably to produce images like those shown in Figure 6-12, drift in the ICP algorithm presents 
problems for precise alignment throughout the duration of a multi-pass scan. The configuration and 
dynamics of the scanner present challenges to alignment. Specifically, the table and C-arm both 
move during a whole-body scan, producing multiple simultaneous object movements in the field of 
view. This leads to errors in alignment that can quickly compound since each depth image is aligned 
to the last. An example of a failed alignment is shown in Figure 6-13 (left). 
 
Figure 6-13: Challenges in alignment of 3D depth images. In regions with few distinct depth features (e.g. the 
near the feet shown at left), there may be insufficient correspondence for reliable alignment. One failed image 
alignment can then cause subsequent images to align incorrectly. Timing information can be used with the 
known movement of the densitometer to predict the exact location at which each image was taken (right). 
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6.2.5	Summary	and	Challenges	
With this initial work we have developed a prototype system integrating depth cameras on a 
modified DXA system. Using high-resolution DXA attenuation measurements and caliper-measured 
thicknesses, we calibrated quadratic and cubic polynomial imaging equations using a 2/4/6-cm thick 
step phantom of water/fat/protein equivalent materials. The cubic model provided 3-component 
thickness separation on images of the phantom with RMSE < 1 mm for each material.  We 
developed a protocol for acquiring depth images sequentially from three Microsoft Kinect cameras at 
a frequency of one complete acquisition (i.e. one image from each camera) every three seconds. 
Given the 45-second pass time of the densitometer in whole-body scan mode, this translates to 
approximately 15 depth images acquired over the 196 cm length of the scan table. Using depth 
images of the step phantom we found that single-image thickness error (SD) was about 2.3 mm. 
Averaging approximately 20 depth measurements reduced standard error of the mean (SEM) of 
thickness measurement below 0.5 mm. Higher depth image acquisition rates could be used to 
improve quality of thickness measurements. All relevant image acquisition code as well as processing 
and analysis scripts developed for this project can be found in the shepherd-lab/ultradxa repository 
(see Appendix: Code Availability). 
We used the prototype system to collect in vivo DXA and 3D image data on thirty-one healthy 
participants. Processing of the image data is ongoing. The primary challenge as of this writing is 
development of a robust algorithm for aligning the depth images collected throughout the scan. A 
more robust approach to alignment would be to (1) use knowledge of the programmed movements 
of the densitometer to provide initial alignment for each depth image in 3D space, (2) enforce 
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limitations on the degrees of freedom for image-to-image transformation based upon the known 
geometry of the system, and (3) use ICP or similar algorithms for fine adjustments rather than coarse 
alignment. Additionally, fiducial markers placed along the table may provide useful landmarks to 
assist the registration algorithms. 
We have characterized the movement of the densitometer during a whole-body scan and 
implemented preliminary timing-based alignment by predicting the location of the cameras at any 
specific time during a scan. The time of each point cloud is calculated by comparing the file creation 
timestamp on each depth image with the start time of the DXA scan. We use measured motion 
patterns of the densitometer to programmatically estimate camera position as a function of time. An 
example of a timing-aligned mesh is shown in Figure 6-13 (right). Note that there are artifacts due 
to inaccuracies in the location prediction, particularly during the lateral transition phases between 
passes. Additional denoising, cropping, and fine alignment are necessary to remove extraneous 
objects in the scene and produce a clean, closed 3D mesh amenable to slicing and thickness 
measurement along the X-ray paths of the densitometer. These tasks are left as future work. 
At a more fundamental level, the Ultra DXA imaging technique requires very high precision 
thickness and X-ray attenuation measurements. Equation 6-1 encapsulates the underlying principle 
of the technique. A potential issue is the stability of this imaging equation, as the 𝐴 matrix has a 
condition number on the order of 103 at the default tube voltages of the DXA scanner. Numerical 
simulations of a three-compartment phantom including 1% white noise on the measurement vector 
𝑦 produce a signal-to-noise ratio loss from 𝑆𝑁𝑅௬ ൌ 59.3 to 𝑆𝑁𝑅௫ො ൌ 9.5. This is due to limited 
orthogonality between 3D depth and X-ray attenuation measurements and underscores the need for 
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highly precise individual measurements. Potential options for improving system stability include 
adjustment of tube energy levels to afford greater attenuation coefficient separation, or use of a more 
precise 3D depth imaging hardware (e.g. laser line scanners).  
Moving forward, the 3D depth imaging component of this project could be improved with 
integration of newer sensors such as the Intel RealSense D435 (Intel Corp., Santa Rosa, CA, USA) 
that provides significantly improved depth resolution (up to 1280x720p) and framerate (up to 90 
Hz) as well as global shutter and more sophisticated onboard processing [212]. With appropriate 
software, these newer sensors may enable simultaneous 60 Hz+ acquisition and alignment of depth 
measurements on a single system where the present setup and protocol was limited to 0.33 Hz. 
Higher frequency acquisition would improve the quality of thickness measurements and may 
mitigate the alignment challenges due to increased image-to-image correspondence. However, with 
increased resolution and sampling rate it is more critical to develop a real-time alignment strategy to 
cope with the high data rate of acquisition. As a reference, 30 Hz 640x480p video rate acquisition of 
color and depth streams (RGB-D) from a single Kinect camera for seven minutes (a duration long 
enough to cover a whole-body scan on the prototype system) produces about 10.5 GB of data.  
 Tighter integration with the densitometer hardware (e.g. synchronizing with the stepper motors 
that drive table and scanner arm movements) could be used to more reliably align 3D thickness 
measurements with absorptiometry measurements and further mitigate the need for empirical post-
hoc alignment. With further development to reliably match 3D optical and DXA measurements, 
true in vivo 3-component Ultra DXA imaging may be demonstrated and characterized. 
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7 | Future Directions 
Several of the studies contained in this dissertation are built around principal component 
analysis of image data to produce compact representations of 3D shape or 2D tissue appearance. A 
logical next step would be to apply these techniques to magnetic resonance imaging data to begin to 
understand the key features of 3D internal body composition. Appearance modeling techniques have 
been successfully applied for several 3D medical image segmentation tasks [213]–[215]. 
Furthermore, other statistical methods beyond PCA could be explored to better detect composition 
features specifically indicative of selected risk and outcome variables. Methods such as linear 
discriminant analysis and deep neural networks have provided revolutionary performance in several 
image classification, segmentation, and analysis tasks [216]–[220], and the 3D and DXA data 
discussed herein are ripe for this type of analysis. Supervised statistical learning of course brings with 
it an increased risk of model overfitting, so increased data collection and diligent validation and data 
augmentation practices should be priorities. 
One limitation of the statistical shape and appearance models described above is that they all 
require some degree of manual annotation to register and analyze new images. This can be a time-
consuming process that requires trained readers. Additional training and careful refinement of fitting 
models [153] may mitigate the need for manual annotation, and more advanced fitting and 
segmentation algorithms may allow for further automation [219], [221]–[223]. Automation is 
highly desirable both for efficiency and practicality of deploying these techniques to end users. More 
sophisticated 3D body shape models informed by internal joint structure and tissue deformation in 
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motion may be investigated to provide better fitting, registration, and pose correction of 3D body 
scans from many different devices [224]–[226]. Estimation of 3D body shape from 2D images 
[227], [228] could enable even greater access to metabolic risk assessment using nothing more than a 
cell phone camera. 
The promising validation of the rapid 4C DXA+BIA technique in healthy adults warrants 
further validation in target populations of growing children, older adults, and individuals with 
cachexia and sarcopenia. Such work would provide insight into the generalizability of the method. 
Analysis of 3D body shape as contained in the Shape Up! studies could be extended to include more 
longitudinal components and investigation of body shape changes in response to different diet and 
activity interventions. Understanding of shape changes in the individual would inform body shape 
models that can more accurately predict realistic change for a specific person. 
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8 | Conclusions 
Over the course of this dissertation we developed techniques to capture and analyze detailed 
information about 3D body shape and internal tissue distribution. These studies are built around 
accessible 3D optical body scanners that are increasingly accessible, with products now in consumer 
homes, and low-dose whole-body dual energy X-ray absorptiometry. A central theme of these works 
is leveraging available technologies in novel ways to extract more meaningful clinical health insight. 
We demonstrated algorithms for high-resolution quantitative fat, lean, and bone image 
derivation from standard whole-body DXA scans. We applied these algorithms and created statistical 
appearance models of whole-body thickness, fat, and lean tissue distribution in populations of older 
adults across five different ethnicities. We showed that these models can be used to classify sex (AUC 
= 0.99), race (AUC = 0.91), and 10-year mortality (AUC = 0.66) in a study of older black and white 
adults. We then applied these techniques to a study of older adults of five different ethnicities to 
reveal characteristic phenotypes of body fat distribution by ethnicity and show that fat distribution 
alone can accurately predict metabolic syndrome status (validation AUC = 0.82-0.87) and diabetes 
status (validation AUC = 0.68-0.75) without the need for ethnicity-specific adjustments. 
As a pilot investigation, we characterized the accuracy and precision of commercial 3D optical 
body scanners for clinical circumference, surface area, and total body volume measurements (R2 ≥ 
0.92) and showed that these measurements could be used to predict total and regional body 
composition (whole-body fat mass validation R2 = 0.76, RMSE = 3.72 kg). These results were used 
as preliminary data to secure NIH funding for the launch of the Shape Up! Adults and Kids studies. 
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As part of ongoing Shape Up! analysis, we built detailed 3D statistical shape models that efficiently 
capture 95% of body shape variance and demonstrated that these models offer improved body 
composition accuracy (whole-body fat mass cross validation R2 = 0.89, RMSE = 2.80 kg) over 
traditional techniques and test-retest precision reasonably comparable to DXA (whole-body fat mass 
RMSE = 1.02 kg / 0.67 kg, %CV = 5.0 / 2.7 for males/females respectively). 3D optical body 
scanning is a rapidly growing market and the technology is uniquely amenable to widespread and 
frequent individual assessment. The findings from these studies could provide enhanced metabolic 
health insight to clinicians and individuals all around the world. 
We validated the accuracy and precision of a rapid DXA and bioelectrical impedance technique 
to provide four-component body composition comparable to gold-standard techniques (%Fat R2 = 
0.96, RMSE = 2.33 units, test-retest RMS-SD = 0.8 units; 4C protein R2 = 0.76, RMSE = 1.8 kg, 
test-retest %CV = 4.4). We discussed implementation and calibration considerations to bring this 
rapid 4C method to the clinic where traditional 4C protocols are impractical. Finally, we 
conceptualized a novel integrated 3D optical + DXA device called “Ultra DXA” for true 3C and 
interpolated 4C imaging of the whole body. We built a prototype of this device, demonstrated proof 
of concept phantom results (separated water, fat, protein RMSE < 1 mm each), and collected in vivo 
data for preliminary analysis and development. 
In total, these works provide affirmative evidence that detailed descriptors of body shape and 
composition reveal meaningful health risk markers beyond traditional methods. By building upon 
proven, accessible technologies, these findings provide enabling translatable tools for clinicians and 
individuals to better assess metabolic status and track progress towards improved health. 
154 
References 
[1] “WHO | Obesity and overweight,” WHO. [Online]. Available: 
http://www.who.int/mediacentre/factsheets/fs311/en/. [Accessed: 08-Nov-2017]. 
[2] “WHO | 10 facts on obesity,” WHO. [Online]. Available: 
http://www.who.int/features/factfiles/obesity/en/. [Accessed: 03-Apr-2018]. 
[3] Y. Wang and H. Lim, “The global childhood obesity epidemic and the association between 
socio-economic status and childhood obesity,” Int. Rev. Psychiatry, vol. 24, no. 3, pp. 176–188, 
Jun. 2012. 
[4] “WHO | Childhood overweight and obesity,” WHO. [Online]. Available: 
http://www.who.int/dietphysicalactivity/childhood/en/. [Accessed: 03-Apr-2018]. 
[5] M. Arnold et al., “Global burden of cancer attributable to high body-mass index in 2012: a 
population-based study,” Lancet Oncol., vol. 16, no. 1, pp. 36–46, Jan. 2015. 
[6] E. A. Finkelstein, J. G. Trogdon, J. W. Cohen, and W. Dietz, “Annual Medical Spending 
Attributable To Obesity: Payer-And Service-Specific Estimates,” Health Aff. (Millwood), vol. 28, 
no. 5, pp. w822–w831, Sep. 2009. 
[7] E. A. Finkelstein et al., “Obesity and severe obesity forecasts through 2030,” Am. J. Prev. Med., 
vol. 42, no. 6, pp. 563–570, Jun. 2012. 
[8] Y. C. Wang, K. McPherson, T. Marsh, S. L. Gortmaker, and M. Brown, “Health and economic 
burden of the projected obesity trends in the USA and the UK,” The Lancet, vol. 378, no. 9793, 
pp. 815–825, Sep. 2011. 
[9] B. A. Swinburn, D. Jolley, P. J. Kremer, A. D. Salbe, and E. Ravussin, “Estimating the effects of 
energy imbalance on changes in body weight in children,” Am. J. Clin. Nutr., vol. 83, no. 4, pp. 
859–863, Jun. 2006. 
[10] A. H. Slyper, “The Pediatric Obesity Epidemic: Causes and Controversies,” J. Clin. 
Endocrinol. Metab., vol. 89, no. 6, pp. 2540–2547, Jun. 2004. 
[11] E. J. McAllister et al., “Ten Putative Contributors to the Obesity Epidemic,” Crit. Rev. Food 
Sci. Nutr., vol. 49, no. 10, pp. 868–913, Nov. 2009. 
[12] R. V. Burkhauser and J. Cawley, “Beyond BMI: The value of more accurate measures of 
fatness and obesity in social science research,” J. Health Econ., vol. 27, no. 2, pp. 519–529, Mar. 
2008. 
[13] WHO Expert Consultation, “Appropriate body-mass index for Asian populations and its 
implications for policy and intervention strategies,” Lancet Lond. Engl., vol. 363, no. 9403, pp. 
157–163, Jan. 2004. 
[14] E. M. Evans, D. A. Rowe, S. B. Racette, K. M. Ross, and E. McAuley, “Is the current BMI 
obesity classification appropriate for black and white postmenopausal women?,” Int. J. Obes., 
vol. 30, no. 5, pp. 837–843, May 2006. 
[15] T. J. Cole, M. S. Faith, A. Pietrobelli, and M. Heo, “What is the best measure of adiposity 
change in growing children: BMI, BMI %, BMI z-score or BMI centile?,” Eur. J. Clin. Nutr., 
vol. 59, no. 3, pp. 419–425, Mar. 2005. 
155 
[16] Alberti K. G. M. M., Zimmet P., and Shaw J., “Metabolic syndrome—a new world‐wide 
definition. A Consensus Statement from the International Diabetes Federation,” Diabet. Med., 
vol. 23, no. 5, pp. 469–480, Apr. 2006. 
[17] P. L. Huang, “A comprehensive definition for metabolic syndrome,” Dis. Model. Mech., vol. 
2, no. 5–6, pp. 231–237, 2009. 
[18] S. M. Grundy et al., “Diagnosis and Management of the Metabolic Syndrome: An American 
Heart Association/National Heart, Lung, and Blood Institute Scientific Statement,” Circulation, 
vol. 112, no. 17, pp. 2735–2752, Oct. 2005. 
[19] W. H. Organization, Global report on diabetes. World Health Organization, 2016. 
[20] E. Selvin et al., “Glycated Hemoglobin, Diabetes, and Cardiovascular Risk in Nondiabetic 
Adults,” N. Engl. J. Med., vol. 362, no. 9, pp. 800–811, Mar. 2010. 
[21] N. R. F. Collaboration, “Worldwide trends in diabetes since 1980: a pooled analysis of 751 
population-based studies with 4· 4 million participants,” The Lancet, vol. 387, no. 10027, pp. 
1513–1530, 2016. 
[22] W. H. Organization, The selection and use of essential medicines: report of the WHO Expert 
Committee, 2017 (including the 20th WHO Model List of Essential Medicines and the 6th Model 
List of Essential Medicines for Children). World Health Organization, 2017. 
[23] M. Maggard-Gibbons et al., “Bariatric surgery for weight loss and glycemic control in 
nonmorbidly obese adults with diabetes: a systematic review,” Jama, vol. 309, no. 21, pp. 2250–
2261, 2013. 
[24] M. A. Colchero, J. Rivera-Dommarco, B. M. Popkin, and S. W. Ng, “In Mexico, evidence 
of sustained consumer response two years after implementing a sugar-sweetened beverage tax,” 
Health Aff. (Millwood), vol. 36, no. 3, pp. 564–571, 2017. 
[25] L. D. Silver et al., “Changes in prices, sales, consumer spending, and beverage consumption 
one year after a tax on sugar-sweetened beverages in Berkeley, California, US: A before-and-after 
study,” PLoS Med., vol. 14, no. 4, p. e1002283, 2017. 
[26] A. J. Cruz-Jentoft et al., “Sarcopenia: European consensus on definition and diagnosisReport 
of the European Working Group on Sarcopenia in Older PeopleA. J. Cruz-Gentoft et al.,” Age 
Ageing, vol. 39, no. 4, pp. 412–423, Jul. 2010. 
[27] S. D. Anker, J. E. Morley, and S. Haehling, “Welcome to the ICD-10 code for sarcopenia,” 
J. Cachexia Sarcopenia Muscle, vol. 7, no. 5, pp. 512–514, Dec. 2016. 
[28] D. R. Thomas, “Loss of skeletal muscle mass in aging: examining the relationship of 
starvation, sarcopenia and cachexia,” Clin. Nutr., vol. 26, no. 4, pp. 389–399, 2007. 
[29] A. B. Newman et al., “Strength, But Not Muscle Mass, Is Associated With Mortality in the 
Health, Aging and Body Composition Study Cohort,” J. Gerontol. A. Biol. Sci. Med. Sci., vol. 
61, no. 1, pp. 72–77, Jan. 2006. 
[30] B. H. Goodpaster et al., “The Loss of Skeletal Muscle Strength, Mass, and Quality in Older 
Adults: The Health, Aging and Body Composition Study,” J. Gerontol. Ser. A, vol. 61, no. 10, 
pp. 1059–1064, Oct. 2006. 
[31] “Facts and Statistics | International Osteoporosis Foundation.” [Online]. Available: 
https://www.iofbonehealth.org/facts-statistics. [Accessed: 01-May-2018]. 
156 
[32] “Bone Density Test, Osteoporosis Screening & T-score Interpretation,” National Osteoporosis 
Foundation. [Online]. Available: https://www.nof.org/patients/diagnosis-information/bone-
density-examtesting/. [Accessed: 01-May-2018]. 
[33] “2015 ISCD Official Positions - Adult - International Society for Clinical Densitometry 
(ISCD).” . 
[34] J. A. Kanis, A. Oden, H. Johansson, F. Borgström, O. Ström, and E. McCloskey, “FRAX® 
and its applications to clinical practice,” Bone, vol. 44, no. 5, pp. 734–743, May 2009. 
[35] R. Hambli, “Micro-CT finite element model and experimental validation of trabecular bone 
damage and fracture,” Bone, vol. 56, no. 2, pp. 363–374, 2013. 
[36] A. M. Parfitt, “Trabecular bone architecture in the pathogenesis and prevention of fracture,” 
Am. J. Med., vol. 82, no. 1, pp. 68–72, 1987. 
[37] “Osteoporosis Treatment: How to Choose the Right Medication,” National Osteoporosis 
Foundation. [Online]. Available: https://www.nof.org/patients/treatment/. [Accessed: 01-May-
2018]. 
[38] X. Chen, G. Mao, and S. X. Leng, “Frailty syndrome: an overview,” Clin. Interv. Aging, vol. 
9, pp. 433–441, Mar. 2014. 
[39] H.-M. Ji, J. Han, and Y.-Y. Won, “Sarcopenia and Osteoporosis,” Hip Pelvis, vol. 27, no. 2, 
pp. 72–76, Jun. 2015. 
[40] A. Heinonen et al., “Randomised controlled trial of effect of high-impact exercise on selected 
risk factors for osteoporotic fractures,” The Lancet, vol. 348, no. 9038, pp. 1343–1347, Nov. 
1996. 
[41] J.-Y. Reginster, C. Beaudart, F. Buckinx, and O. Bruyère, “Osteoporosis and sarcopenia: two 
diseases or one?,” Curr. Opin. Clin. Nutr. Metab. Care, vol. 19, no. 1, pp. 31–36, Jan. 2016. 
[42] M. J. Ormsbee et al., “Osteosarcopenic obesity: the role of bone, muscle, and fat on health,” 
J. Cachexia Sarcopenia Muscle, vol. 5, no. 3, pp. 183–192, Sep. 2014. 
[43] C. M. M. Prado, J. C. K. Wells, S. R. Smith, B. C. M. Stephan, and M. Siervo, “Sarcopenic 
obesity: A Critical appraisal of the current evidence,” Clin. Nutr., vol. 31, no. 5, pp. 583–601, 
Oct. 2012. 
[44] F. Sofi, F. Cesari, R. Abbate, G. F. Gensini, and A. Casini, “Adherence to Mediterranean 
diet and health status: meta-analysis,” BMJ, vol. 337, p. a1344, Sep. 2008. 
[45] W. H. Organization, Global action plan for the prevention and control of NCDs 2013-2020. 
2013. 2016. 
[46] W. Shen, M. P. St-Onge, Z. Wang, and S. B. Heymsfield, “Study of body composition: an 
overview,” Hum. Body Compos., vol. 2, pp. 3–14, 2005. 
[47] “NHANES - National Health and Nutrition Examination Survey Homepage,” 24-Apr-
2018. [Online]. Available: https://www.cdc.gov/nchs/nhanes/index.htm. [Accessed: 03-May-
2018]. 
[48] Z. M. Wang, R. N. Pierson, and S. B. Heymsfield, “The five-level model: a new approach to 
organizing body-composition research,” Am. J. Clin. Nutr., vol. 56, no. 1, pp. 19–28, Jul. 1992. 
[49] H. H. Mitchell, T. S. Hamilton, F. R. Steggerda, and H. W. Bean, “The chemical 
composition of the adult human body and its bearing on the biochemistry of growth,” J. Biol. 
Chem., vol. 158, no. 3, pp. 625–637, 1945. 
157 
[50] A. R. Behnke, “Physiologic studies pertaining to deep sea diving and aviation, especially in 
relation to the fat content and composition of the body: the Harvey lecture, March 19, 1942,” 
Bull. N. Y. Acad. Med., vol. 18, no. 9, p. 561, 1942. 
[51] W. E. Siri, “Body composition from fluid spaces and density: analysis of methods. 1961,” 
Nutr. Burbank Los Angel. Cty. Calif, vol. 9, no. 5, pp. 480–491; discussion 480, 492, Oct. 1993. 
[52] A. Bazzocchi, D. Diano, U. Albisinni, G. Marchesini, G. Battista, and G. Guglielmi, “Liver 
in the analysis of body composition by dual-energy X-ray absorptiometry,” Br. J. Radiol., vol. 
87, p. 20140232, Jun. 2014. 
[53] S. B. Heymsfield et al., “Multi-component molecular-level body composition reference 
methods: evolving concepts and future directions,” Obes. Rev., vol. 16, no. 4, pp. 282–294, Apr. 
2015. 
[54] P. R. Schloerb, B. J. Friis-Hansen, I. S. Edelman, A. K. Solomon, and F. D. Moore, “The 
measurement of total body water in the human subject by deuterium oxide dilution: With a 
consideration of the dynamics of deuterium distribution,” J. Clin. Invest., vol. 29, no. 10, pp. 
1296–1310, 1950. 
[55] J. R. Cameron and J. Sorenson, “Measurement of bone mineral in vivo: an improved 
method,” Science, vol. 142, no. 3589, pp. 230–232, 1963. 
[56] A. Selinger, “The body as a three component system,” University of Illinois at Urbana-
Champaign, 1977. 
[57] R. B. Mazess, J. R. Cameron, and J. A. Sorenson, “Determining body composition by 
radiation absorption spectrometry,” Nature, vol. 228, no. 5273, p. 771, 1970. 
[58] J. A. Stein, J. L. Lazewatsky, and A. M. Hochberg, “Dual-energy x-ray bone densitometer 
incorporating an internal reference system,” in Radiological Society of North America 73rd 
scientific assembly and annual meeting (Abstracts), 1987. 
[59] Z. Wang et al., “Multicomponent methods: evaluation of new and traditional soft tissue 
mineral models by in vivo neutron activation analysis,” Am. J. Clin. Nutr., vol. 76, no. 5, pp. 
968–974, 2002. 
[60] D. Hans et al., “Skeletal Sites for Osteoporosis Diagnosis: The 2005 ISCD Official 
Positions,” J. Clin. Densitom., vol. 9, no. 1, pp. 15–21, Jan. 2006. 
[61] N. Sarkalkan, H. Weinans, and A. A. Zadpoor, “Statistical shape and appearance models of 
bones,” Bone, vol. 60, pp. 129–140, 2014. 
[62] J. C. Baker‐LePain, K. R. Luker, J. A. Lynch, N. Parimi, M. C. Nevitt, and N. E. Lane, 
“Active shape modeling of the hip in the prediction of incident hip fracture,” J. Bone Miner. 
Res., vol. 26, no. 3, pp. 468–474, 2011. 
[63] B. Schuler, K. D. Fritscher, V. Kuhn, F. Eckstein, T. M. Link, and R. Schubert, “Assessment 
of the individual fracture risk of the proximal femur by using statistical appearance models,” 
Med. Phys., vol. 37, no. 6, pp. 2560–2571, Jun. 2010. 
[64] J. A. Shepherd, J. T. Schousboe, S. B. Broy, K. Engelke, and W. D. Leslie, “Executive 
Summary of the 2015 ISCD Position Development Conference on Advanced Measures From 
DXA and QCT: Fracture Prediction Beyond BMD,” J. Clin. Densitom., vol. 18, no. 3, pp. 274–
286, Jul. 2015. 
158 
[65] R. A. McGregor, D. Cameron-Smith, and S. D. Poppitt, “It is not just muscle mass: a review 
of muscle quality, composition and metabolism during ageing as determinants of muscle 
function and mobility in later life,” Longev. Heal., vol. 3, p. 9, Dec. 2014. 
[66] K. M. Beavers et al., “Associations between body composition and gait-speed decline: results 
from the Health, Aging, and Body Composition study,” Am. J. Clin. Nutr., vol. 97, no. 3, pp. 
552–560, Mar. 2013. 
[67] A. H. FAIRFAX, R. BALNAVE, and R. D. ADAMS, “Variability of grip strength during 
isometric contraction,” Ergonomics, vol. 38, no. 9, pp. 1819–1830, Sep. 1995. 
[68] Kuk Jennifer L., Katzmarzyk Peter T., Nichaman Milton Z., Church Timothy S., Blair 
Steven N., and Ross Robert, “Visceral Fat Is an Independent Predictor of All‐cause Mortality in 
Men,” Obesity, vol. 14, no. 2, pp. 336–341, Sep. 2012. 
[69] G. A. Rosito et al., “Pericardial Fat, Visceral Abdominal Fat, Cardiovascular Disease Risk 
Factors, and Vascular Calcification in a Community-Based Sample: The Framingham Heart 
Study,” Circulation, vol. 117, no. 5, pp. 605–613, Feb. 2008. 
[70] G. Marchesini et al., “Nonalcoholic Fatty Liver Disease: A Feature of the Metabolic 
Syndrome,” Diabetes, vol. 50, no. 8, pp. 1844–1850, Aug. 2001. 
[71] L. A. Adams et al., “The Natural History of Nonalcoholic Fatty Liver Disease: A Population-
Based Cohort Study,” Gastroenterology, vol. 129, no. 1, pp. 113–121, Jul. 2005. 
[72] J. Aucouturier, M. Meyer, D. Thivel, M. Taillardat, and P. Duché, “Effect of Android to 
Gynoid Fat Ratio on Insulin Resistance in Obese Youth,” Arch. Pediatr. Adolesc. Med., vol. 163, 
no. 9, pp. 826–831, Sep. 2009. 
[73] J. P. Wilson, A. M. Kanaya, B. Fan, and J. A. Shepherd, “Ratio of Trunk to Leg Volume as a 
New Body Shape Metric for Diabetes and Mortality,” PLoS ONE, vol. 8, no. 7, p. e68716, Jul. 
2013. 
[74] S. B. Heymsfield and J. Stevens, “Anthropometry: continued refinements and new 
developments of an ancient method,” Am. J. Clin. Nutr., vol. 105, no. 1, pp. 1–2, Jan. 2017. 
[75] “Obesity,” nhs.uk. [Online]. Available: https://www.nhs.uk/conditions/obesity/. [Accessed: 
05-May-2018]. 
[76] A. Keys, F. Fidanza, M. J. Karvonen, N. Kimura, and H. L. Taylor, “Indices of relative 
weight and obesity,” J. Chronic Dis., vol. 25, no. 6, pp. 329–343, Jul. 1972. 
[77] K. V. Bailey and A. Ferro-Luzzi, “Use of body mass index of adults in assessing individual 
and community nutritional status.,” Bull. World Health Organ., vol. 73, no. 5, pp. 673–680, 
1995. 
[78] S. P. Garnett, L. A. Baur, and C. T. Cowell, “Waist-to-height ratio: a simple option for 
determining excess central adiposity in young people,” Int. J. Obes., vol. 32, no. 6, pp. 1028–
1030, Apr. 2008. 
[79] N. Y. Krakauer and J. C. Krakauer, “A New Body Shape Index Predicts Mortality Hazard 
Independently of Body Mass Index,” PLoS ONE, vol. 7, no. 7, p. e39504, Jul. 2012. 
[80] I. Janssen, P. T. Katzmarzyk, and R. Ross, “Waist circumference and not body mass index 
explains obesity-related health risk,” Am. J. Clin. Nutr., vol. 79, no. 3, pp. 379–384, Mar. 2004. 
159 
[81] L. de Koning, A. T. Merchant, J. Pogue, and S. S. Anand, “Waist circumference and waist-
to-hip ratio as predictors of cardiovascular events: meta-regression analysis of prospective 
studies,” Eur. Heart J., vol. 28, no. 7, pp. 850–856, Apr. 2007. 
[82] Wei Ming, Gaskill Sharon P., Haffner Steven M., and Stern Michael P., “Waist 
Circumference as the Best Predictor of Noninsulin Dependent Diabetes Mellitus (NIDDM) 
Compared to Body Mass Index, Waist/hip Ratio and Other Anthropometric Measurements in 
Mexican Americans—A 7‐Year Prospective Study,” Obes. Res., vol. 5, no. 1, pp. 16–23, Sep. 
2012. 
[83] M. Ashwell, P. Gunn, and S. Gibson, “Waist‐to‐height ratio is a better screening tool than 
waist circumference and BMI for adult cardiometabolic risk factors: systematic review and meta‐
analysis,” Obes. Rev., vol. 13, no. 3, pp. 275–286, 2012. 
[84] Mason Caitlin and Katzmarzyk Peter T., “Variability in Waist Circumference Measurements 
According to Anatomic Measurement Site,” Obesity, vol. 17, no. 9, pp. 1789–1795, Sep. 2012. 
[85] J. Nadas, Z. Putz, G. Kolev, S. Nagy, and G. Jermendy, “Intraobserver and interobserver 
variability of measuring waist circumference,” Med. Sci. Monit., vol. 14, no. 1, pp. CR15–CR18, 
2008. 
[86] J. Bro_ek and A. Henschel, Techniques for Measuring Body Composition: Proceedings of a 
Conference, Quartermaster Research and Engineering Center, Natick, Massachusetts, January 22-23, 
1959. National Academies, 1961. 
[87] J. Brožek, F. Grande, J. T. Anderson, and A. Keys, “Densitometric analysis of body 
composition: revision of some quantitative assumptions,” Ann. N. Y. Acad. Sci., vol. 110, no. 1, 
pp. 113–140, 1963. 
[88] P. Dempster and S. Aitkens, “A new air displacement method for the determination of 
human body composition.,” Med. Sci. Sports Exerc., vol. 27, no. 12, pp. 1692–1697, 1995. 
[89] M. A. McCrory, T. D. Gomez, E. M. Bernauer, and P. A. Molé, “Evaluation of a new air 
displacement plethysmograph for measuring human body composition.,” Med. Sci. Sports Exerc., 
vol. 27, no. 12, pp. 1686–1691, 1995. 
[90] D. A. Fields, M. I. Goran, and M. A. McCrory, “Body-composition assessment via air-
displacement plethysmography in adults and children: a review,” Am. J. Clin. Nutr., vol. 75, no. 
3, pp. 453–467, Mar. 2002. 
[91] N. Pace and E. N. Rathbun, “Studies on body composition. 3. The body water and 
chemically combined nitrogen content in relation to fat content.,” J. Biol. Chem., vol. 158, pp. 
685–691, 1945. 
[92] IAEA, “Introduction to Body Composition Assessment Using the Deuterium Dilution 
Technique with Analysis of Saliva Samples by Fourier Transform Infrared Spectrometry,” 2011. 
[93] T. C. Prentice et al., “STUDIES OF TOTAL BODY WATER WITH TRITIUM 12,” J. 
Clin. Invest., vol. 31, no. 4, pp. 412–418, Apr. 1952. 
[94] U. G. Kyle et al., “Bioelectrical impedance analysis—part I: review of principles and 
methods,” Clin. Nutr., vol. 23, no. 5, pp. 1226–1243, Oct. 2004. 
[95] M. Y. Jaffrin and H. Morel, “Body fluid volumes measurements by impedance: A review of 
bioimpedance spectroscopy (BIS) and bioimpedance analysis (BIA) methods,” Med. Eng. Phys., 
vol. 30, no. 10, pp. 1257–1269, 2008. 
160 
[96] R. Buendia, “Improvements in Bioimpedance SpectroscopyData Analysis: Artefact 
Correction, ColeParameters, and Body Fluid Estimation,” KTH Royal Institute of Technology, 
2013. 
[97] R. J. Toombs, G. Ducher, J. A. Shepherd, and M. J. Souza, “The Impact of Recent 
Technological Advances on the Trueness and Precision of DXA to Assess Body Composition,” 
Obesity, vol. 20, no. 1, pp. 30–39, Jan. 2012. 
[98] J. A. Shepherd, B. K. Ng, M. J. Sommer, and S. B. Heymsfield, “Body composition by 
DXA,” Bone, Jun. 2017. 
[99] S. Kaul et al., “Dual-Energy X-Ray Absorptiometry for Quantification of Visceral Fat,” 
Obesity, vol. 20, no. 6, pp. 1313–1318, Jun. 2012. 
[100] S. Y. Lee and D. Gallagher, “Assessment methods in human body composition,” Curr. Opin. 
Clin. Nutr. Metab. Care, vol. 11, no. 5, pp. 566–572, Sep. 2008. 
[101] M. J. Delmonico et al., “Longitudinal study of muscle strength, quality, and adipose tissue 
infiltration,” Am. J. Clin. Nutr., vol. 90, no. 6, pp. 1579–1585, Dec. 2009. 
[102] M. Mourtzakis, C. M. M. Prado, J. R. Lieffers, T. Reiman, L. J. McCargar, and V. E. 
Baracos, “A practical and precise approach to quantification of body composition in cancer 
patients using computed tomography images acquired during routine care,” Appl. Physiol. Nutr. 
Metab., vol. 33, no. 5, pp. 997–1006, Sep. 2008. 
[103] G. Delso et al., “Clinical evaluation of zero-echo-time MR imaging for the segmentation of 
the skull,” J. Nucl. Med. Off. Publ. Soc. Nucl. Med., vol. 56, no. 3, pp. 417–422, Mar. 2015. 
[104] M. A. Bredella et al., “Comparison of DXA and CT in the Assessment of Body Composition 
in Premenopausal Women With Obesity and Anorexia Nervosa,” Obes. Silver Spring Md, vol. 
18, no. 11, pp. 2227–2233, Nov. 2010. 
[105] M. Hadi, C. C. Chen, M. Whatley, K. Pacak, and J. A. Carrasquillo, “Brown fat imaging 
with 18F-6-fluorodopamine PET/CT, 18F-FDG PET/CT, and 123I-MIBG SPECT: a study of 
patients being evaluated for pheochromocytoma,” J. Nucl. Med., vol. 48, no. 7, pp. 1077–1083, 
2007. 
[106] M. J. Devlin, “The ‘Skinny’ on brown fat, obesity, and bone,” Am. J. Phys. Anthropol., vol. 
156, no. S59, pp. 98–115, Feb. 2015. 
[107] K. I. Stanford et al., “Brown adipose tissue regulates glucose homeostasis and insulin 
sensitivity,” J. Clin. Invest., vol. 123, no. 1, pp. 215–223, Jan. 2013. 
[108] S. Paquette, “3D scanning in apparel design and human engineering,” IEEE Comput. Graph. 
Appl., vol. 16, no. 5, pp. 11–15, Sep. 1996. 
[109] P. R. M. Jones and M. Rioux, “Three-dimensional surface anthropometry: Applications to 
the human body,” Opt. Lasers Eng., vol. 28, no. 2, pp. 89–117, Sep. 1997. 
[110] L. A. P. Kohn, J. M. Cheverud, G. Bhatia, P. Commean, K. Smith, and M. W. Vannier, 
“Anthropometric optical surface imaging system repeatability, precision, and validation.,” Ann. 
Plast. Surg., vol. 34, no. 4, pp. 362–371, 1995. 
[111] Y. Cui, S. Schuon, D. Chan, S. Thrun, and C. Theobalt, “3D shape scanning with a time-
of-flight camera,” in 2010 IEEE Conference on Computer Vision and Pattern Recognition (CVPR), 
2010, pp. 1173–1180. 
161 
[112] J. C. K. Wells, “Three-Dimensional (3-D) Photonic Scanning: A New Approach to 
Anthropometry,” in Handbook of Anthropometry, V. R. Preedy, Ed. Springer New York, 2012, 
pp. 205–217. 
[113] B. Allen, B. Curless, and Z. Popović, “The Space of Human Body Shapes: Reconstruction 
and Parameterization from Range Scans,” in ACM SIGGRAPH 2003 Papers, New York, NY, 
USA, 2003, pp. 587–594. 
[114] J. C. Wells, P. Treleaven, and T. J. Cole, “BMI compared with 3-dimensional body shape: 
the UK National Sizing Survey,” Am. J. Clin. Nutr., vol. 85, no. 2, pp. 419–425, Feb. 2007. 
[115] J. Wang, D. Gallagher, J. C. Thornton, W. Yu, M. Horlick, and F. X. Pi-Sunyer, 
“Validation of a 3-dimensional photonic scanner for the measurement of body volumes, 
dimensions, and percentage body fat,” Am. J. Clin. Nutr., vol. 83, no. 4, pp. 809–816, 2006. 
[116] M. R. Pepper et al., “Validation of a 3-dimensional laser body scanner for assessment of waist 
and hip circumference,” J. Am. Coll. Nutr., vol. 29, no. 3, pp. 179–188, 2010. 
[117] J. C. K. Wells et al., “Acceptability, Precision and Accuracy of 3D Photonic Scanning for 
Measurement of Body Shape in a Multi-Ethnic Sample of Children Aged 5-11 Years: The SLIC 
Study,” PLoS ONE, vol. 10, no. 4, p. e0124193, Apr. 2015. 
[118] G. M. Price, R. Uauy, E. Breeze, C. J. Bulpitt, and A. E. Fletcher, “Weight, shape, and 
mortality risk in older persons: elevated waist-hip ratio, not high body mass index, is associated 
with a greater risk of death,” Am. J. Clin. Nutr., vol. 84, no. 2, pp. 449–460, Aug. 2006. 
[119] W. E. Consultation, “Waist circumference and waist-hip ratio,” 2011. 
[120] L. M. Browning, S. D. Hsieh, and M. Ashwell, “A systematic review of waist-to-height ratio 
as a screening tool for the prediction of cardiovascular disease and diabetes: 0·5 could be a 
suitable global boundary value,” Nutr. Res. Rev., vol. 23, no. 2, pp. 247–269, Dec. 2010. 
[121] D. M. Thomas et al., “Relationships between body roundness with body fat and visceral 
adipose tissue emerging from a new geometrical model,” Obesity, vol. 21, no. 11, pp. 2264–
2271, Nov. 2013. 
[122] J. P. Bougourd and P. C. Treleaven, “Capturing the shape of a nation: size UK,” in 
Proceedings of the International Federation of the Fashion Technology Institute (IFFTI) Conference, 
2002. 
[123] P. R. Apeagyei, “Application of 3 D body scanning technology to human measurement for 
clothing Fit,” change, vol. 4, no. 7, 2010. 
[124] L. A. Schwarz, A. Mkhitaryan, D. Mateus, and N. Navab, “Human skeleton tracking from 
depth data using geodesic distances and optical flow,” Image Vis. Comput., vol. 30, no. 3, pp. 
217–226, Mar. 2012. 
[125] R. A. Clark et al., “Validity of the Microsoft Kinect for assessment of postural control,” Gait 
Posture, vol. 36, no. 3, pp. 372–377, Jul. 2012. 
[126] H. Funaya, T. Shibata, Y. Wada, and T. Yamanaka, “Accuracy assessment of kinect body 
tracker in instant posturography for balance disorders,” in 2013 7th International Symposium on 
Medical Information and Communication Technology (ISMICT), 2013, pp. 213–217. 
[127] M. Reyes, A. Clapés, S. Escalera, J. Ramírez, and J. R. Revilla, “Posture Analysis and Range 
of Movement Estimation Using Depth Maps,” in Advances in Depth Image Analysis and 
162 
Applications, X. Jiang, O. R. P. Bellon, D. Goldgof, and T. Oishi, Eds. Springer Berlin 
Heidelberg, 2013, pp. 97–105. 
[128] J. J. Lee, J. H. Freeland-Graves, M. R. Pepper, P. R. Stanforth, and B. Xu, “Prediction of 
Android and Gynoid Body Adiposity via a Three-dimensional Stereovision Body Imaging 
System and Dual-Energy X-ray Absorptiometry,” J. Am. Coll. Nutr., pp. 1–11, Apr. 2015. 
[129] J. J. Lee, J. H. Freeland‐Graves, M. R. Pepper, W. Yu, and B. Xu, “Efficacy of thigh volume 
ratios assessed via stereovision body imaging as a predictor of visceral adipose tissue measured by 
magnetic resonance imaging,” Am. J. Hum. Biol., vol. 27, no. 4, pp. 445–457, 2015. 
[130] G. M. Blake, H. W. Wahner, and I. Fogelman, Evaluation Of Osteoporosis. Taylor & Francis, 
1998. 
[131] J. A. Shepherd and M. K. Oates, “ISCD DXA Body Composition Course,” 09-Aug-2014. 
[132] D. A. Schoeller et al., “QDR 4500A dual-energy X-ray absorptiometer underestimates fat 
mass in comparison with criterion methods in adults,” Am. J. Clin. Nutr., vol. 81, no. 5, pp. 
1018–1025, May 2005. 
[133] G. Danaei et al., “National, regional, and global trends in systolic blood pressure since 1980: 
systematic analysis of health examination surveys and epidemiological studies with 786 country-
years and 5·4 million participants,” Lancet Lond. Engl., vol. 377, no. 9765, pp. 568–577, Feb. 
2011. 
[134] S. Basu, P. Yoffe, N. Hills, and R. H. Lustig, “The relationship of sugar to population-level 
diabetes prevalence: an econometric analysis of repeated cross-sectional data,” PloS One, vol. 8, 
no. 2, p. e57873, 2013. 
[135] E. S. Ford, “Risks for All-Cause Mortality, Cardiovascular Disease, and Diabetes Associated 
With the Metabolic Syndrome: A summary of the evidence,” Diabetes Care, vol. 28, no. 7, pp. 
1769–1778, Jul. 2005. 
[136] R. J. Garrison and W. P. Castelli, “Weight and thirty-year mortality of men in the 
Framingham Study,” Ann. Intern. Med., vol. 103, no. 6 ( Pt 2), pp. 1006–1009, Dec. 1985. 
[137] S. W. Rabkin, F. A. L. Mathewson, and P.-H. Hsu, “Relation of body weight to 
development of ischemic heart disease in a cohort of young north American men after a 26 year 
observation period: The manitoba study,” Am. J. Cardiol., vol. 39, no. 3, pp. 452–458, Jan. 
1977. 
[138] A. Romero-Corral et al., “Association of bodyweight with total mortality and with 
cardiovascular events in coronary artery disease: a systematic review of cohort studies,” The 
Lancet, vol. 368, no. 9536, pp. 666–678, Aug. 2006. 
[139] C. J. Lavie, A. De Schutter, D. A. Patel, A. Romero-Corral, S. M. Artham, and R. V. Milani, 
“Body Composition and Survival in Stable Coronary Heart DiseaseImpact of Lean Mass Index 
and Body Fat in the ‘Obesity Paradox,’” J. Am. Coll. Cardiol., vol. 60, no. 15, pp. 1374–1380, 
Oct. 2012. 
[140] C. Zhang, K. M. Rexrode, R. M. van Dam, T. Y. Li, and F. B. Hu, “Abdominal Obesity 
and the Risk of All-Cause, Cardiovascular, and Cancer Mortality,” Circulation, vol. 117, no. 13, 
pp. 1658–1667, Apr. 2008. 
163 
[141] T. Coutinho et al., “Central obesity and survival in subjects with coronary artery disease: a 
systematic review of the literature and collaborative analysis with individual subject data,” J. Am. 
Coll. Cardiol., vol. 57, no. 19, pp. 1877–1886, 2011. 
[142] R. Alissa, M. Esposito, K. Horner, and R. Oliver, “The influence of platelet-rich plasma on 
the healing of extraction sockets: an explorative randomised clinical trial.,” Eur. J. Oral 
Implantol., vol. 3, no. 2, 2010. 
[143] T. F. Cootes, G. J. Edwards, and C. J. Taylor, “Active appearance models,” Pattern Anal. 
Mach. Intell. IEEE Trans. On, vol. 23, no. 6, pp. 681–685, 2001. 
[144] T. F. Cootes, C. J. Taylor, D. H. Cooper, and J. Graham, “Active shape models-their 
training and application,” Comput. Vis. Image Underst., vol. 61, no. 1, pp. 38–59, 1995. 
[145] D. Shi, S. R. Gunn, and R. I. Damper, “Handwritten Chinese radical recognition using 
nonlinear active shape models,” IEEE Trans. Pattern Anal. Mach. Intell., vol. 25, no. 2, pp. 277–
280, 2003. 
[146] G. J. Edwards, T. F. Cootes, and C. J. Taylor, “Face recognition using active appearance 
models,” in Computer Vision—ECCV’98, Springer, 1998, pp. 581–595. 
[147] B. Van Ginneken, A. F. Frangi, J. J. Staal, B. M. ter Haar Romeny, and M. A. Viergever, 
“Active shape model segmentation with optimal features,” IEEE Trans. Med. Imaging, vol. 21, 
no. 8, pp. 924–933, 2002. 
[148] D. Beymer and T. Syeda-Mahmood, “Cardiac disease recognition in echocardiograms using 
spatio-temporal statistical models,” in Engineering in Medicine and Biology Society, 2008. EMBS 
2008. 30th Annual International Conference of the IEEE, 2008, pp. 4784–4788. 
[149] S. Solloway, C. E. Hutchinson, J. C. Waterton, and C. J. Taylor, “The use of active shape 
models for making thickness measurements of articular cartilage from MR images,” Magn. 
Reson. Med., vol. 37, no. 6, pp. 943–952, 1997. 
[150] T. Whitmarsh et al., “Hip fracture discrimination from dual-energy X-ray absorptiometry by 
statistical model registration,” Bone, vol. 51, no. 5, pp. 896–901, 2012. 
[151] J. P. Wilson et al., “Dual-energy X-ray absorptiometry–based body volume measurement for 
4-compartment body composition,” Am. J. Clin. Nutr., vol. 95, no. 1, pp. 25–31, Jan. 2012. 
[152] J. P. Wilson, B. Fan, and J. A. Shepherd, “Total and Regional Body Volumes Derived From 
Dual-Energy X-Ray Absorptiometry Output,” J. Clin. Densitom., vol. 16, no. 3, pp. 368–373, 
Jul. 2013. 
[153] T. F. Cootes, M. C. Ionita, C. Lindner, and P. Sauer, “Robust and Accurate Shape Model 
Fitting Using Random Forest Regression Voting,” in Computer Vision – ECCV 2012, 2012, pp. 
278–291. 
[154] D. Cristinacce and T. Cootes, “Automatic feature localisation with constrained local 
models,” Pattern Recognit., vol. 41, no. 10, pp. 3054–3067, 2008. 
[155] M. Visser et al., “Muscle mass, muscle strength, and muscle fat infiltration as predictors of 
incident mobility limitations in well-functioning older persons,” J. Gerontol. A. Biol. Sci. Med. 
Sci., vol. 60, no. 3, pp. 324–333, 2005. 
[156] M. Visser et al., “Validity of fan-beam dual-energy X-ray absorptiometry for measuring fat-
free mass and leg muscle mass,” J. Appl. Physiol., vol. 87, no. 4, pp. 1513–1520, 1999. 
164 
[157] J. P. Wilson, “The search for advanced imaging descriptors of human body shape and their 
association to diabetes and other metabolic disorders,” University of California, San Francisco, 
2013. 
[158] L. Humbert et al., “3D-DXA: Assessing the Femoral Shape, the Trabecular Macrostructure 
and the Cortex in 3D from DXA images,” IEEE Trans. Med. Imaging, vol. 36, no. 1, pp. 27–39, 
2017. 
[159] S. R. Goodyear et al., “Can we improve the prediction of hip fracture by assessing bone 
structure using shape and appearance modelling?,” Bone, vol. 53, no. 1, pp. 188–193, 2013. 
[160] C. S. Fox et al., “Abdominal Visceral and Subcutaneous Adipose Tissue Compartments 
Association With Metabolic Risk Factors in the Framingham Heart Study,” Circulation, vol. 
116, no. 1, pp. 39–48, Jul. 2007. 
[161] O. Hamdy, S. Porramatikul, and E. Al-Ozairi, “Metabolic Obesity: The Paradox Between 
Visceral and Subcutaneous Fat,” Curr. Diabetes Rev., vol. 2, no. 4, pp. 367–373, Nov. 2006. 
[162] Haarbo J., Gotfredsen A., Hassager C., and Christiansen C., “Validation of body 
composition by dual energy X‐ray absorptiometry (DEXA),” Clin. Physiol., vol. 11, no. 4, pp. 
331–341, Apr. 2008. 
[163] T. L. Kelly, N. Berger, and T. L. Richardson, “DXA body composition: theory and 
practice,” Appl. Radiat. Isot., vol. 49, no. 5, pp. 511–513, May 1998. 
[164] L. K. Micklesfield, J. H. Goedecke, M. Punyanitya, K. E. Wilson, and T. L. Kelly, “Dual‐
Energy X‐Ray performs as well as clinical computed tomography for the measurement of visceral 
fat,” Obesity, vol. 20, no. 5, pp. 1109–1114, 2012. 
[165] E. Expert Panel on Detection, “Executive Summary of the Third Report of the National 
Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment 
of High Blood Cholesterol in Adults (Adult Treatment Panel III),” JAMA, vol. 285, no. 19, pp. 
2486–2497, May 2001. 
[166] N. D. D. Group, “Classification and diagnosis of diabetes mellitus and other categories of 
glucose intolerance,” Diabetes, vol. 28, no. 12, pp. 1039–1057, 1979. 
[167] Goodpaster BH, Krishnaswami S, Harris TB, and et al, “OBesity, regional body fat 
distribution, and the metabolic syndrome in older men and women,” Arch. Intern. Med., vol. 
165, no. 7, pp. 777–783, Apr. 2005. 
[168] J.-D. Lin, W.-K. Chiou, H.-F. Weng, Y.-H. Tsai, and T.-H. Liu, “Comparison of three-
dimensional anthropometric body surface scanning to waist–hip ratio and body mass index in 
correlation with metabolic risk factors,” J. Clin. Epidemiol., vol. 55, no. 8, pp. 757–766, Aug. 
2002. 
[169] J.-D. Lin, W.-K. Chiou, H.-F. Weng, J.-T. Fang, and T.-H. Liu, “Application of three-
dimensional body scanner: observation of prevalence of metabolic syndrome,” Clin. Nutr., vol. 
23, no. 6, pp. 1313–1323, 2004. 
[170] H. A. M. Daanen and F. B. Ter Haar, “3D whole body scanners revisited,” Displays, vol. 34, 
no. 4, pp. 270–275, Oct. 2013. 
[171] J. J. Lee, J. H. Freeland-Graves, M. R. Pepper, M. Yao, and B. Xu, “Predictive equations for 
central obesity via anthropometrics, stereovision imaging and MRI in adults,” Obesity, vol. 22, 
no. 3, pp. 852–862, Mar. 2014. 
165 
[172] P. Tikuisis, P. Meunier, and C. Jubenville, “Human body surface area: measurement and 
prediction using three dimensional body scans,” Eur. J. Appl. Physiol., vol. 85, no. 3–4, pp. 264–
271, 2001. 
[173] C. Jelenko, “Studies in burns. I. Water loss from the body surface.,” Ann. Surg., vol. 165, no. 
1, pp. 83–96, Jan. 1967. 
[174] D. Pinkel, “The Use of Body Surface Area as a Criterion of Drug Dosage in Cancer 
Chemotherapy,” Cancer Res., vol. 18, no. 7, pp. 853–856, Aug. 1958. 
[175] A. L. Collins and H. D. McCarthy, “Evaluation of factors determining the precision of body 
composition measurements by air displacement plethysmography,” Eur. J. Clin. Nutr., vol. 57, 
no. 6, p. 770, 2003. 
[176] R. H. Eckel et al., “Obesity and Type 2 Diabetes: What Can Be Unified and What Needs to 
Be Individualized?,” J. Clin. Endocrinol. Metab., vol. 96, no. 6, pp. 1654–1663, Jun. 2011. 
[177] E. E. Calle and R. Kaaks, “Overweight, obesity and cancer: epidemiological evidence and 
proposed mechanisms,” Nat. Rev. Cancer, vol. 4, no. 8, pp. 579–591, Aug. 2004. 
[178] Javed A. et al., “Diagnostic performance of body mass index to identify obesity as defined by 
body adiposity in children and adolescents: a systematic review and meta‐analysis,” Pediatr. 
Obes., vol. 10, no. 3, pp. 234–244, Jun. 2014. 
[179] B. Bourgeois et al., “Clinically applicable optical imaging technology for body size and shape 
analysis: comparison of systems differing in design,” Eur. J. Clin. Nutr., Sep. 2017. 
[180] B. K. Ng, B. J. Hinton, B. Fan, A. M. Kanaya, and J. A. Shepherd, “Clinical 
anthropometrics and body composition from 3D whole-body surface scans,” Eur. J. Clin. Nutr., 
vol. 70, no. 11, pp. 1265–1270, Nov. 2016. 
[181] P. Treleaven and J. Wells, “3D body scanning and healthcare applications,” Computer, no. 7, 
pp. 28–34, 2007. 
[182] Y. Lu et al., “Dual X‐ray absorptiometry quality control: Comparison of visual examination 
and process‐control charts,” J. Bone Miner. Res., vol. 11, no. 5, pp. 626–637, 1996. 
[183] P. J. Besl and N. D. McKay, “A method for registration of 3-D shapes,” IEEE Trans. Pattern 
Anal. Mach. Intell., vol. 14, no. 2, pp. 239–256, Feb. 1992. 
[184] K. M. Robinette, S. Blackwell, H. Daanen, M. Boehmer, and S. Fleming, “Civilian 
American and European Surface Anthropometry Resource (CAESAR), Final Report. Volume 1. 
Summary,” Jun. 2002. 
[185] M. Hronek et al., “Skinfold Anthropometry –The Accurate Method for Fat Free Mass 
Measurement in COPD,” COPD J. Chronic Obstr. Pulm. Dis., vol. 10, no. 5, pp. 597–603, Oct. 
2013. 
[186] F. Bogo, J. Romero, M. Loper, and M. J. Black, “FAUST: Dataset and Evaluation for 3D 
Mesh Registration,” in 2014 IEEE Conference on Computer Vision and Pattern Recognition, 2014, 
pp. 3794–3801. 
[187] S. Zuffi and M. J. Black, “The stitched puppet: A graphical model of 3D human shape and 
pose,” in 2015 IEEE Conference on Computer Vision and Pattern Recognition (CVPR), 2015, pp. 
3537–3546. 
[188] A. Myronenko and X. Song, “Point set registration: Coherent point drifts,” IEEE Trans. 
Pattern Anal. Mach. Intell., vol. 32, no. 12, pp. 2262–2275, 2010. 
166 
[189] S. Sperandei, M. C. Vieira, and A. C. Reis, “Adherence to physical activity in an 
unsupervised setting: Explanatory variables for high attrition rates among fitness center 
members,” J. Sci. Med. Sport, vol. 19, no. 11, pp. 916–920, 2016. 
[190] B. Allen, B. Curless, and Z. Popović, “Exploring the space of human body shapes: Data-
driven synthesis under anthropometric control,” SAE Technical Paper, 2004. 
[191] F. Pedregosa et al., “Scikit-learn: Machine learning in Python,” J. Mach. Learn. Res., vol. 12, 
no. Oct, pp. 2825–2830, 2011. 
[192] “WHO | Obesity and overweight,” WHO. [Online]. Available: 
http://www.who.int/mediacentre/factsheets/fs311/en/. [Accessed: 04-Apr-2016]. 
[193] “WHO | Double burden of malnutrition,” WHO. [Online]. Available: 
http://www.who.int/nutrition/double-burden-malnutrition/en/. [Accessed: 08-Nov-2017]. 
[194] E. Tzioumis and L. S. Adair, “Childhood Dual Burden of Under- and Overnutrition in 
Low- and Middle-inCome Countries: A Critical Review,” Food Nutr. Bull., vol. 35, no. 2, pp. 
230–243, Jun. 2014. 
[195] Z. Wang, P. Deurenberg, W. Wang, A. Pietrobelli, R. N. Baumgartner, and S. B. 
Heymsfield, “Hydration of fat-free body mass: review and critique of a classic body-composition 
constant,” Am. J. Clin. Nutr., vol. 69, no. 5, pp. 833–841, May 1999. 
[196] M. K. Mwangome, G. Fegan, A. M. Prentice, and J. A. Berkley, “Are diagnostic criteria for 
acute malnutrition affected by hydration status in hospitalized children? A repeated measures 
study,” Nutr. J., vol. 10, p. 92, Sep. 2011. 
[197] M. J. Bossingham, N. S. Carnell, and W. W. Campbell, “Water balance, hydration status, 
and fat-free mass hydration in younger and older adults,” Am. J. Clin. Nutr., vol. 81, no. 6, pp. 
1342–1350, Jun. 2005. 
[198] S. von Haehling, J. E. Morley, and S. D. Anker, “An overview of sarcopenia: facts and 
numbers on prevalence and clinical impact,” J. Cachexia Sarcopenia Muscle, vol. 1, no. 2, pp. 
129–133, Dec. 2010. 
[199] T. G. Lohman, “Applicability of body composition techniques and constants for children 
and youths,” Exerc. Sport Sci. Rev., vol. 14, pp. 325–357, 1986. 
[200] J. P. Wilson, B. J. Strauss, B. Fan, F. W. Duewer, and J. A. Shepherd, “Improved 4-
compartment body-composition model for a clinically accessible measure of total body protein,” 
Am. J. Clin. Nutr., vol. 97, no. 3, pp. 497–504, Mar. 2013. 
[201] T. G. Lohman and S. B. Going, “Multicomponent models in body composition research: 
opportunities and pitfalls,” Basic Life Sci., vol. 60, pp. 53–58, 1993. 
[202] C. J. Bartok-Olson, D. A. Schoeller, J. C. Sullivan, and R. R. Clark, “The ‘B’ in the Selinger 
Four-Compartment Body Composition Formula Should Be Body Mineral Instead of Bone 
Mineral,” Ann. N. Y. Acad. Sci., vol. 904, no. 1, pp. 342–344, May 2000. 
[203] C. C. Glüer, G. Blake, Y. Lu, B. A. Blunt, M. Jergas, and H. K. Genant, “Accurate 
assessment of precision errors: how to measure the reproducibility of bone densitometry 
techniques,” Osteoporos. Int. J. Establ. Result Coop. Eur. Found. Osteoporos. Natl. Osteoporos. 
Found. USA, vol. 5, no. 4, pp. 262–270, 1995. 
[204] F. R. Hampel, “The Influence Curve and its Role in Robust Estimation,” J. Am. Stat. Assoc., 
vol. 69, no. 346, pp. 383–393, Jun. 1974. 
167 
[205] “FAQ - International Society for Clinical Densitometry (ISCD).” . 
[206] A. E. Smith-Ryan, M. G. Mock, E. D. Ryan, G. R. Gerstner, E. T. Trexler, and K. R. 
Hirsch, “Validity and reliability of a 4-compartment body composition model using dual energy 
x-ray absorptiometry-derived body volume,” Clin. Nutr., vol. 36, no. 3, pp. 825–830, Jun. 
2017. 
[207] I. of M. (US) C. on M. N. Research, S. J. Carlson-Newberry, and R. B. Costello, 
Bioelectrical Impedance: A History, Research Issues, and Recent Consensus. National Academies 
Press (US), 1997. 
[208] C. Vaché et al., “Bioelectrical impedance analysis measurements of total body water and 
extracellular water in healthy elderly subjects,” Int. J. Obes. Relat. Metab. Disord. J. Int. Assoc. 
Study Obes., vol. 22, no. 6, pp. 537–543, Jun. 1998. 
[209] R. A. Newcombe et al., “KinectFusion: Real-time dense surface mapping and tracking,” in 
2011 10th IEEE International Symposium on Mixed and Augmented Reality (ISMAR), 2011, pp. 
127–136. 
[210] A. D. Laidevant, S. Malkov, C. I. Flowers, K. Kerlikowske, and J. A. Shepherd, 
“Compositional breast imaging using a dual-energy mammography protocol,” Med. Phys., vol. 
37, no. 1, pp. 164–174, Jan. 2010. 
[211] S. Malkov and J. Shepherd, “Combining 3D optical imaging and dual energy 
absorptiometry to measure three compositional components,” 2014, vol. 8937, pp. 893714-
893714–6. 
[212] F. L. Siena, B. Byrom, P. Watts, and P. Breedon, “Utilising the Intel RealSense Camera for 
Measuring Health Outcomes in Clinical Research,” J. Med. Syst., vol. 42, no. 3, p. 53, Mar. 
2018. 
[213] S. C. Mitchell, J. G. Bosch, B. P. Lelieveldt, R. J. van der Geest, J. H. Reiber, and M. Sonka, 
“3-D active appearance models: segmentation of cardiac MR and ultrasound images,” Med. 
Imaging IEEE Trans. On, vol. 21, no. 9, pp. 1167–1178, 2002. 
[214] X. Gao, Y. Su, X. Li, and D. Tao, “A review of active appearance models,” IEEE Trans. Syst. 
Man Cybern. Part C Appl. Rev., vol. 40, no. 2, pp. 145–158, 2010. 
[215] R. Cheng et al., “Active appearance model and deep learning for more accurate prostate 
segmentation on MRI,” in Medical Imaging 2016: Image Processing, 2016, vol. 9784, p. 97842I. 
[216] I. Goodfellow, Y. Bengio, A. Courville, and Y. Bengio, Deep learning, vol. 1. MIT press 
Cambridge, 2016. 
[217] H. Greenspan, B. van Ginneken, and R. M. Summers, “Guest editorial deep learning in 
medical imaging: Overview and future promise of an exciting new technique,” IEEE Trans. Med. 
Imaging, vol. 35, no. 5, pp. 1153–1159, 2016. 
[218] G. Litjens et al., “A survey on deep learning in medical image analysis,” Med. Image Anal., 
vol. 42, pp. 60–88, 2017. 
[219] O. Ronneberger, P. Fischer, and T. Brox, “U-Net: Convolutional Networks for Biomedical 
Image Segmentation,” in Medical Image Computing and Computer-Assisted Intervention – 
MICCAI 2015, 2015, pp. 234–241. 
[220] A. Krizhevsky, I. Sutskever, and G. E. Hinton, “ImageNet Classification with Deep 
Convolutional Neural Networks,” in Advances in Neural Information Processing Systems 25, F. 
168 
Pereira, C. J. C. Burges, L. Bottou, and K. Q. Weinberger, Eds. Curran Associates, Inc., 2012, 
pp. 1097–1105. 
[221] Z. Zhang, P. Luo, C. C. Loy, and X. Tang, “Facial landmark detection by deep multi-task 
learning,” in European Conference on Computer Vision, 2014, pp. 94–108. 
[222] Y. Zheng, D. Liu, B. Georgescu, H. Nguyen, and D. Comaniciu, “3D deep learning for 
efficient and robust landmark detection in volumetric data,” in International Conference on 
Medical Image Computing and Computer-Assisted Intervention, 2015, pp. 565–572. 
[223] R. Ranjan, V. M. Patel, and R. Chellappa, “Hyperface: A deep multi-task learning 
framework for face detection, landmark localization, pose estimation, and gender recognition,” 
IEEE Trans. Pattern Anal. Mach. Intell., 2017. 
[224] M. Loper, N. Mahmood, J. Romero, G. Pons-Moll, and M. J. Black, “SMPL: A skinned 
multi-person linear model,” ACM Trans. Graph. TOG, vol. 34, no. 6, p. 248, 2015. 
[225] G. Pons-Moll, J. Romero, N. Mahmood, and M. J. Black, “Dyna: A model of dynamic 
human shape in motion,” ACM Trans. Graph. TOG, vol. 34, no. 4, p. 120, 2015. 
[226] F. Bogo, J. Romero, G. Pons-Moll, and M. J. Black, “Dynamic faust: Registering human 
bodies in motion,” in Proc. the Conference on Computer Vision and Pattern Recognition, 2017. 
[227] C. Lassner, J. Romero, M. Kiefel, F. Bogo, M. J. Black, and P. V. Gehler, “Unite the people: 
Closing the loop between 3d and 2d human representations,” in IEEE Conf. on Computer Vision 
and Pattern Recognition (CVPR), 2017. 
[228] F. Bogo, A. Kanazawa, C. Lassner, P. Gehler, J. Romero, and M. J. Black, “Keep it SMPL: 
Automatic Estimation of 3D Human Pose and Shape from a Single Image,” ArXiv160708128 
Cs, Jul. 2016. 
 
  
169 
Appendix: Code Availability 
Several software tools and analysis scripts were developed over the course of this dissertation. 
These pieces of code are maintained in secure repositories on the Shepherd Lab GitHub 
(https://github.com/shepherd-lab). A listing of relevant repositories is provided below. Please direct 
inquiries to Bennett Ng (bennett.ng@berkeley.edu) or John Shepherd (johnshep@hawaii.edu). 
 3c_dxa (https://github.com/shepherd-lab/3c_dxa) 
MATLAB program to extract quantitative 3-component bone, fat, and lean images from 
Hologic DXA scan files. Refer to section 4.1: High-resolution 3-component DXA image 
separation.  
 dxa_sam (https://github.com/shepherd-lab/dxa_sam)  
Statistical appearance model files for whole-body DXA scans to be used with am_tools and 
related software from Timothy F. Cootes (University of Manchester). Includes SAS and R 
code for analysis of statistical appearance models. Refer to section 4.2.2 Statistical 
Appearance Modeling. 
 shapeup (https://github.com/shepherd-lab/shapeup) 
Python scripts for processing 3D body shape meshes generated using Ganger template fitting 
software (Brett Allen and Brian Curless, University of Washington). Includes scripts for 
handling files and performing principal component analysis to generate shape models and 
synthesize predicted body meshes. Refer to 5.2: The Shape Up! Studies.  
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 4c_dxa_bia (https://github.com/shepherd-lab/4c_dxa_bia) 
Python and SAS analysis code for simplified 4-component body composition from DXA 
and BIA measurements. Refer to section 6.1: Validation of DXA + BIA for Clinical 4C 
Body Composition Assessment. 
 ultradxa (https://github.com/shepherd-lab/ultradxa) 
Development scripts to support the Ultra DXA project. This includes KScan3D scripts for 
acquiring and processing depth images from Kinect cameras, MATLAB and Python scripts 
to perform timing-based alignment, and analysis code for step phantom data. Refer to 
section 6.2: Ultra DXA + 3D Optical Imaging for True 3C and 4C Whole-Body Imaging.  
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